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Abstract
 
 Wittig rearrangements are useful carbon-carbon bond forming reactions that 
have been prominently featured in a number of total syntheses, however narrow 
functional group tolerance and issues with competing reaction pathways have limited 
the utility of these transformations. Consequently, recent innovations focus on improving 
functional group tolerance and selectivity. The Wolfe group has reported a tandem 
Wittig rearrangement/aldol reaction of O-allyl or O-benzyl glycolate esters to generate 
enantioenriched α-alkyl-α,β-dihydroxy esters and α-alkyl-α-hydroxy-β-amino esters 
under mild Lewis acid conditions with excellent stereoselectivity. The work herein 
describes recent advances in the application of this Wittig rearrangement methodology 
for the synthesis of 3-hydroxy-2-furanones, N-aryl phenylalanine and allylglycine methyl 
esters, and α-alkyl-α,β-dihydroxy esters. 
 Under strongly basic conditions, O-propargyl ethers are capable of undergoing 
[2,3] Wittig rearrangements to afford structurally rearranged allenic alcohols. However, 
O-propargyl glycolate methyl esters, when subjected to dibutylboron triflate and Hunig’s 
base, were observed to undergo a [2,3] Wittig rearrangement and subsequent alkylative 
cyclization sequence resulting in 3-hydroxy-2-furanone derivatives that have 
incorporated an alkyl group from the boron reagent. This unusual reaction sequence is 
explored in Chapter 2. Nitrogen analogs of Wittig rearrangements are investigated in 
Chapter 3. These aza-Wittig rearrangements of tertiary amines are less common and 
typically less facile than rearrangements of the corresponding ethers. Rearrangements 
of N-benzyl and N-allyl glycine methyl esters required higher temperatures and N-aryl 
protecting groups in order to undergo the desired [1,2] and [2,3] rearrangements. When 
N-carbonyl protecting groups were used, 1,4,2-oxazaborole derivatives were formed 
instead of the expected secondary amines. Additionally, N-allyl N-aryl glycine methyl 
esters in the presence of excess dibutylboron triflate undergo the [2,3] rearrangement 
as well as a hydroboration reaction to generate secondary amines bearing pendant 
	   xi	  
primary alcohols. The final chapter describes an asymmetric tandem Wittig 
rearrangement/aldol reaction of O-benzyl and O-allyl glycolate esters coupled with 
ketone electrophiles. With the use of the trans-2-phenylcyclohexyl chiral auxiliary, these 
reactions generate α,β-dihydroxy esters bearing vicinal quaternary stereocenters with 
excellent enantio- and diastereoselectivity. 	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Chapter 1 
The Wittig Rearrangement 	  
1.1 Background and Significance 
The Wittig rearrangement is a powerful and well-known method of carbon-carbon 
bond formation. The [1,2] rearrangement of a metallated benzylic ether into an α-benzyl 
alcohol was first observed in 1924,1 though extensive work by Wittig led to significant 
improvement in understanding this transformation.2 Wittig rearrangements are classified 
using a notation system in which the atoms are numbered in both directions starting at 
the bond that is breaking. The type of rearrangement is titled numerically according to 
the numbers assigned to the atoms forming the new bond. [1,2] and [2,3] 
rearrangements are most common, although [1,4] and [3,4] rearrangements are also 
known. 
 
Scheme 1.1 [1,2] and [2,3] Wittig Rearrangements 
 
  
Typically, both [1,2] and [2,3] Wittig rearrangements require strongly basic 
conditions. Several studies have determined that base-mediated [1,2] Wittig 
rearrangements proceed through a radical pathway via metallation, homolytic cleavage, 
and recombination (Scheme 1.1a). As such, the yield of this [1,2] shift is highly 
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dependent on the radical stability of the migrating group. [2,3] rearrangements, 
however, proceed through a thermally allowed sigmatropic rearrangement pathway via 
a highly ordered 5-membered cyclic transition state (Scheme 1.1b). 
Despite the incredible potential of Wittig rearrangements in organic synthesis, the 
utility of these transformations is limited for a number of reasons. In order to initiate the 
reaction, a strong base, typically n-BuLi, is required. These harsh conditions severely 
limit the classes of compounds able to employ this method. Additionally, these reactions 
display insufficient chemoselectivity, as deprotonation can occur on either side of the 
oxygen atom, or at any other acidic site on the substrate. This issue is commonly 
remedied by incorporating an anion-stabilizing group on the appropriate side of the 
oxygen atom in order to favor the desired deprotonation. Due to the nature of radical 
intermediates in the [1,2] mechanistic pathway, the transformations suffer from low 
stereoselectivity. Furthermore, these rearrangements can proceed in low yield, due to 
competing processes, such as E2 elimination or radical rearrangement. 
A number of modern variants of Wittig rearrangements have been developed. 
These new methods aim to circumvent the practical limitations of the transformation 
with the use of milder conditions in order to increase the functional group tolerance. 
Additionally, the reaction conditions have been applied to several other types of 
substrates in addition to the relatively common O-allyl and O-benzyl ethers. The 
following chapter will describe a number of Wittig rearrangement variations as well as 
recent advances in tandem Wittig reactions. 
 
1.2 Wittig Rearrangements of Propargyl Ethers 
 In Wittig rearrangements, propargyl substituents are commonly utilized as anion 
stabilizing groups, for example in the rearrangement of allyl propargyl ether 1-13 
(Scheme 1.2a). However, propargyl groups can also function as the migrating fragment 
in a [2,3] Wittig rearrangement resulting in allenic alcohols. In arylmethyl propargyl4 or 
bis-propargyl5 ethers, selective deprotonation can be achieved under certain conditions 
(Scheme 1.2b), though competing [1,2] and [2,3] rearrangement pathways can be 
problematic.  
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Scheme 1.2 Propargyl Substituents as Anion Stabilizing Groups (a) or Migrating 
Groups (b) in Wittig Rearrangements 
 
 
By comparison, Wittig rearrangements of O-propargyl glycolic acid derivatives 
are easier to control, as enolate formation is much more favorable than deprotonation at 
the propargylic position. Enolate Wittig rearrangements will be discussed in detail in 
section 1.4. 
 Under basic conditions, these O-propargyl ethers typically undergo [2,3] Wittig 
rearrangements to afford allenic alcohols. Alkyl substitution at the propargylic position is 
tolerated, as these substrates generate allenic alcohols in high yield and 
diastereoselectivity.6 Rearrangements of these nonracemic propargyl ethers occur with 
high stereoselectivity, due to the rigidity of the proposed five-centered transition state 
(Scheme 1.3). 
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Scheme 1.3 Proposed Transition State for Propargyl [2,3] Wittig Rearrangement 
 
 
1.3 The Aza-Wittig Rearrangement 
 Analogous to the Wittig Rearrangement, the aza-Wittig rearrangement is the 
conversion of an α-metallated tertiary amine to a structurally rearranged secondary 
amine. The mechanisms of these transformations are believed to parallel to those of the 
oxygen analog, that is, a [1,2] radical mediated pathway and a [2,3] sigmatropic 
rearrangement. Aza-Wittig rearrangements are less prevalent than Wittig 
rearrangements of metallated ethers, though the transformation provides a useful 
synthetic tool for the formation of homoallylic and phenethyl secondary amines. 
The driving force of the Wittig rearrangement is the transfer of electron density 
from the metallated carbanion to the more electronegative oxygen atom. The difference 
in electronegativity between oxygen and nitrogen atoms makes the aza-Wittig 
rearrangement slightly less favorable than the corresponding Wittig rearrangement. 
Consequently, aza-Wittig rearrangements by comparison are typically slower and less 
facile. Initial reports of aza-Wittig rearrangements required extremely harsh conditions; 
for example, in a 1960 report by Johnstone and Stevens, an aza-Wittig rearrangement 
is induced by treatmenting tertiary benzylic amines with potassium hydroxide or 
methyllithium at 110–300 ºC for 0.5–3 hr.7 As such, acyclic aza-Wittig rearrangements 
were initially scarce. Instead, many studies were focused on small-ring assisted 
rearrangements. Aza-Wittig rearrangements of vinyl aziridines, for example, are high 
yielding even at low temperature due to the relief of ring strain.8,9 An aza-[2,3]-Wittig 
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rearrangement of a vinyl aziridine 1-10 was a key step in the enantioselective total 
synthesis of (–)-indolizines 209B and 209D (Scheme 1.4).10 
 
Scheme 1.4 Small-ring Assisted Aza-[2,3]-Wittig Rearrangement 
 
 
The first example of acyclic aza-[2,3]-Wittig rearrangements in synthetically 
useful yields was reported by Anderson in 1995.11 Though yields are good, 
diastereoselectivity is modest (Scheme 1.5). Aza-[2,3]-rearrangements are believed to 
proceed through a five-membered envelope-like cyclic transition state. Therefore, the 
diastereoselectivity is determined by the relative energy difference between the two 
transition state configurations. Excellent stereoselectivity can be obtained, though the 
results are highly substrate-dependent. 
 
Scheme 1.5 First Acyclic Aza-[2,3]-Rearrnangement 
 
 
Though aza-[2,3]-Wittig rearrangements are not uncommon, reports of aza-[1,2]-
Wittig rearrangements are relatively rare.  Most frequently, these transformations are 
observed as side products from competing [1,2] vs [2,3] reaction pathways.12,13 An aza-
[1,2]-Wittig rearrangement in synthetically useful yield has only been reported on a 
single occasion.14 This rearrangement occurred unexpectedly in the synthesis of 
polysubstituted piperidines via radical cyclization. [1,2] Wittig rearrangement was 
observed in substrates bearing an N-benzyl group. The authors hypothesize that two 
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equivalents of SmI2 generate the α-amino carbanion, which undergoes a [1,2] benzyl 
shift, resulting in the observed product (Scheme 1.6). 
 
Scheme 1.6 Aza-[1,2]-Wittig Rearrangement 
 
 
1.4 Enolate Wittig Rearrangement 
Wittig rearrangements require the formation of an α-alkoxy anion. In order to 
facilitate this deprotonation/metallation, an anion-stabilizing group, such as an aryl, 
alkenyl, or alkynyl group, is required. One variant of this transformation involves the use 
of an electron-withdrawing group such an acid, ester, or amide moiety, which can 
stabilize the anion through the formation of a metallated enolate. Due to the relative 
acidity of these α-protons, enolate Wittig rearrangements can occur under significantly 
milder conditions, such that the typical strong bases, e.g. nBuLi or LDA, are not 
required.  
The reactivity and diastereoselectivity of enolate rearrangements differs slightly 
depending on the variety of metal enolate in question. Though lithium enolates are most 
common, several enolate rearrangements have been reported with the use of tin, 
titanium, boron, and zirconium reagents, often in higher yield and diastereoselectivity 
when compared to the corresponding lithium enolate.15  
Enolate [1,2] Wittig rearrangements are rare, and there are currently no 
examples of [1,2] Wittig rearrangements of boron enolates with the exception of those 
published by the Wolfe group. Enolate [2,3] rearrangements, however, are more 
prevalent, and the rearrangements of boron enolates in particular have been studied in 
detail.16  It was found that Bu2BOTf and iPr2NEt promote [2,3] Wittig rearrangement in 
moderate yield and diastereoselectivity. In a representative example, 1-18 underwent 
rearrangement in 55% yield and 4:1 dr (Scheme 1.7). 
NR1
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THF HMPA NR1
R2
NR1
R2
+
HN
R2R1
N
N
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Scheme 1.7 [2,3] Wittig Rearrangement of a Boron Enolate 
 
 
Enolate [2,3] Wittig rearrangements appear to bypass the issue of competitive 
[1,2] Wittig rearrangement pathways, consistently providing the [2,3] product 
exclusively.17 However, these enolate rearrangements can suffer from competitive 
sigmatropic rearrangements: [2,3] Wittig vs [3,3] Claisen rearrangements (Scheme 
1.8).18,19 Through several studies, it has been determined that metal enolates of esters 
or amides preferentially under go a [2,3] Wittig rearrangement, whereas metal enolates 
of ketones provide mixtures of [2,3] and [3,3] products.16,20 21 
 
Scheme 1.8 [2,3] vs [3,3] Sigmatropic Rearrangements of Allylic Glycolate Esters 
 
 
Additionally, asymmetric variants of [2,3] Wittig rearrangements have been 
developed.22 Specifically, asymmetric Wittig rearrangements of boron enolates have 
been explored with the use of chiral auxiliaries23 or chiral boron reagents. Nakai 
successfully utilized the chiral bis-sulfonamide boron reagent 1-27 for an asymmetric 
Wittig rearrangement. In a representative example, 1-24 performed [2,3] rearrangement 
in 57% yield, and though diastereoselectivity was modest, the major diastereomer was 
generated in 90% ee (Scheme 1.9).24  
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Scheme 1.9 Asymmetric Wittig Rearrangements of Boron Enolates 
 
 
1.5 Tandem Wittig Rearrangement/Aldol Reactions 
In the course of study towards anisomycin, Wolfe and Bertrand discovered an 
unusual tandem Wittig rearrangement/aldol reaction.25 In the presence of dibutylboron 
triflate and triethylamine, O-benzyl glycolate esters undergo an enolate [1,2] Wittig 
rearrangement, followed by a subsequent aldol reaction with the addition of an aldehyde 
(Scheme 1.10). 
 
Scheme 1.10 Unexpected Tandem Wittig/Aldol Reaction 
 
 
Further experimentation revealed that the transformation was both general and 
highly stereoselective for the syn-diol. Under the described reaction conditions, O-
benzyl and O-allyl glycolate methyl esters undergo the tandem rearrangement/aldol 
reaction with a variety of alkyl, alkenyl, and aryl aldehyde coupling partners (Table 1.1).  
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Table 1.1 Representative Wittig/aldol productsa 
 
Entry R1 R2 Yield,b drc 
1 Bn CHCH2 67%, >20:1 
2 Bn Ph 72%, >20:1 
3 Bn C9H19 78%, >20:1 
4 Allyl iPr 66%, >20:1d 
5 Allyl Ph 75%, >20:1 
aConditions: 1.0 equiv of ester, 3.2 equiv of Bu2BOTf, 4.0 equiv of Et3N, CH2Cl2, 0.2 M, rt, 
15 min, then add 1.5 equiv of aldehyde, 0 °C to rt. bYields represent average isolated 
yields of two or more experiments. bDiastereomeric ratio obtained upon purification. In 
most cases, the crude product was obtained in >20:1 dr prior to purification. dThe crude 
product was obtained in 20:1 dr. 
 
The reactions are high yielding and generate syn-diol products with excellent 
stereoselectivity. It was determined that the Wittig rearrangement occurs first in the 
tandem sequence. When aldehyde is excluded from the reaction conditions, an 
aqueous workup generates the Wittig product in 81% yield. Thus, the proposed 
mechanism involves an initial enolate Wittig rearrangement, followed by formation of a 
second boron enolate, which undergoes the subsequent aldol reaction (Scheme 1.11). 
The high syn-stereoselectivity of the diol product is likely due to the selective formation 
of the E(O)-enolate 1-34, due to chelation between the ester carbonyl and the boron 
alkoxide. 
 
Scheme 1.11 Proposed Mechanism for Tandem Wittig Rearrangement/aldol Reaction 
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Next, asymmetric variants of this reaction were explored.26 Several chiral 
auxiliaries were examined, and optimal results were obtained with the use of trans-2-
phenylcyclohexanol. This chiral auxiliary is commercially available, though large 
quantities of the enantioenriched auxiliary can be prepared easily in two steps from 
cyclohexene oxide.27 Furthermore, the 2-phenylcyclohexanol can be removed from the 
diol product via two methods: reduction using lithium aluminum hydride or a two-step 
sequence of acetonide formation followed by hydrolysis. When the O-benzyl glycolate 
ester bearing this chiral auxiliary was subjected to the reaction conditions previously 
employed, the diol product was obtained in 83% yield and >20:1 dr. LiAlH4 reduction of 
this product generated the enantioenriched triol in 59% yield and 89% ee. With these 
promising results, the scope of this transformation was explored. 
 As previously observed, both O-benzyl and O-allyl glycolate esters underwent 
the tandem Wittig rearrangement/aldol reaction in good yield and excellent selectivity. 
With the use of alkyl, alkenyl, or aryl aldehyde coupling partners, diol products were 
generated with a high syn-selectivity. After reduction of the auxiliary, enatioenriched 
triols were afforded in 75–95% ee (Table 1.2, Entries 1–4). 
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Table 1.2 Asymmetric Tandem Wittig/Aldol and Wittig/Mannich Reactionsa 
 
Entry R1 R2 Y Yield,b drc 
ee after LAH 
reductiond 
1 Bn Ph O 83%, 20:1 89% 
2 Bn Cy O 71%, 20:1 91% 
3 Allyl Ph O 83%, 20:1 90% 
4 Allyl iPr O 68%, 20:1 89% 
5 Bn Ph NBn 71%, >20:1 96% 
6 Bn 2-furyl NBn 70%, 20:1 90% 
7 Allyl p-F-Ph NBn 69%, >20:1 94% 
aConditions: 1.0 equiv 1-36 or 1-37, 1.5–2 equiv aldehyde or imine, 3.2 equiv Bu2BOTf, 4 
equiv Et3N (R1 = Bn) or i-Pr2NEt (R1 = allyl), CH2Cl2, 0°C → rt → 0°C. bIsolated yield 
(average of two or more experiments). cRatios were determined by 1H NMR analysis. All 
products were obtained with >20:1 syn:anti selectivity. dEnantiomeric excess was 
determined by chiral HPLC or Mosher ester analysis after reduction to the corresponding 
triol with LiAlH4. 
 
This tandem Wittig/aldol methodology was utilized in the synthesis of 1-39, a key 
intermediate in the synthesis of the antifungal agent alternaric acid.28 This intermediate 
1-39 had previously been generated via a seven-step sequence in Trost’s total 
synthesis.29 However, the aforementioned tandem Wittig rearrangement/aldol sequence 
allowed this intermediate to be prepared in just three steps. The key Wittig/aldol step 
afforded 1-39 in 80% yield and >20:1 dr (Scheme 1.12). 
 
Scheme 1.12 Key Step in the Synthesis of Alternaric Acid 
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enantioenriched α-hydroxy-β-amino acids from O-benzyl and O-allyl glycolate esters. A 
number of protecting groups were examined for the aldimine coupling partner. 
Expectedly, the nature of the protecting group had a significant impact on the outcome 
of the reaction. Imines bearing electron-withdrawing groups such as tosyl groups failed 
to undergo the reaction. The best results were obtained with the use of an aldimine 
bearing a benzyl protecting group. A number of benzyl protected aryl aldimines were 
successfully coupled with 1-36 and 1-37 in good yield and at least 20:1 dr, though 
unbranched alkyl imines failed to undergo the Mannich reaction. After cleavage of the 
chiral auxiliary, the desired α-hydroxy-β-amino acids were obtained in 93–96% ee 
(Table 1.2, Entries 5–8).  
 
Scheme 1.13 Representative Examples Wittig/Mannich Reactions of N-Boc 
Electrophiles 
 
 
Though imines bearing other electron-poor protecting groups were unsuccessful 
coupling partners for these reactions, N-Boc imine electrophiles were used successfully 
to perform the desired Wittig/Mannich reaction. However, isoxazolidin-2-one 1-41 was 
formed rather than the expected amino alcohol (Scheme 1.13a). Furthermore, reactions 
with N-Boc-2-(phenylsulfonyl)amine electrophiles proceeded in excellent yield, though, 
interestingly, with high anti-stereoselectivity (Scheme 1.13b). 
The mechanism of these transformations likely begins with an enolate Wittig 
rearrangement followed by the generation of a second boron enolate. The 
stereoselectivity of the Mannich reaction is dependent on the electrophile being utilized. 
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Mannich reactions with N-benzyl or N-Boc imines proceed through a boat-like six-
membered cyclic transition state, yielding products with high syn-selectivity, whereas 
Mannich reactions with N-Boc-2-(phenylsulfonyl)amine electrophiles proceed through 
an open transition state, yielding products with high anti-selectivity. 
 
1.6 Aldol Reactions with Ketone Electrophiles 
 Given the success of these tandem Wittig/aldol and Wittig/Mannich reactions, we 
hoped to further develop the scope of these transformations. We envisioned a tandem 
Wittig/aldol reaction between 1-36 or 1-37 and a ketone electrophile, which could 
potentially generate vicinal quaternary stereocenters rapidly and selectively, as depicted 
in Scheme 1.14. 
 
Scheme 1.14 Generation of Vicinal Quaternary Stereocenters via Tandem Wittig/Aldol 
Reactions 
 
 
 While aldol reactions between ketone enolates and aldehyde electrophiles are 
ubiquitous, there are a number of inherent difficulties when attempting to employ ketone 
electrophiles in these reactions. Relative to aldehydes, ketones are less electrophilic, 
leading to low conversion to the tertiary alcohol product. Furthermore, the retro-aldol 
reaction of this transformation is rapid. Additionally, the lack of steric and electronic 
differences between the ketone substituents generally leads to low stereo-
discrimination.31,32 Therefore, the scope of these reactions is extremely narrow and the 
practical applications are limited. 
 Despite these challenges, a variety of conditions have been developed for aldol 
reactions with ketone coupling partners. In order to circumvent the aforementioned 
complications, a number of adaptations have been adopted. Frequently, Mukaiyama 
aldol conditions are used, as pre-formed silyl enol ethers permit milder conditions and 
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reduce the risk of self-coupling of the ketone components.33 These pre-formed 
nucleophiles are effectively paired with Lewis acids or Lewis bases in aldol reactions 
with ketone acceptors.34-37 Denmark developed an enantioselective aldol reaction with 
ketones utilizing chiral Lewis base catalysts. A number of ketone electrophiles were 
successfully coupled, though the nucleophilic partner is limited to the highly reactive 
trichlorosilyl enolate of methyl acetate (Table 1.3).  
 
Table 1.3 Denmark’s Catalytic, Enantioselective Aldol Addition to Ketones 
 
Entry R1 R2 Promoter Yield er 
1 Ph Et 1-44 92% - 
2   1-45 90% 90:10 
3 Me (CH2)2Ph 1-44 94% - 
4   1-45 91% 66:33 
 
However, the poor atom economy of these reactions has led to the development 
of reductive aldol reactions of copper enolates, which do not require pre-generation of 
the enolate (Scheme 1.15).38,39 
 
Scheme 1.15 Enantioselective Reductive Aldol Reactions with Ketone Electrophiles 
 
  
Initial experiments exploring our tandem Wittig/aldol reaction were conducted 
with 1-46 and 1-47 and a variety of methyl ketones.40 Rather than the anticipated diols, 
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be excellent coupling partners, affording boronate esters in high yield and selectivity 
(Table 1.4, entry 4). However, reactions with di-aliphatic ketones proceed with low 
stereoselectivity due to the lack of steric differentiation between the two similarly sized 
substituents (Table 1.4, entries 1–3). 
 
Table 1.4 Tandem Wittig/Aldol Reactions with Ketones 
 
 
Entry R1 R2 Yield 
dr 
(2S,3S):(2S,3R) 
ee after LAH 
reduction 
1 Bn (CH2)2Ph 74% 4:1 96% 
2 Bn C3H7 67% 3:1 93% 
3 Allyl  55% 7:1 79% 
4 Bn p-F-Ph 56% 20:1 91% 
aConditions: 1.0 equiv ester, 1.5 equiv ketone, 3.2 equiv Bu2BOTf, 4.0 equiv base, 
CH2Cl2, 0 °C → rt →0 °C → rt. bIsolated yield (average of two or more experiments). 
cDiastereomeric ratio of isolated material (determined by 1H NMR analysis). The dr value 
of the crude product could not be determined due to signal overlap with boron-containing 
by-products. dThe enantiomeric excess was determined by Mosher ester analysis after 
reduction to the diol. 
  
By resubjecting the boronate ester to hydrogen peroxide, the diol can be freed 
(Scheme 1.16). Enantiopurity of the products was determined via Mosher ester analysis 
of the triol resulting from boronate ester cleavage and LiAlH4 reduction. 
 
Scheme 1.16 Boronate Ester Cleavage 
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examination of these tandem Wittig/aldol reaction with ketone coupling partners will be 
elaborated in Chapter 4. 
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Chapter 2
Synthesis of Substituted 3-Hydroxy-2-Furanone Derivatives via an Unusual 
Enolate Wittig Rearrangement/Alkylative Cyclization Sequence. 
 
2.1 Introduction 
In recent years our group has explored the development and applications of 
boron-mediated cascade Wittig rearrangement/aldol reactions of glycolate ester 
derivatives 2-1 for the stereoselective construction of α-alkyl-α,β-dihydroxy esters 2-2 
(Scheme 2.1).1-3 These reactions proceed with excellent diastereoselectivity, and use of 
the readily available chiral auxiliary trans-2-phenylcyclohexanol provides access to 
enantiomerically enriched products with up to 94% ee after auxiliary cleavage. Although 
these reactions have demonstrated synthetic utility, the scope of this method is currently 
limited to substrates bearing O-allyl or O-benzyl migrating groups. Substrates that 
contain simple O-alkyl or O-aryl groups fail to undergo the initial Wittig rearrangement. 
 
Scheme 2.1 Boron-mediated Tandem Wittig Rearrangment/aldol Reaction 
 
 
2.2 Preliminary Results 
In order to further expand the scope of this method, we sought to employ 
substrates bearing O-propargyl groups. Related substrates are known to undergo 2,3-
Wittig rearrangement when treated with a strong base,4-6 and the resulting products 2-2 
where R is an allenyl group could be valuable intermediates for the construction of 
substituted heterocycles.7,8 To this end we prepared ester substrate 2-3 and subjected 
this compound to our standard reaction conditions whereby the ester was treated with 
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Bu2BOTf and iPr2NEt, stirred at rt for ca 15 min, and then an aldehyde was added to the 
resulting mixture. We were quite surprised to discover that 2-3 failed to undergo the 
sequential rearrangement/aldol reaction, and instead was transformed to the substituted 
3-hydroxy-2-furanone 2-4 (Scheme 2.2). Interestingly, although the aldehyde 
electrophile apparently did not participate in the reaction, a butyl group from the 
Bu2BOTf reagent was incorporated at the product C5 position. Omission of the 
aldehyde from the reaction mixture led to the formation of 2-4 in 62% yield. 
 
Scheme 2.2 Unexpected 3-hydroxy-2-furanone Formation 
 
 
2.3 Synthesis of 3-Hydroxy-2-Furanones 
Given the potential synthetic utility and biological relevance of substituted 
furanone derivatives,9-11 we sought to further examine this unusual transformation. 
Efforts to optimize reaction conditions by modifying temperature, solvent, base, etc. did 
not lead to significant improvements in yield. As such, we proceeded to explore the 
effect of substrate structure on reactivity. As shown in Table 2.1, the best results were 
obtained with substrates bearing aryl groups on the alkyne moiety (entries 1–4 and 8). 
These substrates were converted to substituted furanones in moderate yield. In 
contrast, substrates that contain alkyl-substituted alkynes were transformed in low 
yields (entries 5–7).12 
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Table 2.1 Tandem Wittig Rearrangement/Alkylative Cyclization Reactionsa 
 
Entry R R1 Product Yieldb 
1 Bu Ph (2-3) 2-4 62% 
2 Bu p-F-C6H4 (2-5) 2-6 47% 
3 Bu 2-naphthyl (2-7) 2-8 56% 
4 Bu p-Me-C6H4 (2-9) 2-10 43% 
5 Bu Ph(CH2)2 (2-11) 2-12 29% 
6 Bu iPr (2-13) 2-14 23% 
7 Bu Me (2-15) 2-16 20% 
8 Et Ph (2-3) 2-17 50% 
aConditions: i) 1.0 equiv ester, 3.2 equiv R2BOTf, 4.0 equiv iPr2NEt, CH2Cl2, 0.25 M, 0 °C 
→ rt. ii) H2O2, pH 7 buffer. b Isolated yields (average of two experiments). 
 
Attempts to employ substrate 2-18 bearing an ethyl group at the propargylic 
position led to formation of allene 2-19 in 52% yield; no furanone product was observed 
(Scheme 2.3). The rearrangement/cyclization reactions appear to be limited to internal 
alkyne substrates, as subjection of terminal alkyne substrate 2-20 to the standard 
reaction conditions resulted in generation of substituted allylic alcohol 2-21 in low yield 
rather than a substituted furanone (Scheme 2.4).13 
 
Scheme 2.3 Allene Formation 
 
 
Scheme 2.4 Attempted Rearrangement of Terminal Alkyne 
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2.4 Effect of Boron Reagent 
We also briefly examined the influence of the dialkylboron reagent structure on 
reactivity. As anticipated, use of diethylboron triflate resulted in the formation of 
furanone product 2-17 in which an ethyl group had been incorporated at C5 (Table 2.1, 
entry 8). However, use of the hindered and less electrophilic Cy2BCl reagent led to no 
observable reaction. Interestingly, treatment of 2-3 with 9-BBN-OTf/iPr2NEt led to clean 
formation of allene 2-22 in 53% yield (Scheme 2.5). 
 
Scheme 2.5 Rearrangement using of 9-BBNOTf 
 
 
During the course of our initial optimization studies, we examined an alternative 
workup procedure in which the reaction of substrate 2-3 with Bu2BOTf/iPr2NEt was 
quenched with aqueous HCl rather than treated with H2O2 and pH 7 buffer. Interestingly, 
use of this acidic workup led to the formation of 2-23 (39% yield) (Scheme 2.6); the 
furanone product was not observed by NMR analysis of the crude reaction mixture. 
 
Scheme 2.6 Alternative Acidic Workup Procedure 
 
 
2.5 Mechanistic Studies 
Taken together, the results illustrated in equations 3–6 provide a considerable 
amount of information about the likely mechanism of the rearrangement/cyclization 
reactions. The conversion of 2-20 to 2-21, 2-3 to 2-22, and 2-3 to 2-23 suggest the 
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mechanism of this unusual rearrangement/alkylation involves initial [2,3]-Wittig 
rearrangement of the substrate to generate an intermediate allene.14 A subsequent alkyl 
transfer from the boron reagent to the allene leads to carbon–carbon bond formation, 
and likely proceeds via a radical pathway that is presumably initiated by small amounts 
of oxygen.15-19,20 Finally, the fact that the modified (acidic) workup generates 2-23 rather 
than 2-31 suggests that α-ketoester 2-23 may be an intermediate in the 
alkylation/cyclization reactions, and that conversion of 2-29 to 2-31 may occur during 
the H2O2/ pH 7 buffer workup step.  
 
Scheme 2.7 Radical Cage Mechanism for Conversion of 4-24 to 4-31 
 
 
On the basis of these results, two plausible mechanisms for the conversion of 2-3 
to 2-4 are illustrated in Schemes 2.7–2.8; the former involves a radical cage process 
whereas the latter proceeds via a radical chain mechanism. In both pathways treatment 
of ester 2-24 with the dialkylboron triflate and Hünig’s base leads to formation of boron 
enolate 2-25, which undergoes 2,3-Wittig rearrangement to afford allene 2-26. In the 
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2-27. An intramolecular 1,5-hydrogen atom transfer of 2-27 would then afford enolate 2-
28. Upon workup, protonation of the enolate would generate 2-29, which can then 
undergo conjugate addition of water or hydroxide to provide alcohol 2-30.21-24 
Intramolecular acylation of the alcohol then yields the product 2-31.25  
Alternatively, the radical reaction may also occur via a chain mechanism 
(Scheme 2.8) whereby oxygen could lead to generation of an alkyl radical from 2-26 in 
the initiation step. Propagation would then involve addition of the alkyl radical to a 
second molecule of 2-26 to yield 2-32, which could be captured by oxygen to afford 2-
33 along with another alkyl radical. Base-mediated elimination of 2-34 (or the analogous 
boronate ester derived from homolysis of the O–O bond and rearrangement) would 
provide 2-35, which upon workup could be transformed to 2-26 and then 2-31. 
 
Scheme 2.8 Radical Chain Mechanism 
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substituted allene intermediate. The reason behind the failed cyclization of terminal 
alkene substrate 2-20 is less clear. However, the radical intermediate generated from 
rearrangement and alkyl transfer of 2-20 (2-32, R1 = H) is considerably less stable than 
analogous intermediates derived from internal alkynes.  
In order to further probe the question of cage vs. chain mechanism, we carried 
out a crossover experiment in which the rearrangement of 2-3 was carried out in the 
presence of 3.2 equiv of Et3B (Scheme 2.9). This reaction provided a ca. 1:1 mixture of 
2-4 and 2-17, which indicates an intermolecular (i.e. non-cage) alkyl radical transfer to 
the allene is a viable mechanistic pathway and suggests that the mechanism illustrated 
in Scheme 2.8 may be operational (although this does not unambiguously rule out the 
radical cage mechanism shown in Scheme 2.7).26 
 
Scheme 2.9 Crossover Experiment 
 
 
2.6 Conclusion 
In conclusion, we have discovered an unusual Wittig rearrangement/alkylative 
cyclization reaction of methyl O-propargyl glycolate derivatives. The reactions produce 
potentially useful 3-hydroxy-furan-2-one products in moderate yield, and appear to 
proceed via radical alkylation of an intermediate allene. Future studies will be directed 
towards improving and expanding the scope of these transformations. 
 
The work described in this chapter was published in Organic Letters.27 
 
2.7 Experimental 
General: All reactions were carried out under a nitrogen atmosphere in flame-dried 
glassware. All reagents were obtained from commercial sources and were used as 
MeO
O
O
Ph
O
O
HO
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H3C Bu
1) Bu2BOTf, Et3B
   iPr2NEt, CH2Cl2, 
        0 °C → rt
2) H2O2, pH 7 buffer
+ O
O
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H3C Et29%, 1:1
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obtained unless otherwise noted. Dichloromethane, THF, and triethylamine were 
purified using a GlassContour solvent purification system. Hünig’s base was purified by 
distillation from CaH2 prior to use. Yields refer to isolated yields of compounds 
estimated to be ≥95% pure as determined by 
1
H NMR analysis unless otherwise noted. 
The yields reported in the supporting information describe the result of a single 
experiment, whereas yields reported in Table 2.1 and schemes 2.3–2.6 are average 
yields of two or more experiments. Thus, the yields reported in the supporting 
information may differ from those shown in Table 2.1 and schemes 2.3–2.6.  
 
Handling of Dialkylboron reagents: Dibutylboron triflate (1.0 M solution in methylene 
chloride) was obtained from Aldrich Chemical Co. and used as obtained. Diethylboron 
triflate was prepared according to Evans’ procedure.28 Due to the air and moisture 
sensitivity of these reagents, they must be stored and transferred under a rigorously 
maintained nitrogen atmosphere. 
 
Synthesis and Characterization of Substrates 
 
 
General Procedure 1: A flame-dried flask was cooled under a stream of nitrogen and 
charged with a solution of the alkyne substrate in THF (1.0 equiv, 0.8 M). The solution 
was cooled to –78 ºC and a solution of 1.6 M n-BuLi in hexanes (1.2 equiv) was added 
dropwise. The mixture was stirred at –78 ºC for 40 min before the aldehyde substrate 
(1.4 equiv) was added. The reaction mixture was warmed to rt over 16 hours and then 
quenched with saturated NH4Cl. The mixture was transferred to a separatory funnel and 
then extracted twice with Et2O. The combined organic layers were dried over anhydrous 
sodium sulfate then concentrated in vacuo. The crude product was purified by flash 
chromatography on silica gel using 20–40% ethyl acetate/hexanes as the eluent, unless 
stated otherwise. 
 
R HO
R1. nBuLi, THF
2. R1CHO R1
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4-Methylpent-2-yn-1-ol.29 General procedure 1 was used for the alkylation of 3-
methylbut-1-yne (1 g, 14.7 mmol) with paraformaldehyde (620 mg, 20.6 mmol) except 
the product was not purified by chromatography. This procedure afforded 1.2 g (83%) of 
the title compound as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 4.25 (dd, J = 2.0, 6.0 
Hz, 2 H), 2.56–2.63 (m, 1 H), 1.45–1.49 (m, 1 H), 1.17 (d, J = 6.8 Hz, 6 H). 
 
 
5-Phenylpent-2-yn-1-ol.30 General procedure 1 was used for the alkylation of but-3-yn-
1-ylbenzene (1 g, 7.68 mmol) with paraformaldehyde (323 mg, 10.8 mmol). This 
procedure afforded 1.22 g (99%) of the title compound as a colorless oil. 1H NMR (500 
MHz, CDCl3) δ 7.32 (t, J = 7.6 Hz, 2 H), 7.24 (d, J = 8.1 Hz, 3 H), 4.25 (dd, J = 2.2, 4.2 
Hz, 2 H), 2.85 (t, J = 7.6 Hz, 2 H), 2.53 (tt, J = 2.1, 7.6 Hz, 2 H), 1.47 (t, J = 6.1 Hz, 1 H). 
 
 
1-Phenylpent-1-yn-3-ol.31 General procedure 1 was used for the alkylation of 
phenylacetylene (2.0 g, 19.6 mmol) with propionaldehyde (1.97 mL, 27.4 mmol). This 
procedure afforded 2.33 g (74%) of the title compound as a colorless oil. 1H NMR (400 
MHz, CDCl3) δ 7.43–7.41 (m, 2 H), 7.30–7.29 (m, 3 H), 4.54 (q, J = 6.2 Hz, 1 H), 1.85–
1.78 (m, 3 H), 1.07 (t, J = 14 Hz, 3 H). 
 
 
3-(p-Tolyl)prop-2-yn-1-ol.32 General procedure 1 was used for the alkylation of 4-
ethynyltoluene (1.0 g, 8.58 mmol) with paraformaldehyde (361 mg, 12.0 mmol). This 
procedure afforded 1.21 g (97%) of the title compound as a colorless oil.  1H NMR (700 
MHz, CDCl3) δ 7.31 (d, J = 7.9 Hz, 2 H), 7.10 (d, J = 7.8 Hz, 2 H), 4.47 (d, J = 6.2 Hz, 2 
H), 2.33 (s, 3 H), 1.64 (m, br, J = 2.1, 6.0 Hz, 1 H). 
HO
HO
Ph
HO
Ph
HO
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General Procedure 2:  
(a) Sonogashira Coupling: A flame-dried Schlenk tube was cooled under a stream of 
nitrogen and charged with Pd(PPh)2Cl2 (1 mol%), CuI (1 mol%), and the appropriate 
aryl bromide (1.0 equiv). The tube was purged with nitrogen before triethylamine and 
(trimethylsilyl)acetylene were added via syringe. The resulting mixture was heated to 70 
ºC until the starting material had been consumed as judged by TLC analysis (ca. 14 h). 
After cooling the reaction to rt, the solution was filtered through celite, which was 
washed with Et2O until the washes appeared colorless. The filtrate was concentrated in 
vacuo to afford the crude product, which was purified by flash column chromatography 
on silica gel. 
(b) Desilylation and Alkylation: A flame-dried flask was cooled under a stream of 
nitrogen and charged with dry paraformaldehyde (3.0 equiv). The flask was purged with 
nitrogen and a 0.5 M solution of the aryl substrate (1.0 equiv) in THF was added. To this 
was added a 1.0 M solution of TBAF in THF (3.0 equiv.). The reaction was stirred at 40 
ºC until the starting material had been completely consumed, as judged by TLC analysis 
(ca. 20 h). The reaction was quenched with saturated NH4Cl, and the aqueous layer 
was extracted twice with EtOAc. The combined organic layers were washed with brine, 
dried over anhydrous sodium sulfate, and concentrated in vacuo. The crude product 
was purified by flash chromatography on silica gel using 20–40% ethyl acetate/hexanes 
as the eluent. 
 
 
3-(Naphthalen-2-yl)prop-2-yn-1-ol.33 General procedure 2(a) was used for the 
alkylation of 2-bromonaphthalene (1.04 g, 5.0 mmol) with (trimethylsilyl)acetylene (0.8 
Br
R
R
SiMe3
R
OH
TBAF, THF
1 mol% Pd(PPh3)2Cl2
1 mol% CuI
Et3N, SiMe3
H2CO
HO
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mL, 7.5 mmol). This procedure afforded 908 mg (81%) of trimethyl(naphthalen-2-
ylethynyl)silane as a pale orange solid with spectroscopic properties identical to those 
previously reported.34 1H NMR (500 MHz, CDCl3) δ 8.00 (s, 1 H), 7.75–7.81 (m, 3 H), 
7.47–7.51 (m, 3 H), 0.29 (s, 9 H). 
 
General procedure 2(b) was used for the alkylation of trimethyl(naphthalen-2-
ylethynyl)silane (1.0 g, 4.46 mmol) with paraformaldehyde (187 mg, 6.24 mmol). This 
procedure afforded 667 mg (82%) of the title compound as a white solid, mp 53–59 °C. 
1H NMR (500 MHz, CDCl3) δ 7.97 (s, 1 H), 7.82–7.72 (m, 3 H), 7.51–7.47 (m, 3 H), 4.55 
(d, J = 6.4 Hz, 2 H), 1.67 (t, J = 6.4 Hz, 1 H). 
 
 
3-(4-Fluorophenyl)prop-2-yn-1-ol. General procedure 2(a) was used for the alkylation 
of 1-bromo-4-fluorobenzene (1.5 g, 8.57 mmol) with (trimethylsilyl)acetylene (1.83 mL, 
12.9 mmol). This procedure afforded 1.24 g (75%) of [(4-
fluorophenyl)ethynyl]trimethylsilane as a pale orange oil with spectroscopic properties 
identical to those previously reported.35 1H NMR (500 MHz, CDCl3) δ 7.45 (dd, J = 3.2, 
8.6 Hz, 2 H), 6.99 (t, J = 8.6 Hz , 2 H), 0.24 (s, 9 H). 
 
General procedure 2(b) was used for the alkylation of [(4-
fluorophenyl)ethynyl]trimethylsilane (181 mg, 0.94 mmol) with paraformaldehyde (85 
mg, 2.82 mmol). This procedure afforded 116 mg (82%) of the title compound as a 
colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.41 (dd, J = 5.4, 8.8 Hz, 2 H), 7.00 (t, J = 8.7 
Hz, 2 H), 4.47 (d, J = 6.0 Hz, 2 H), 1.64 (t, J = 6.3 Hz, 1 H). 
 
 
General Procedure 3: A flame-dried flask was cooled under a stream of nitrogen and 
charged with 60% NaH in mineral oil (1.2 equiv), which was then suspended in THF and 
HO
F
MeO
O
Br
HO
R
MeO
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R
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cooled to 0 ºC. A solution of the alcohol substrate (1.0 equiv) in THF was added 
dropwise, and the mixture was stirred at rt for 30 min. The reaction solution was again 
cooled to 0 ºC and neat methyl 2-bromoacetate (1.0 equiv) was added.  The resulting 
mixture was stirred at rt overnight (ca. 16 h). Water was then added, and the aqueous 
layer was extracted twice with EtOAc. The combined organic layers were washed with 
brine, dried over anhydrous sodium sulfate, and concentrated in vacuo. The crude 
product was purified by flash chromatography on silica gel using 5–20% ethyl 
acetate/hexanes as the eluent. 
 
 
Methyl-2-[(3-phenylprop-2-yn-1-yl)oxy]acetate (2-3). General procedure 3 was 
employed for the alkylation of 3-phenylprop-2-yn-1-ol (2 g, 15.1 mmol) with methyl 2-
bromoacetate (1.44 mL, 15.1 mmol). This procedure afforded 1.94 g (63%) of the title 
compound as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.44 (dd, J = 1.2, 8.3 Hz, 2 
H), 7.32 (t, J = 6.6 Hz, 3 H), 4.53 (s, 2 H), 4.28 (s, 2 H), 3.78 (s, 3 H); 13C NMR (125 
MHz, CDCl3) δ 170.4, 131.8, 128.7, 128.3, 122.3, 87.4, 83.7, 66.2, 59.1, 52.0; IR (film) 
1754, 1213, 1119 cm–1. MS (ESI) 227.0676 (227.0679 calcd for C12H12O3, M + Na+). 
 
 
Methyl 2-{[3-(4-fluorophenyl)prop-2-yn-1-yl]oxy}acetate (2-5). General procedure 3 
was employed for the alkylation of 3-(4-fluorophenyl)prop-2-yn-1-ol (819 mg, 5.64 
mmol) with methyl 2-bromoacetate (0.52 mL, 5.64 mmol). This procedure afforded 615 
mg (51%) of the title compound as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.42 
(dd, J = 5.4, 9.1 Hz, 2 H), 7.01 (t, J = 8.8 Hz, 2 H), 4.51 (s, 2 H), 4.26 (s, 2 H), 3.78 (s, 3 
H); 13C NMR (125 MHz, CDCl3) δ 170.4, 162.7 (d, J = 249.9 Hz), 133.8 (d, J = 8.6 Hz), 
118.3, 115.6 (d, J = 22.9 Hz), 86.3, 83.4, 66.3, 59.1, 52.0; IR (film) 1755, 1220, 1120 
cm–1. MS (ESI) 245.0587 (245.0584 calcd for C12H11FO3, M + Na+). 
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Methyl 2-{[3-(naphthalen-2-yl)prop-2-yn-1-yl]oxy}acetate (2-7). General procedure 3 
was employed for the alkylation of 3-(naphthalen-2-yl)prop-2-yn-1-ol (195 mg, 1.07 
mmol) with methyl 2-bromoacetate (0.10 mL, 1.07 mmol). This procedure afforded 175 
mg (64%) of the title compound as a pale yellow solid, mp 46–50 °C. 1H NMR (500 
MHz, CDCl3) δ 7.98 (s, 1 H), 7.82–7.77 (m, 3 H), 7.51–7.47 (m, 3 H), 4.59 (s, 2 H), 4.32 
(s, 2 H), 3.79 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ 170.4, 132.9, 132.8, 131.9, 128.3, 
128.0, 127.8, 127.7, 126.9, 126.6, 119.5, 87.7, 84.0, 66.3, 59.2, 52.0; IR (film) 1754, 
1213, 1118 cm–1. MS (EI) 254.2 (254.09 calcd for C16H14O3, M +). 
 
 
Methyl 2-{[3-(p-tolyl)prop-2-yn-1-yl]oxy}acetate (2-9). General procedure 3 was 
employed for the alkylation of 3-(p-tolyl)prop-2-yn-1-ol (1.25 g, 8.58 mmol) with methyl 
2-bromoacetate (0.81 mL, 8.58 mmol). This procedure afforded 835 mg (45%) of the 
title compound as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.33 (d, J = 8.3 Hz, 2 H), 
7.12 (d, J = 8.3 Hz, 2 H), 4.52 (s, 2 H), 4.27 (s, 2 H), 3.78 (s, 3 H), 2.35 (s, 3 H); 13C 
NMR (125 MHz, CDCl3) δ 170.5, 138.8, 131.7, 129.1, 119.2, 87.5, 83.0, 66.2, 59.2, 
51.9, 21.5; IR (film) 1755, 1213, 1120 cm–1. MS (ESI) 241.0837 (241.0835 calcd for 
C13H14O3, M + Na+). 
 
 
Methyl-2-[(5-phenylpent-2-yn-1-yl)oxy]acetate (2-11). General procedure 3 was 
employed for the alkylation of 5-phenylpent-2-yn-1-ol (250 mg, 1.56 mmol) with methyl 
2-bromoacetate (0.15 mL, 1.56 mmol). This procedure afforded 264 mg (73%) of the 
title compound as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.29 (t, J = 7.8 Hz, 2 H), 
7.22 (t, J = 7.8 Hz, 3 H), 4.26 (t, J = 4.5 Hz, 2 H), 4.13 (s, 2 H), 3.77 (s, 3 H), 2.83 (t, J = 
7.6 Hz, 2 H), 2.52 (tt, J = 1.7, 7.6 Hz, 2 H); 13C NMR (125 MHz, CDCl3) δ 170.5, 140.4, 
MeO
O
O
MeO
O
O
MeO
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128.4, 126.3, 87.5, 75.4, 65.9, 58.8, 51.9, 34.8, 20.9 (one carbon signal is missing due 
to incidental equivalence); IR (film) 1754, 1212 cm–1. MS (ESI+) 255.0993 (255.0992 
calcd for C14H16O3, M + Na+). 
 
 
Methyl-2-[(4-methylpent-2-yn-1-yl)oxy]acetate (2-13). General procedure 3 was 
employed for the alkylation of 4-methylpent-2-yn-1-ol (226 mg, 2.31 mmol) with methyl 
2-bromoacetate (0.22 mL, 2.31 mmol). This procedure afforded 163 mg (42%) of the 
title compound as a colorless oil.  1H NMR (500 MHz, CDCl3) δ 4.28 (s, 2 H), 4.20 (s, 2 
H), 3.78 (s, 3 H), 2.63–2.56 (m, 1 H), 1.18 (d, J = 6.8 Hz, 6 H); 13C NMR (125 MHz, 
CDCl3) δ 170.6, 93.8, 73.7, 65.9, 58.9, 51.9, 22.8, 20.5; IR (film) 1736, 1239, 1114 cm–1. 
MS (ESI) 193.0833 (198.0835 calcd for C9H14O3, M + Na+). 
 
 
Methyl-2-(but-2-yn-1-yloxy)acetate (2-15).36 General procedure 3 was employed for 
the alkylation of 2-butyn-1-ol (1.60 mL, 21.4 mmol) with methyl 2-bromoacetate (2.03 
mL, 21.4 mmol). This procedure afforded 1.42 g (47%) of the title compound as a 
colorless oil with spectroscopic properties identical to those previously reported.  1H 
NMR (500 MHz, CDCl3) δ 4.27 (d, J = 2.4 Hz, 2 H), 4.21 (s, 2 H), 3.78 (s, 3 H), 1.87 (t, J  
= 2.3 Hz, 3 H). 
 
 
Methyl-2-(prop-2-yn-1-yloxy)acetate (2-20).37 General procedure 3 was employed for 
the alkylation of propargyl alcohol (0.52 mL, 8.92 mmol) with methyl 2-bromoacetate 
(0.85 mL, 8.92 mmol). This procedure afforded 769 mg (67%) of the title compound as a 
colorless oil. 1H NMR (500 MHz, CDCl3) δ 4.31 (dd, J = 1.0, 2.5 Hz, 2 H), 2.21 (s, 2 H), 
3.77 (s, 3 H), 2.48 (t, J = 2.5 Hz, 1 H). 
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Methyl-2-[(1-phenylpent-1-yn-3-yl)oxy]acetate (2-18). General procedure 3 was 
employed for the alkylation of 1-phenylpent-1-yn-3-ol (336 mg, 2.10 mmol) with methyl 
2-bromoacetate (0.20 mL, 2.10 mmol). This procedure afforded 217 mg (45%) of the 
title compound as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.45 (dd, J = 2.9, 4.9 Hz, 
2 H), 7.33 (d, J = 7.1 Hz, 3 H), 4.45 (t, J = 6.4 Hz, 1 H), 4.34 (m, 2 H), 3.78 (s, 3 H), 1.86 
(m, 2 H), 1.11 (t, J = 7.3 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 170.8, 131.8, 128.5, 
128.3, 122.4, 86.8, 86.7, 71.8, 65.5, 51.8, 28.8, 9.7; IR (film) 1756, 1211, 1119 cm–1. 
MS (EI) 231.1 (231.10 calcd for C14H16O3, M - H+). 
 
Synthesis and Characterization of Furanone Products 
 
 
General Procedure 4: A flame-dried flask was evacuated and backfilled with nitrogen 
three times then charged with a 1 M solution of dialkylboron triflate in methylene 
chloride (3.2 equiv). The solution was cooled to 0 ºC and Hünig’s base (4.0 equiv) was 
added dropwise. A 1 M solution of the ester substrate (1.0 equiv) in methylene chloride 
was then added, and the resulting solution was warmed to rt over 15 min, at which point 
the flask was opened to air and quenched by the addition of pH 7 buffer (2 mL/mmol 
substrate). The heterogeneous mixture was transferred to a larger flask and diluted with 
MeOH (ca. 5–8 mL/mmol substrate) to afford a clear and homogeneous solution. This 
solution was cooled to 0 °C, 30% aqueous H2O2 (ca. 4 mL/mmol substrate) was added 
slowly, and the resulting mixture was warmed to rt and stirred for 1 h. The solution was 
then diluted with water and extracted twice with Et2O. The combined organic layers 
were washed with water, saturated Na2S2O3, and brine. The aqueous washes were 
extracted once more with Et2O, and the combined organic layers were dried over 
anhydrous sodium sulfate, filtered, and concentrated in vacuo. The crude product was 
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purified by flash chromatography on silica gel using 10–30% ethyl acetate/hexanes as 
the eluent. 
 
 
5-Butyl-3-hydroxy-5-methyl-4-phenylfuran-2(5H)-one (2-4). General procedure 4 
was employed to cyclize substrate 2-3 (50 mg, 0.238 mmol) to form lactone 2-4 using 
dibutylboron triflate. This procedure afforded 37 mg (62%) of the title compound as a 
pale yellow solid, mp 107–112 °C. 1H NMR (500 MHz, CDCl3) δ 7.75 (d, J = 8.6 Hz, 2 
H), 7.44 (td, J = 1.7, 7.6 Hz, 2 H), 7.37 (t, J = 7.3 Hz, 1 H), 6.19 (s, br, 1 H), 2.08 (dt, J = 
4.9, 12.7 Hz, 1 H), 1.99 (dt, J = 4.8, 11.3 Hz, 1 H), 1.70 (s, 3 H), 1.06–1.31 (m, 4 H), 
0.83 (t, J = 7.1 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 169.7, 137.2, 133.0, 130.2, 
128.8, 128.7, 127.9, 87.9, 38.5, 26.1, 25.3, 22.5, 13.8; IR (film) 3295, 1727 cm–1. MS 
(ESI) 247.11 (246.13 calcd for C15H18O3, M + H+). 
 
 
5-Butyl-4-(4-fluorophenyl)-3-hydroxy-5-methylfuran-2(5H)-one (2-6). General 
procedure 4 was employed to cyclize substrate 2-5 (75 mg, 0.338 mmol) to form lactone 
2-6 using dibutylboron triflate. This procedure afforded 49 mg (41%) of the title 
compound as a pale yellow solid, mp 87–90 °C. 1H NMR (500 MHz, CDCl3) δ 7.77 (dd, 
J = 5.4, 9.1 Hz, 2 H), 7.14 (t, J = 8.6 Hz, 2 H), 2.08 (td, J = 4.4, 13.6 Hz, 1 H), 1.95 (td, J 
= 5.0, 13.1 Hz, 1 H), 1.69 (s, 3 H), 1.04–1.29 (m, 4 H), 0.82 (s, 3 H); 13C NMR (125 
MHz, CDCl3) δ 169.6, 162.5 (d, J = 250.8 Hz), 137.0, 132.2, 129.9 (d, J = 7.6 Hz), 126.3 
(d, J = 2.9 Hz), 116.0 (d, J = 21.0 Hz), 87.7, 38.4, 26.0, 25.2, 22.4, 13.8; IR (film) 3292, 
1727 cm–1. MS (ESI) 265.1229 (265.1234 calcd for C15H17FO3, M + H+).  
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5-Butyl-3-hydroxy-5-methyl-4-(naphthalen-2-yl)furan-2(5H)-one (2-8). General 
procedure 4 was employed to cyclize substrate 2-7 (50 mg, 0.197 mmol) to form lactone 
2-8 using dibutylboron triflate. This procedure afforded 47 mg (81%) of the title 
compound as a pale yellow viscous oil. 1H NMR (500 MHz, CDCl3) δ 8.17 (s, 1 H), 
7.96–7.84 (m, 3 H), 7.56–7.51 (m, 3 H), 6.68 (s, br, 1 H), 2.05–2.19 (m, 2 H), 1.79 (s, 3 
H), 1.31–1.11 (m, 4 H), 0.83 (t, J = 14 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 169.5, 
137.3, 133.1, 133.0, 132.8, 128.6, 128.5, 127.6, 127.5, 127.2, 126.6, 125.1, 88.0, 38.6, 
26.3, 25.3, 22.5, 13.8 (one carbon signal is missing due to incidental equivalence); IR 
(film) 3290, 1725 cm–1. MS (ESI) 297.1491 (297.1485 calcd for C19H20O3, M + H+). 
 
 
5-Butyl-3-hydroxy-5-methyl-4-(p-tolyl)furan-2(5H)-one (2-10). General procedure 4 
was employed to cyclize substrate 2-9 (100 mg, 0.458 mmol) to form lactone 2-10 using 
dibutylboron triflate. This procedure afforded 52 mg (44%) of the title compound as a 
pale yellow solid, mp 114–118 °C. 1H NMR (500 MHz, CDCl3) δ 7.68 (d, J = 8.3 Hz, 2 
H), 7.25 (d, J = 8.3 Hz, 2 H), 7.03 (s, br, 1 H), 2.39 (s, 3 H), 2.08 (td, J = 4.4, 13.4 Hz, 1 
H), 1.98 (td, J = 5.5, 13.0 Hz, 1 H), 1.69 (s, 3 H), 1.07–1.29 (m, 4 H), 0.82 (s, 3 H); 13C 
NMR (125 MHz, CDCl3) δ 169.8, 139.0, 136.7, 133.3, 129.5, 127.8, 127.3, 87.8, 38.5, 
26.1, 25.3, 22.5, 21.4, 13.8; IR (film) 3293, 1724 cm–1. MS (ESI) 261.1487 (261.1485 
calcd for C16H20O3, M + H+). 
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5-Butyl-3-hydroxy-5-methyl-4-phenethylfuran-2(5H)-one (2-12). General procedure 
4 was employed to cyclize substrate 2-11 (100 mg, 0.431 mmol) to form lactone 2-12 
using dibutylboron triflate. This procedure afforded 39 mg (33%) of the title compound 
as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.30 (t, J = 7.3 Hz, 2 H), 7.20–7.24 (m, 3 
H), 5.70 (s, br, 1 H), 3.03 (t, J = 7.8 Hz, 2 H), 2.49–2.55 (m, 1 H), 2.39–2.45 (m, 1 H), 
1.74–1.80 (m, 1 H), 1.50–1.56 (m, 1 H), 1.31 (s, 3H), 1.11–1.24 (m, 3 H), 0.94–1.03 (m, 
1 H), 0.84 (t, J = 7.3 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 169.8, 141.1, 137.0, 135.6, 
128.5, 128.3, 126.4, 87.2, 37.0, 32.1, 27.2, 25.1, 24.1, 22.5, 13.9; IR (film) 3320, 1731 
cm–1. MS (APCI) 275.1636 (275.1642 calcd for C17H22O3, M + H+). 
 
 
5-Butyl-3-hydroxy-4-isopropyl-5-methylfuran-2(5H)-one (2-14). General procedure 4 
was employed to cyclize substrate 2-13 (75 mg, 0.441 mmol) to form lactone 2-14 using 
dibutylboron triflate. This procedure afforded 27 mg (29%) of the title compound as a 
white solid, mp 97–99 °C. 1H NMR (500 MHz, CDCl3) δ 6.41 (s, br, 1 H), 2.28–2.34 (m, 
1 H), 1.82 (dt, J = 4.8, 13.3 Hz, 1 H), 1.61 (dt, J = 4.8, 12.9 Hz, 1 H), 1.43 (s, 3 H), 1.12–
1.32 (m, 10 H), 0.87 (t, J = 7.2 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 170.5, 143.4, 
136.3, 87.3, 37.1, 25.9, 25.4, 24.1, 22.6, 20.6, 19.8, 13.9; IR (film) 3332, 1728 cm–1. MS 
(ESI) 235.1305 (235.1305 calcd for C12H20O3, M + Na+). 
 
 
5-Butyl-3-hydroxy-4,5-dimethylfuran-2(5H)-one (2-16). General procedure 4 was 
employed to cyclize substrate 2-15 (50 mg, 0.351 mmol) to form lactone 2-16 using 
HO
O
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dibutylboron triflate. This procedure afforded 15 mg (23%) of the title compound as a 
colorless oil. 1H NMR (700 MHz, CDCl3) δ 5.74 (s, br, 1 H), 1.81–1.85 (m, 4 H), 1.60 
(dd, J = 4.6, 12.1 Hz, 1 H), 1.42 (s, 3 H), 1.26–1.31 (m, 2 H), 1.15–1.21 (m, 1 H), 1.03–
1.09 (m, 1 H), 0.87 (t, J = 7.3 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 169.8, 136.6, 
134.5, 87.1, 36.8, 25.0, 24.1, 22.5, 13.9, 8.7; IR (film) 3330, 1737 cm–1. MS (EI) 
184.1100 (184.1099 calcd for C10H16O3, M+). 
 
 
5-Ethyl-3-hydroxy-5-methyl-4-phenylfuran-2(5H)-one (2-17). General procedure 4 
was employed to cyclize substrate 2-3 (75 mg, 0.367 mmol) to form lactone 2-17 using 
diethylboron triflate. This procedure afforded 45 mg (56%) of the title compound as a 
pale yellow solid, mp 109–113 °C. 1H NMR (500 MHz, CDCl3) δ 7.72 (d, J = 7.3 Hz, 2 
H), 7.44 (t, J = 7.3 Hz, 2 H), 7.37 (t, J = 7.6 Hz, 1 H), 2.01–2.17 (m, 1 H), 1.98–2.06 (m, 
1 H), 1.70 (s, 3 H), 0.79 (t, J = 7.3 Hz, 3 H); 13C NMR (175 MHz, CDCl3) δ 170.8, 139.1, 
132.0, 130.8, 128.6, 128.2, 127.7, 87.7, 31.7, 25.8, 7.6; IR (film) 3296,1726 cm–1. MS 
(EI) 218.0935 (218.0943 calcd for C13H14O3, M+). 
 
 
Methyl-2-hydroxy-3-phenylhepta-3,4-dienoate (2-19). General procedure 4 was 
employed to rearrange substrate 2-18 (75 mg, 0.32 mmol) to form allene 2-19 using 
dibutylboron triflate. This procedure afforded 39 mg (53%) of the title compound as a 
yellow oil. This compound was isolated as a ca. 1:1 mix of diastereomers. Data are for 
the mixture. 1H NMR (500 MHz, CDCl3) δ 7.67–7.62 (m, 2 H), 7.36–7.31 (m, 2 H), 7.24–
7.20 (m, 1 H), 5.80–5.75 (m, 1 H), 5.20 (s, 0.5 H), 5.16 (s, 0.5 H), 3.77 (s, 3 H), 3.03–
2.99 (m, 1 H), 2.13–2.19 (m, 2 H), 1.09–1.06 (m, 3 H); 13C NMR (125 MHz, CDCl3) δ 
203.1, 173.7, 134.5, 128.5, 127.2, 126.4, 99.4, 71.0, 52.5, 23.5, 21.8, 13.0; IR (film) 
3475, 1740 cm–1. MS (ESI) 255.0987 (255.0992 calcd for C14H16O3, M + Na+). 
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(E/Z)-Methyl-2-hydroxy-4-methyloct-3-enoate (2-21). General procedure 4 was 
employed to transform substrate 2-20 (50 mg, 0.39 mmol) into product 2-21 using 
dibutylboron triflate. This procedure afforded 9 mg (12%) of the title compound as a 
colorless oil. This material was judged to be a ca 1:1 mixture of E:Z isomers by 1H NMR 
analysis. Data are for the mixture. 1H NMR (500 MHz, CDCl3) δ 5.15 (s, 0.5 H), 5.13 (s, 
0.5 H), 4.88–4.84 (m, 1 H), 3.77 (s, 3 H), 2.82–2.76 (m, 1 H), 2.18–2.14 (m, 1 H), 2.05–
2.01 (m, 1 H), 1.77–1.75 (m, 3 H), 1.45–1.25 (m, 4 H), 0.84–0.94 (m, 3 H); 13C NMR 
(125 MHz, CDCl3) δ 174.9, 143.9, 143.4, 121.6, 121.1, 68.1, 67.7, 52.7, 39.2, 32.2, 
30.2, 29.6, 23.5, 22.7, 22.3, 16.8, 14.0, 13.9; IR (film) 3472, 1742 cm–1. MS (ESI) 
209.11 (209.11 calcd for C10H18O3, M + Na+). 
 
 
Methyl-2-hydroxy-3-phenylpenta-3,4-dienoate (2-22). General procedure 4 was 
employed to rearrange substrate 2-3 (100 mg, 0.490 mmol) to form allene 2-22 using 9-
BBNOTf. This procedure afforded 53 mg (53%) of the title compound as a yellow oil. 1H 
NMR (500 MHz, CDCl3) δ 7.46 (d, J = 7.6 Hz, 2 H), 7.34 (t, J = 7.6 Hz , 2 H), 7.25 (t, J = 
7.3 Hz, 1 H), 5.26 (s, 2 H), 5.18 (d, J = 7.6 Hz, 1 H), 3.79 (s, 3H), 3.10 (d, J = 7.8 Hz, 1 
H); 13C NMR (125 MHz, CDCl3) δ 208.4, 173.5, 133.2, 128.6, 127.4, 126.6, 105.5, 80.7, 
71.0, 52.8; IR (film) 3470, 1744 cm–1. MS (ESI) 277.0681 (277.0679 calcd for C12H12O3, 
M + Na+). 
 
 
(E/Z)-Methyl 4-methyl-2-oxo-3-phenyloct-3-enoate (2-23). A modified general 
procedure 4 was employed to transform substrate 2-3 (100 mg, 0.490 mmol) into 
product 2-23 using dibutylboron triflate. The H2O2/pH 7 buffer workup step was omitted, 
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and instead the reaction was quenched with 2 mL of 1 M HCl. The resulting mixture was 
stirred at rt for 5 min, then was transferred to a separatory funnel and the layers were 
separated. The aqueous layer was extracted with Et2O then the organic layers were 
combined, dried over anhydrous sodium sulfate, filtered, and concentrated. The 
resulting crude product was purified by flash chromatography on silica gel to afford 49 
mg (39%) of the title compound as a yellow oil. This material was judged to be a ca 1:1 
mixture of E:Z isomers. Data are for the mixture. 1H NMR (500 MHz, CDCl3) δ 7.30–
7.39 (m, 6 H), 7.19–7.17 (m, 4 H), 3.57 (s, 3 H), 3.55 (s, 3 H), 2.55–2.50 (m, 2 H), 2.22 
(s, 3H), 2.09–2.04 (m, 2 H), 1.80 (s, 3H), 1.60–1.54 (m, 2 H), 1.47–1.37 (m, 4 H), 1.23–
1.15 (m, 2 H), 0.97 (t, J = 7.3 Hz, 3 H), 0.79 (t, J = 7.3 Hz, 3 H); 13C NMR (175 MHz, 
CDCl3) δ 187.8, 187.4, 164.8, 164.5, 157.9, 157.2, 136.2, 136.1, 133.8, 133.5, 130.4, 
130.3, 128.4, 128.3, 127.8, 52.1, 52.0, 37.2, 35.8, 30.6, 29.9, 22.9, 22.6, 22.3, 20.6, 
13.9, 13.8, 13.7; IR (film) 1739, 1680 cm–1. MS (ESI) 261. 1480 (261.1485 calcd for 
C16H20O3, M + H+). 
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Chapter 3
Aza-Wittig Rearrangements of N-Benzyl and N-Allyl Glycine Methyl Esters 
 
3.1 Introduction 
Wittig rearrangements of α-alkoxy carbanions have been well established over 
the past 70 years1,2,3 and provide a useful synthetic method for carbon-carbon bond 
formation. Our group has recently reported a tandem Wittig rearrangements/aldol 
reaction sequence, which affords substituted α,β-dihydroxy esters in good yield and 
high diastereoselectivity using mild, boron-mediated conditions (Scheme 3.1).4 With the 
use of 2-phenylcyclohexanol as a chiral auxiliary, these reactions can be performed 
asymmetrically yielding the diol products in up to 95% ee.5 Furthermore, analogous 
tandem Wittig rearrangement/Mannich reactions provide access to the corresponding 
amino alcohols.6 We sought to expand the scope of these enolate Wittig 
rearrangements, given the synthetic utility of the aforementioned transformations. We 
hypothesized that the corresponding enolate aza-Wittig rearrangement could be 
achieved under similar conditions from a tertiary amine.7 The rearrangement itself would 
provide access to unnatural amino acid derivatives, and if coupled with a subsequent 
aldol reaction, this sequence could produce biologically interesting β-hydroxy-α-amino 
acid derivatives. 
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Scheme 3.1 Tandem Wittig Rearrangement/Aldol Reaction 
 
 
Though Wittig rearrangements of α-alkoxy carbanions are well documented, the 
corresponding nitrogen analogue has been less explored.8 Moreover, while there is no 
lack of aza-[2,3]-Wittig rearrangements, reports of aza-[1,2]-Wittig rearrangements are 
much less frequent.9-12 In fact, the migration of benzyl groups in synthetically useful 
yields (>60%) has only been reported on a single occasion.13 More frequently, these 
transformations have been reported as side reactions in aza-[2,3]-Wittig 
rearrangements.10-13 Aza-Wittig rearrangements are typically slower and less facile than 
the analogous oxy-rearrangements, so the development of mild, boron-mediated 
conditions for the proposed transformation could prove to be synthetically useful.  
 
3.2 Initial Studies 
We elected to begin our initial studies by focusing solely on the aza-
rearrangement (rather than the tandem rearrangement/aldol sequence) in order to 
determine the optimal conditions for the transformation. Considering the scarcity of 
successful aza-[1,2]-Wittig rearrangements, we first elected to first examine the 
migration of benzyl groups. N-benzyl-N-boc-glycine methyl ester was prepared for this 
purpose, as prior studies on aza-[2,3]-Wittig rearrangements have shown that electron-
withdrawing N-substituents have improved reactivity. However, as illustrated in equation 
1, when 3-6 was subjected to the reaction conditions we have previously employed in 
[1,2]-Wittig rearrangements of 3-1, no rearrangement occurred. Instead, 1,4,2-
oxazaborole derivative 3-7 was formed (Scheme 3.2).14-18 
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Scheme 3.2 Formation of 1,4,2 Oxazaborole Derivative 
 
 
3.3 Synthesis of 1,4,2-Oxazaborole Derivatives 
The reactivity of other N-benzyl glycine methyl ester derivatives was briefly 
explored. Substrates bearing N-pivalolyl or N-acetyl groups gave similar results (Table 
3.1), as did the use of a substrate bearing an N-allyl rather than an N-benzyl group 
(Table 3.1, entry 4). Furthermore, similar reactivity was observed when 9-BBNOTf was 
used in place of Bu2BOTf (Table 3.1, Entry 5).  
 
Table 3.1 Formation of 1,4,2-Oxazaborole Derivativesa 
 
Entry R1 R2 R2BOTf Product Yieldb 
1 Bn OtBu (3-6) Bu2BOTf 3-7 40% 
2 Bn tBu (3-9) Bu2BOTf 3-10 87% 
3 Bn CH3 (3-11) Bu2BOTf 3-12 48% 
4 Allyl OtBu (3-13) Bu2BOTf 3-14 66% 
5 Bn tBu (3-9) 9-BBNOTf 3-15 90% 
aConditions: (i) 1.0 equiv of ester, 3.2 equiv of R2BOTf, 4.0 equiv of iPr2NEt, CH2Cl2, 0.25 
M, 15 min, 0º C to rt. (ii) H2O2, pH 7 buffer, MeOH, 1 h, 0º C to rt. bIsolated yield, average 
of two or more experiments. 
 
The structure of 3-15 was confirmed via x-ray crystallography,19 which clearly 
revealed the presence of a boron-oxygen bond (Figure 3.1). Unfortunately, even with an 
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increase in temperature and reaction time, these compounds failed to undergo the 
desired rearrangement. Moreover these compounds were also unreactive towards 
acids, bases, and oxidants such as alkaline hydrogen peroxide. 
 
Figure 3.1 X-Ray Structure of Compound 3-15 
 
 
The reactivity of these compounds towards palladium-catalyzed coupling 
reactions was briefly explored. We envisioned a Suzuki-like coupling reaction occurring 
between an aryl halide and the oxazaborole at the carbon–boron bond in the presence 
of a palladium catalyst. However, under the described conditions, we observed a 
mixture of products, none of which were the results of the desired coupling reaction 
(Scheme 3.3). With various ligands and bases, unreacted starting material was always 
obtained in addition to 3-17, which results from the cleavage of the boron, and 
occasionally 3-18, which results from a coupling reaction between the aryl halide and 
one of the butyl groups from the boron species. 
 
 
 
 
	   45	  
Scheme 3.3 Suzuki Reaction of Oxazaborole with Aryl Halides 
 
 
3.4 Aza-Wittig Optimization 
Considering the fact that substrates 3-6 failed to undergo rearrangement, efforts 
were focused on modifying the glycine N-substituent in hopes that the desired 
transformation could be facilitated with alterations to the steric or electronic properties of 
the nitrogen atom. N-benzyl glycine methyl esters bearing N-alkyl, N-phosphoryl, and N-
tosyl groups were examined, though efforts to effect rearrangements of these 
substrates were also unsuccessful. However, we were gratified to find that the desired 
[1,2] rearrangement could be achieved with the use of an N-benzyl substrate bearing an 
N-phenyl group. Further experimentation revealed that by extending reaction time and 
increasing temperature, the desired amine could be isolated in 65% yield (Table 3.2, 
Entry 1).20 
 
3.5 Aza-[1,2]-Wittig Rearrangement 
Once the optimized reaction conditions had been determined, additional 
substrates were prepared in order to examine the scope of the transformation. The 
requisite substrates were prepared in three steps from substituted anilines and 
benzaldehyde derivatives via imine formation, reduction, and N-alkylation with α-bromo 
methyl acetate. As shown in Table 3.2, substitution on both the N-aryl group and benzyl 
group was tolerated. Additionally, substrates bearing heteroaromatic groups underwent 
the [1,2] rearrangement in good yield (Table 3.2, Entries 7–9).21 However, due to a 
combination of slow reaction rate and product decomposition as a result of the extended 
reaction time, the rearrangement of 3-25, which contains an N-p-trifluoromethylphenyl 
group, proceeded in poor yield. 
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Table 3.2 Aza-[1,2]-Wittig Rearrangementa 
 
Entry R Ar Product Yieldb 
1 H Ph (3-19) 3-20 64% 
2 p-Br Ph (3-21) 3-22 54% 
3 p-OMe Ph (3-23) 3-24 65% 
4 p-CF3 Ph (3-25) 3-26 24% 
5 H p-BrPh (3-27) 3-28 67% 
6 H o-BrPh (3-29) 3-30 53% 
7 H 2-furyl (3-31) 3-32 68% 
8 H 2-thiophenyl (3-33) 3-34 66% 
9 H N-Ts-2-pyrrolyl (3-35) 3-36 54% 
aConditions: (i) 1.0 equiv of ester, 3.2 equiv of Bu2BOTf, 4.0 equiv of iPr2NEt, CH2Cl2, 
0.25 M, 0º C to 40 °C (ii) H2O2, pH 7 buffer, MeOH. bIsolated yield, average of two or 
more experiments. 
 
3.6 Aza-[1,2]-Wittig Scope 
The scope and stereocontrol of this reaction was explored by preparing 
substrates 3-37 and 3-39, which bear a methyl group at the benzylic position or 
adjacent to the ester, respectively. The rearrangement of 3-37 to 3-38 proceeded in 
good yield, though the diastereoselectivity of this reaction was low (Scheme 3.3a). The 
diastereoselectivity was not improved with the use of 9-BBN-OTf in place of Bu2BOTf; a 
similar mixture of diastereomers was obtained under these conditions. Though 
substitution at the benzylic position was tolerated (Scheme 3.3a), substrate 3-39 proved 
to be unreactive toward our standard conditions (Scheme 3.3b). We hypothesize that 
the lack of reactivity is due to difficulty generating the requisite boron enolate from the 
more sterically encumbered substrate. This is consistent with our observation that no 
aldol product was generated when 3-19 was treated with excess Bu2BOTf/iPr2NEt 
followed by addition of an aldehyde to the reaction mixture (Scheme 3.3c), unlike the 
reactivity that was previously observed in reactions of 3-1 (Scheme 3.1). 
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Scheme 3.4 Scope and Stereocontrol of Aza-[1,2]-Rearrangement 
 
 
3.7 Aza-[2,3]-Rearrangement 
In order to explore the feasibility of the analogous aza-[2,3]-Wittig 
rearrangements, N-allyl-N-phenyl glycine methyl ester was prepared. However, when 3-
40 was subjected to the standard conditions, a mixture of two products was observed 
(Scheme 3.4). Both products appear to be the consequence of a [2,3] rearrangement, 
though 3-42 appears to have undergone a subsequent alkene oxidation. Efforts to 
reproduce this result provided variable mixtures of 3-41 and 3-42, and further 
experimentation revealed that temperature variation led to the inconsistent distribution 
of products. By lowering reaction temperature to 35 ºC and reducing the amount of 
Bu2BOTf to 1.5 equivalents, 3-41 could be isolated as the sole product in 70% yield 
(Table 3.3, entry 1). 
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Scheme 3.5 Initial Results of aza-[2,3]-Wittig Rearrangement 
 
 
 A number of N-allyl substrates were prepared in a manner analogous to the 
synthesis of the substrates used in Table 2 in order to explore the scope of this [2,3] 
rearrangement. When subjected to the optimized reaction conditions, a variety of 
substrates cleanly underwent [2,3] rearrangement, as shown in Table 3.3. Terminal and 
internal substitution on the alkene was tolerated as well as substitution on the N-aryl 
group. Substrates bearing internal alkenes underwent diastereoselective rearrangement 
to provide products in 5:1 and 8:1 dr in most cases. However, substrate 3-45 
rearranged in much higher dr (>20:1), and selectivity was low with cyclohexene derived 
substrate 3-55 (2:1 dr). Aza-[2,3]-Wittig rearrangements are believed to proceed 
through a highly ordered cyclic transition state analogous to that of the corresponding 
allyic ethers. Two substrates, 3-45 and 3-47 yielded a mixture of [1,2] and [2,3] 
rearrangement products (Table 3.3, entries 2 and 3), indicating competing pathways, 
which is common in Wittig rearrangements of allylic compounds.22 Additionally, a 
substrate bearing a cyclic N-allyl group (Table 3.3, entry 8) underwent the [2,3] 
rearrangement in modest yield and diastereoselectivity.  
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Table 3.3 Aza-[2,3]-Wittig Rearrangementa 
 
Entry Substrate product Product yieldb 
1 
  
3-41 70% 
2 
  
3-44 60%, (7:1 dr) 
3 
  
3-46 73%c, (>20:1 dr) 
4 
  
3-48 75%d 
5 
  
3-50 55% 
6 
  
3-52 58%, (5:1 dr) 
7 
  
3-54 62%, (8:1 dr) 
8 
 
 
3-56 56%, (2:1 dr) 
aConditions: (i) 1.0 equiv of ester, 1.5 equiv of Bu2BOTf, 1.7 equiv of iPr2NEt, CH2Cl2, 
0.25 M, 4 hr, 0º C to 35º C. (ii) H2O2, pH 7 buffer, MeOH, 1 h, 0º C to rt. bIsolated yield, 
average of two or more experiments. cProduct was generated as a 4:1 mixture of [2,3] 
and [1,2] rearrangement products, respectively. dProduct was generated as a 2:1 mixture 
of [2,3] and [1,2] rearrangement products, respectively.  
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3.8 Tandem Aza-[2,3]-Wittig Rearrangement/Hydroboration Oxidation 
The curious hydroboration reaction observed previously warranted additional 
investigation (Scheme 3.5). Further experimentation revealed that higher temperatures 
and a large excess of Bu2BOTf favor the subsequent hydroboration reaction, though 
complete conversion from the alkene intermediate is difficult to achieve. Optimal results 
were attained when 3-40 was reacted with two sequential additions of 2.0 equivalents of 
Bu2BOTf at 40 ºC, which generated 3-42 in 56% yield (Table 3.4, entry 1). The 
remaining mass balance, however, was observed to be alkene 3-41, which failed to 
undergo the hydroboration after the [2,3] rearrangement. Additionally, we observed that 
hydroboration only occurred on terminal alkenes. In cases where competing reaction 
pathways resulted in two products, only the [2,3] rearrangement product, which bears a 
terminal alkene, was observed to undergo the subsequent oxidation (Table 3.4, entries 
3 and 4).   
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Table 3.4 Aza-[2,3]-Wittig Rearrangement/Hydroborationa 
 
Entry Substrate Product Product Yieldb, dr 
1 
  
3-42 52% 
2 
  
3-57 54%, 10:1 
3 
  
3-58 57%, >20:1 
4 
  
3-59 51% 
5 
  
3-60 41%, 1:1 
6 
  
3-61 44%, 9:1 
7 
  
3-62 48%, 13:1 
8 
 
 
3-63 38%, 3:1 
aConditions: (i) 1.0 equiv of ester, 2.0 equiv of Bu2BOTf, 4.0 equiv of iPr2NEt, CH2Cl2, 
0.25 M, 2 hr, 0º C to 35º C. (ii) 2.0 equiv of Bu2BOTf, 4 hr, 0º C to 40º C. (iiI) H2O2, pH 7 
buffer, MeOH, 1 h, 0º C to rt. bIsolated yield, average of two or more experiments. 
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The observed alkene oxidation likely occurs via hydroboration. We hypothesize 
that β-hydride elimination of dibutylboron triflate can occur at elevated temperatures,23-25 
leading to in situ generation of an alkyl borohydride species. This intermediate can react 
with an alkene in an anti Markovnikov manner similar to that of a traditional 
hydroboration reagent. The organoboron species is then oxidized in the workup by 
hydrogen peroxide, generating the observed terminal alcohol. 
To assess the limitations of this transformation, compound 3-64, which bears a 
methyl group adjacent to the ester moiety, was prepared. As observed previously 
(Scheme 3.3b), the [2,3]-rearrangement did not occur. However, in this case, the methyl 
ester was hydrolyzed, likely due to decomposition of the boron enolate under thermal 
conditions,26 leading to a ketene intermediate 3-65 that can be hydrolyzed during the 
aqueous workup to form the observed product, 3-66 (Scheme 3.5). Additionally, no aldol 
product was generated when 3-40 was treated with excess Bu2BOTf/iPr2NEt followed by 
addition of an aldehyde to the reaction mixture. 
 
Scheme 3.6 Decomposition of α-Substituted Substrate 
 
 
3.9 Asymmetric Aza-Wittig Rearrangements 
Finally, we have conducted preliminary studies on asymmetric enolate aza-Wittig 
rearrangements. We have previously executed asymmetric Wittig rearrangement/aldol 
reactions of glycolate esters successfully with the use of 2-phenylcyclohexanol as a 
chiral auxiliary. Thus, substrates 3-68 and 3-70 bearing this chiral auxiliary were 
synthesized and subjected to the standard reaction conditions. Unfortunately, although 
the yields of these transformations were good, the diastereoselectivity in each case was 
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modest (Table 3.5). Nonetheless, this experiment indicates the possibility of achieving 
asymmetric induction, although further optimization is clearly needed. 
 
Table 3.5 Asymmetric Aza-Wittig Rearrangement 
 
Entry R Yieldc dr 
1 benzyla (3-68) 85% (3-69) 1.6:1 
2 allylb (3-70) 64% (3-71) 1.3:1 
aConditions: (i) 1.0 equiv of 3-68, 3.2 equiv of Bu2BOTf, 4.0 equiv of iPr2NEt, CH2Cl2, 0.25 
M, 2 h, 0º C to 40 ºC. (ii) H2O2, pH 7 buffer, MeOH, 1 h, 0º C to rt. bConditions: (i) 1.0 
equiv of 3-70, 1.5 equiv of Bu2BOTf, 1.7 equiv of iPr2NEt, CH2Cl2, 0.25 M, 4 h, 0º C to 35 
ºC. (ii) H2O2, pH 7 buffer, MeOH, 1 h, 0º C to rt. cIsolated yield. 
 
3.10 Conclusion 
In conclusion, we have developed a new aza-[1,2]-Wittig rearrangement of N-
aryl-N-benzyl glycine methyl esters. These transformations constitute rare examples of 
benzyl group migration in aza-Wittig rearrangements and provide a concise four-step 
approach to the construction of substituted N-aryl phenylalanine derivatives. 
Additionally, we have developed an analogous aza-[2,3]-Wittig rearrangement of N-aryl-
N-allyl glycine methyl esters. With slightly modified reaction conditions, we have shown 
that these same substrates can undergo an aza-[2,3]-rearrangement and consecutive 
hydroboration oxidation. These reactions do not require the use of the strong reducing 
agents or strong bases, and proceed under relatively mild conditions. 
 
A portion of the work described in this chapter was published in Tetrahedron 
Letters.27 
 
3.11 Experimental 
General: All reactions were carried out under a nitrogen atmosphere in flame-dried 
glassware. All reagents were obtained from commercial sources and were used as 
obtained unless otherwise noted. Dichloromethane was purified using a GlassContour 
NO
O
R
Ph Bu2BOTf
iPr2NEt, CH2Cl2
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solvent purification system. Hünig’s base was distilled under nitrogen from CaH2. Yields 
refer to isolated yields of compounds estimated to be ≥95% pure as determined by 
1
H 
NMR analysis unless otherwise noted. The yields reported in the supporting information 
describe the result of a single experiment, whereas yields reported in Tables 3.1–3.5 
are average yields of two or more experiments. Thus, the yields reported in the 
supporting information may differ from those shown in Tables 3.1–3.5.  
 
Handling of Dialkylboron reagents: Dibutylboron triflate (1.0 M solution in 
dichloromethane) and 9-BBN triflate (0.5 M solution in hexanes) were purchased from 
Aldrich Chemical Co. and used as obtained. Due to the air and moisture sensitivity of 
these reagents, they must be stored and transferred under a rigorously maintained 
nitrogen atmosphere. 
 
Synthesis of N-Boc- and N-Acyl-N-Benzyl Glycine Methyl Ester Substrates 
 
 
Methyl 2-(benzylamino)acetate. A flame dried flask was cooled under a stream of 
nitrogen and charged with benzylamine (2.36 mL, 21.6 mmol) In THF (10 mL, 1 M). This 
solution was cooled to 0 ºC before methyl bromoacetate (0.93 mL, 9.8 mmol) was 
added dropwise. The mixture was allowed to warm to rt over 2.5 h, at which point the 
starting material had been completely consumed as judged by TLC analysis. The 
mixture was concentrated in vacuo and the resulting residue was dissolved in Et2O and 
filtered. The filtrate was concentrated in vacuo, and the crude product was purified by 
flash chromatography to afford 1.12 g (63%) of the title compound as a colorless oil with 
spectroscopic properties identical to those previously reported.28 1H NMR (500 MHz, 
CDCl3) δ 7.30 (d, J = 4.3 Hz, 4 H), 7.29–7.24 (m, 1 H), 3.81 (s, 2 H), 3.73 (s, 3 H), 3.43 
(s, 2 H), 1.93 (s, br, 1 H). 
 
 
MeO
O H
N
MeO
O
N
Boc
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Methyl 2-[benzyl(tert-butoxycarbonyl)amino]acetate (3-6). A flame dried flask was 
cooled under a stream of nitrogen and charged with methyl 2-(benzylamino)acetate 
(400 mg, 2.23 mmol), dichloromethane (11 mL, 0.2 M), Boc2O (536 mg, 2.46 mmol), 
and triethylamine (0.94, 6.70 mmol). The resulting solution was stirred at rt overnight 
and then concentrated in vacuo. The crude product was purified by flash 
chromatography to afford 618 mg (99%) of the title compound as a colorless oil. 1H 
NMR (500 MHz, CDCl3) δ 7.35–7.21 (m, 5 H), 4.53 (d, J = 7.8, 2 H), 3.93 (s, 1 H), 3.79 
(s, 1 H), 3.70 (d, J = 2.5 Hz, 3 H), 1.47 (d, J = 5.7, 9 H); 13C NMR (176 MHz, CDCl3) δ 
170.4, 155.8, 155.6, 137.5, 137.3, 128.6, 128.1, 127.5, 127.4, 80.7, 80.5, 52.0, 51.9, 
51.5, 51.0, 47.9, 47.5, 28.3, 28.2 (three carbon signals are missing due to incidental 
equivalence); IR (film) 1749, 1690 cm–1. MS (ESI+) 302.1366 (302.1363 calcd for 
C15H21NO4, M + Na+). 
 
 
Methyl 2-(N-benzylpivalamido)acetate (3-9). A flame dried flask was cooled under a 
stream of nitrogen and charged with methyl 2-(benzylamino)acetate (400 mg, 2.23 
mmol), pyridine (5.6 mL, 0.4 M), and pivaloyl chloride (0.5 mL, 3.78 mmol). The 
resulting solution was stirred at rt for 1 h and then concentrated in vacuo. The resulting 
material was dissolved in Et2O, dried over anhydrous sodium sulfate, filtered, and 
concentrated in vacuo. The crude product was purified by flash chromatography to 
afford 495 mg (84%) of the title compound as a colorless oil. 1H NMR (400 MHz, CDCl3) 
δ 7.38–7.26 (m, 3 H), 7.21 (d, J = 7.2 Hz, 2 H), 4.83 (s, 2 H), 3.91 (s, 2 H), 3.71 (s, 3 H), 
1.35 (s, 9 H); 13C NMR (176 MHz, CDCl3) δ 170.1, 128.8, 127.7, 126.9, 52.0, 48.4, 38.9, 
28.4, 27.1 (two carbon signals are missing due to incidental equivalence); IR (film) 
1748, 1634 cm–1. MS (ESI+) 264.1596 (264.1594 calcd for C15H21NO3, M + H+). 
 
 
Methyl 2-(N-benzylacetamido)acetate (3-11). A flame dried flask was cooled under a 
stream of nitrogen and charged with methyl 2-(benzylamino)acetate (370 mg, 2.06 
MeO
O
N
Piv
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O
N
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mmol), DCM (4.1 mL, 0.5 M), acetyl chloride (0.22 mL, 3.09 mmol), and triethylamine 
(0.43 mL, 3.09 mmol). The resulting solution was stirred at rt for 14 h then was poured 
into water. The layers were separated, and the organic layer was extracted twice with 
DCM. The combined organic layers were washed with water then brine, dried over 
anhydrous sodium sulfate, filtered, and concentrated in vacuo. The crude product was 
purified by flash chromatography to afford 236 mg (52%) of the title compound as a 
colorless oil. The compound was isolated as a mixture of rotamers with spectroscopic 
properties identical to those previously reported.29 1H NMR (700 MHz, CDCl3) δ 7.36 
(t, J = 7.6 Hz, 1.4 H), 7.34–7.23 (m, 1.6 H), 7.24–7.20 (m, 0.6 H), 7.21–7.16 (m, 1.4 H), 
4.63 (s, 0.6 H), 4.61 (s, 1.4 H), 4.05 (s, 1.4 H), 3.91 (s, 0.6 H), 3.70 (s, 3 H), 2.21 (s, 
2.15 H), 2.11 (s, 0.85 H); 13C NMR (126 MHz, CDCl3) δ 171.4, 171.0, 169.7, 169.5, 
136.6, 136.0, 128.9, 128.6, 128.4, 127.8, 127.6, 126.6, 52.9, 52.3, 52.0, 49.4, 49.0, 
46.8, 21.4, 21.2. 
 
 
Methyl N-allylglycinate. A flame dried flask was cooled under a stream of nitrogen and 
charged with allylamine (2.16 mL, 18.8 mmol) in THF (13 mL, 1 M). This solution was 
cooled to 0 ºC before methyl bromoacetate (1.24 mL, 13.0 mmol) was added dropwise. 
The mixture was allowed to warm to rt over 2.5 h, at which point the starting material 
had been completely consumed as judged by TLC analysis. The mixture was 
concentrated in vacuo and the resulting residue was dissolved in Et2O and filtered. The 
filtrate was concentrated in vacuo, and the crude product was purified by flash 
chromatography to afford 1.28 g (75%) of the title compound as a colorless oil with 
spectroscopic properties identical to those previously reported.30 1H NMR (400 MHz, 
CDCl3) δ 5.89–5.79 (m, 1 H), 5.20–5.08 (m, 2 H), 3.71 (s, 3 H), 3.39 (s, 2 H), 3.24 (dd, J 
= 6.1, 1.2 Hz, 2 H), 1.64 (s, br, 1 H). 
 
 
Methyl-N-allyl-N-(tert-butoxycarbonyl)glycinate (3-13). A flame dried flask was 
cooled under a stream of nitrogen and charged with methyl allylglycinate (98.3 mg, 0.76 
MeO
O H
N
MeO
O
N
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mmol), dichloromethane (4 mL, 0.2 M), Boc2O (183 mg, 0.84 mmol), and triethylamine 
(0.32, 2.28 mmol). The resulting solution was stirred at rt overnight and then 
concentrated in vacuo. The crude product was purified by flash chromatography to 
afford 170 mg (98%) of the title compound as a colorless oil. The product was isolated 
as a mixture of rotamers and displayed spectroscopic properties identical to those 
previously reported.31 1H NMR (400 MHz, CDCl3) δ 5,84–5.73 (m, 1 H), 5.18–5.10 (m, 2 
H), 3.96–3.84 (m, 4 H), 3.73 (s, 3 H), 1.47–1.43 (m, 9 H); 13C NMR (176 MHz, CDCl3) δ 
170.6, 133.7, 133.6, 117.6, 116.8, 80.4, 51.9, 51.8, 50.7, 50,2, 47.9, 47.5, 28.3, 28.2 
(four carbon signals are missing due to incidental equivalence). 
 
Synthesis of 1,2,4-Oxazaborole Derivatives 
 
 
General Procedure 1: An oven-dried flask was evacuated and backfilled with nitrogen 
three times then charged with a 1 M solution of dialkylboron triflate in methylene 
chloride (3.2 equiv). The solution was cooled to 0 ºC and iPr2NEt (4.0 equiv) was added 
dropwise. A 1 M solution of the ester substrate (1.0 equiv) in dichloromethane was then 
added, and the resulting solution was warmed to rt. After stirring for 15 min, the mixture 
was cooled to 0 ºC, opened to air, diluted with diethyl ether, and quenched by the 
addition of water. The mixture was transferred to a separatory funnel, the layers were 
separated, and the aqueous layer was extracted twice with Et2O. The combined organic 
layers were dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. 
The crude product was purified by flash chromatography on silica gel using 5–10% ethyl 
acetate in hexanes as the eluent. 
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Methyl 2-[benzyl(tert-butoxycarbonyl)amino]-2-(dibutylboryl)acetate (3-7). General 
procedure 1 was employed for the transformation of 3-6 (84 mg, 0.3 mmol) using 1 M 
dibutylboron triflate solution in dichloromethane (0.96 mL, 0.96 mmol) and iPr2NEt (0.21 
mL, 1.2 mmol). This procedure afforded 48 mg (40%) of the title compound as a 
colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.37–7.25 (m, 3 H), 7.16 (d, J = 6.8 Hz, 2 H), 
4.80 (d, J = 15.2 Hz, 1 H), 4.09 (d, J = 15.2 Hz, 1 H), 3.63 (s, 3 H), 3.33 (s, 1 H), 1.54 (s, 
9 H), 1.34–1.08 (m, 6 H), 1.00–0.91 (m, 2 H), 0.85 (t, J = 7.1 Hz, 3 H) , 0.80 (t, J = 7.3 
Hz, 3 H) , 0.42–0.25 (m, 2 H), 0.25–0.18 (m, 2 H); 13C NMR (126 MHz, CDCl3) δ 175.6, 
162.1, 135.3, 128.7, 127.9, 127.8, 87.9, 57.4, 50.7, 49.0, 29.7, 28.3, 28.2, 28.0, 27.7, 
26.6, 26.5, 14.3, 14.2; IR (film) 1723 cm–1. MS (ESI+) 426.2795 (426.2786 calcd for 
C23H38BNO4, M + Na+). 
 
 
Methyl 2-(N-benzylpivalamido)-2-(dibutylboryl)acetate (3-10). General procedure 1 
was employed for the transformation of 3-9 (103 mg, 0.39 mmol) using 1 M dibutylboron 
triflate solution in dichloromethane (1.22 mL, 1.25 mmol) and iPr2NEt (0.26 mL, 1.56 
mmol). This procedure afforded 133 mg (90%) of the title compound as a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 7.40–7.27 (m, 3 H), 7.15 (d, J = 6.7 Hz, 2 H), 5.20 (d, J = 
15.5 Hz, 1 H), 4.42 (d, J = 15.5 Hz, 1 H), 3.59 (s, 3 H), 3.31 (s, 1 H), 1.41 (s, 9 H), 1.35–
1.07 (m, 6 H), 1.02–0.94 (m, 2 H), 0.83 (t, J = 7.2 Hz, 6 H), 0.35–0.07 (m, 4 H); 13C 
NMR (126 MHz, CDCl3) δ 183.0, 175.4, 133.9, 129.0, 128.3, 127.5, 51.2, 50.7, 36.2, 
28.0, 27.8, 27.7, 26.6, 26.5, 14.3; IR (film) 1717 cm–1. MS (ESI+) 410.2834 (410.2837 
calcd for C23H38BNO3, M + Na+). 
 
 
Methyl 2-(N-benzylacetamido)-2-(dibutylboryl)acetate (3-12). General procedure 1 
was employed for the transformation of 3-11 (44 mg, 0.20 mmol) using 1 M dibutylboron 
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triflate solution in dichloromethane (0.64 mL, 0.64 mmol) and iPr2NEt (0.14 mL, 0.80 
mmol). This procedure afforded 23 mg (33%) of the title compound as a colorless oil. 1H 
NMR (500 MHz, CDCl3) δ 7.42–7.30 (m, 3 H), 7.16 (d, J = 6.9 Hz, 2 H), 4.78 (d, J = 15.7 
Hz, 1 H), 4.46 (d, J = 15.7 Hz, 1 H), 3.64 (s, 3 H), 3.46 (s, 1 H), 2.28 (s, 3 H), 1.32–1.09 
(m, 6 H), 1.00–0.90 (m, 2 H), 0.83 (dt, J = 13.3, 7.2 Hz, 6 H), 0.38–0.30 (m, 2 H), 0.25–
0.17 (m, 2 H); 13C NMR (126 MHz, CDCl3) δ 175.6, 175.1, 133.7, 129.1, 128.5, 127.5, 
51.3, 50.9, 27.9, 27.7, 26.8, 26.5, 16.0, 14.3; IR (film) 1719, 1582 cm–1. MS (ESI+) 
368.2359 (368.2367 calcd for C20H32BNO3, M + Na+). 
 
 
4-Allyl-5-(tert-butoxy)-2,2-dibutyl-3-(methoxycarbonyl)-2,3-dihydro-1,4,2-
oxazaborol-4-ium-2-uide (3-14). An oven-dried flask was evacuated and backfilled 
with nitrogen three times then charged with a 1 M solution of dialkylboron triflate in 
methylene chloride (1.39 mL, 1.39 mmol). The solution was cooled to 0 ºC and iPr2NEt 
(0.30 mL, 1.74 mmol) was added dropwise. A 1 M solution of 3-13 (100 mg, 0.44 mmol) 
in dichloromethane was then added, and the resulting solution was warmed to rt. After 
stirring for 15 min, the mixture was cooled to 0 ºC, opened to air, diluted with diethyl 
ether, and quenched by the addition of water. The mixture was transferred to a 
separatory funnel, the layers were separated, and the aqueous layer was extracted 
twice with Et2O. The combined organic layers were dried over anhydrous sodium 
sulfate, filtered, and concentrated in vacuo. The crude product was purified by flash 
chromatography on silica gel using 5–10% ethyl acetate in hexanes as the eluent. This 
procedure afforded 134.2 mg (87%) of the title compound as a colorless oil. 1H NMR 
(400 MHz, CDCl3) δ 5.76–5.65 (m, 1 H), 5.21–5.15 (m, 2 H), 4.10 (dd, J = 15.7, 5.0 Hz, 
1 H), 3.64–3.52 (m, 4 H), 3.47 (s, 1 H), 1.53 (s, 9 H), 1.35–1.03 (m, 8 H), 0.84 (dt, J = 
12.4, 7.2 Hz, 6 H), 0.43–0.35 (m, 2 H), 0.23–0.16 (m, 2H); 13C NMR (176 MHz, CDCl3) δ 
175.6, 162.0, 131.3, 118.3, 87.6, 76.6, 57.8, 50.7, 47.9, 28.2, 28.0, 27.6, 26.6, 26.5, 
14.3, 14.2 (one carbon signal is missing due to incidental overlap); IR (film) 1730, 1594 
cm–1. MS (ESI+) 376.2630 (376.2630 calcd for C19H36BNO4, M + Na+). 
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Methyl 2-[benzyl(tert-butoxycarbonyl)amino]-2-(9-borabicyclo[3.3.1]nonan-9-
yl)acetate (3-15). General procedure 1 was employed for the transformation of 3-9 (103 
mg, 0.39 mmol) using 0.5 M 9-BBN triflate solution in hexanes (2.50 mL, 1.25 mmol) 
and iPr2NEt (0.27 mL, 1.56 mmol) except using a modified workup protocol. The 
reaction was quenched with 0.5 mL pH 7 buffer solution, 1.0 mL methanol, and 0.2 mL 
30% H2O2. This mixture was allowed to stir for 1 h before 1 mL sodium thiosulfate was 
added. The biphasic mixture was transferred to a separatory funnel, the layers were 
separated, and the aqueous layer was extracted three times with diethyl ether. The 
crude product was purified using flash column chromatography. This procedure afforded 
135 mg (90%) of the title compound as a white solid, mp 171–173 ºC. 1H NMR (500 
MHz, CDCl3) δ 7.39–7.38 (m, 3 H), 7.16 (d, J = 7.6 Hz, 2 H), 5.25 (d, J = 15.9 Hz, 1 H), 
4.27 (d, J = 16.0 Hz, 1 H), 3.64 (s, 3 H), 3.50 (s, 1 H), 1.95–1.31 (m, 21 H), 0.52 (s, 2 
H); 13C NMR (126 MHz, CDCl3) δ 183.0, 175.2, 134.2, 129.1, 128.2, 126.9, 51.6, 50.8, 
36.2, 32.1, 31.3, 30.9, 30.8, 27.7, 24.6, 24.3; IR (film) 1718, 1547 cm–1. MS (ESI+) 
384.2712 (384.2705 calcd for C23H34BNO3, M + H+). 
 
Synthesis and Characterization of N-Aryl-N-(Arylmethyl) Glycine Methyl Esters 
 
 
General Procedure 2: A flame-dried flask was cooled under a stream of nitrogen and 
charged with a solution of aryl amine (1.0 equiv), aldehyde (1.0 equiv), triethylamine 
(1.0 equiv) and methanol (0.5 M). This mixture was allowed to stir at rt until the starting 
material had been completely consumed as judged by TLC analysis. The mixture was 
then cooled to 0 ºC and NaBH4 (1.4 equiv) was added slowly. The mixture was allowed 
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to warm to rt and stirred until the intermediate imine had been completely consumed as 
judged by TLC analysis. The reaction mixture was then diluted with water and 
transferred to a separatory funnel. The layers were separated and the aqueous layer 
was extracted twice with hexanes. The combined organic layers were washed with 
brine, dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. The 
crude product was purified by flash chromatography on silica gel using 5–20% ethyl 
acetate in hexanes as the eluent. 
 
General Procedure 3: A flame-dried flask was cooled under a stream of nitrogen and 
charged with a solution of aryl amine (1.0 equiv), methyl bromoacetate (1.5–3.0 equiv), 
and iPr2NEt (3.0 equiv) in acetonitrile (0.1 M). The mixture was heated to 80 ºC for ca 
16 h then was cooled rt, concentrated in vacuo, then partitioned between saturated 
NaHCO3 and CH2Cl2. The organic layer was dried over anhydrous sodium sulfate, 
filtered, and concentrated in vacuo. The crude product was purified by flash 
chromatography on silica gel using 3–10% ethyl acetate in hexanes as the eluent. 
 
 
N-Benzylaniline. General procedure 2 was used for the condensation and subsequent 
reduction of aniline (0.86 mL, 9.42 mmol) and benzaldehyde (0.96 mL, 9.42 mmol). This 
procedure afforded 1.55 g (90%) of the title compound as a colorless oil with 
spectroscopic properties identical to those previously reported.32 1H NMR (700 MHz, 
CDCl3) δ 7.37 (d, J = 7.5 Hz, 2 H), 7.34 (t, J = 7.3 Hz, 2 H), 7.27 (t, J = 7.4 Hz, 1 H), 
7.17 (t, J = 7.6 Hz, 2 H), 6.72 (t, J = 7.3 Hz, 1 H), 6.65 (d, J = 7.8 Hz, 2 H), 4.33 (s, 2 H), 
4.12 (s, br, 1 H). 
 
N-Benzyl-4-bromoaniline. General procedure 2 was used for the condensation and 
subsequent reduction of 4-bromoaniline (0.57 mL, 5 mmol) and benzaldehyde (0.51 mL, 
5 mmol). This procedure afforded 990 mg (76%) of the title compound as a colorless oil 
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with spectroscopic properties identical to those previously reported.33 1H NMR (400 
MHz, CDCl3) δ 7.34 (d, J = 4.5 Hz, 4 H), 7.30–7.22 (m, 3 H), 6.52–6.49 (m, 2 H), 4.30 
(s, 2 H), 4.08 (s, br, 1 H). 
 
 
N-Benzyl-4-methoxyaniline. General procedure 2 was used for the condensation and 
subsequent reduction of 4-anisidine (616 mg, 5 mmol) and benzaldehyde (0.51 mL, 5 
mmol). This procedure afforded 857 mg (80%) of the title compound as a yellow oil with 
spectroscopic properties identical to those previously reported.34 1H NMR (400 MHz, 
CDCl3) δ 7.38–7.26 (m, 5 H), 6.80–6.78 (m, 2 H), 6.63–6.59 (m, 2 H), 4.29 (s, 2 H), 3.79 
(s, br, 1 H), 3.74 (s, 3 H). 
 
 
N-Benzyl-4-(trifluoromethyl)aniline. General procedure 2 was used for the 
condensation and subsequent reduction of 4-(trifluoromethyl)aniline (0.78 mL, 6.20 
mmol) and benzaldehyde (0.64 mL, 6.20 mmol). This procedure afforded 0.734 g (47%) 
of the title compound as a yellow oil with spectroscopic properties identical to those 
previously reported.35 1H NMR (400 MHz, CDCl3) δ 7.40–7.26 (m, 7 H), 6.63 (d, J = 8.6 
Hz, 2 H), 4.38 (s, 3 H). 
 
 
N-(4-Bromobenzyl)aniline. General procedure 2 was used for the condensation and 
subsequent reduction of aniline (0.46 mL, 5 mmol) and 4-bromobenzaldehyde (0.93 g, 5 
mmol). This procedure afforded 1.14 g (87%) of the title compound as a pale yellow oil 
with spectroscopic properties identical to those previously reported.Error! Bookmark not defined. 
1H NMR (400 MHz, CDCl3) δ 7.47–7.44 (m, 2 H), 7.26–7.23 (m, 2 H), 7.19–7.14 (m, 2 
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H), 6.72 (t, J = 1.2, 7.4 Hz, 1 H), 6.62–6.59 (m, 2 H), 4.30 (d, J = 4.3 Hz, 2 H), 4.06 (s, 
br, 1 H). 
 
 
N-(2-Bromobenzyl)aniline. General procedure 2 was used for the condensation and 
subsequent reduction of aniline (0.46 mL, 5.0 mmol) and 2-bromobenzaldehyde (0.58 
mL, 5.0 mmol). This procedure afforded 753 mg (57%) of the title compound as a 
colorless oil with spectroscopic properties identical to those previously reported.36 1H 
NMR (400 MHz, CDCl3) δ 7.55 (d, J = 7.9 Hz, 1 H), 7.40 (d, J = 7.7 Hz, 1 H), 7.27–7.24 
(m, 1 H), 7.19–7.11 (m, 3 H), 6.71 (t, J = 7.3 Hz, 1 H), 6.62 (d, J = 7.6 Hz, 2 H), 4.40 (s, 
2 H), 4.18 (s, br, 1 H). 
 
 
N-(Furan-2-ylmethyl)aniline. General procedure 2 was used for the condensation and 
subsequent reduction of aniline (0.95 mL, 10.4 mmol) and furfural (0.86 mL, 10.4 
mmol). This procedure afforded 1.46 g (81%) of the title compound as a colorless oil 
with spectroscopic properties identical to those previously reported.37 1H NMR (500 
MHz, CDCl3) δ 7.36 (s, 1 H), 7.18 (dd, J = 6.3, 7.5 Hz, 2 H), 6.74 (t, J = 7.6 Hz, 1 H), 
6.68 (d, J = 8.6, 2 H), 6.31 (dd, J = 2.0, 3.2 Hz, 1 H), 6.23 (dd, J = 0.7, 3.1 Hz, 1 H), 
4.32 (s, 2 H), 4.04 (s, br, 1 H). 
 
 
N-(Thiophen-2-ylmethyl)aniline. General procedure 2 was used for the condensation 
and subsequent reduction of aniline (0.46 mL, 5.0 mmol) and thiophene-2-
carboxaldehyde (0.47 mL, 5.0 mmol). This procedure afforded 190 mg (20%) of the title 
compound as a colorless oil with spectroscopic properties identical to those previously 
reported.38 1H NMR (400 MHz, CDCl3) δ 7.22–7.17 (m, 3 H), 7.02–7.00 (m, 1 H), 6.97 
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(dd, J = 5.1 Hz, 1 H), 6.74 (tt, J = 7.4, 1.1 Hz, 1 H), 6.69–6.67 (m, 2 H), 4.51 (d, J = 1.0 
Hz, 2 H), 4.05 (s, br, 1 H).  
 
 
N-((1-Tosyl-1H-pyrrol-2-yl)methyl)aniline. A slightly modified general procedure 2 
was used for the condensation (16 h, 60 ºC) and subsequent reduction of aniline (0.11 
mL, 1.22 mmol) and 1-tosyl-1H-pyrrole-2-carbaldehyde (304 mg, 1.22 mmol). This 
procedure afforded 68.4 mg (17%) of the title compound as a white solid (m.p. 78–82 
ºC) with spectroscopic properties identical to those previously reported.39 1H NMR (400 
MHz, CDCl3) δ 7.64 (d, J = 8.4 Hz, 2 H), 7.30–7.24 (m, 3 H), 7.10 (dd, J = 8.4, 7.6 Hz, 2 
H), 6.68 (t, J = 7.2 Hz, 1 H), 6.45 (d, J = 7.9 Hz, 2 H), 7.20–7.18 (m, 2 H), 4.38 (d, J = 
5.0 Hz, 2 H), 4.05 (s, br, 1 H), 2.40 (s, 3 H).  
 
 
Methyl 2-[benzyl(phenyl)amino]acetate (3-19). General procedure 3 was used for the 
alkylation of N-benzylaniline (712 mg, 3.9 mmol) with bromoacetic acid (0.74 mL, 7.8 
mmol) and iPr2NEt (2.0 mL, 11.7 mmol) in 39 mL of CH3CN. This procedure afforded 
539 mg (54%) of the title compound as a pale yellow solid (m.p. 52–55 ºC) with 
spectroscopic properties identical to those previously reported.40 1H NMR (500 MHz, 
CDCl3) δ 7.34–7.24 (m, 5 H), 7.22–7.19 (m, 2 H), 6.77 (t, J = 7.4 Hz, 1 H), 6.70 (d, J = 
7.8 Hz, 2 H), 4.65 (s, 2 H), 4.10 (s, 2 H), 3.74 (s, 3 H). 13C NMR (176 MHz, CDCl3) δ 
171.6, 148.4, 138.2, 129.3, 128.7, 127.1, 126.8, 117.9, 112.7, 55.7, 52.3, 52.0. 
 
 
Methyl 2-[benzyl(4-bromophenyl)amino]acetate (3-21). General procedure 3 was 
used for the alkylation of N-benzyl-4-bromoaniline (350 mg, 1.33 mmol) with 
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bromoacetic acid (0.38 mL, 3.99 mmol) and iPr2NEt (0.70 mL, 3.99 mmol) in 13 mL of 
CH3CN. This procedure afforded 289 mg (65%) of the title compound as a pale yellow 
oil. 1H NMR (500 MHz, CDCl3) δ 7.22 (t, J = 7.0 Hz, 2 H), 7.28–7.24 (m, 5 H), 6.56–6.53 
(m, 2 H), 4.61 (s, 2 H), 4.07 (s, 2 H), 3.74 (s, 3 H); 13C NMR (176 MHz, CDCl3) δ 171.2, 
147.5, 137.7, 131.9, 128.8, 127.3, 126.7, 114.2, 109.7, 55.7, 52.4, 52.1; IR (film) 1745 
cm–1. MS (ESI+) 334.0436 (334.0437 calcd for C16H16BrNO2, M + H+). 
 
 
Methyl 2-[benzyl(4-methoxyphenyl)amino]acetate (3-23). General procedure 3 was 
used for the alkylation of N-benzy-4-methoxylaniline (540 mg, 2.53 mmol) with 
bromoacetic acid (0.72 mL, 7.59 mmol) and iPr2NEt (1.32 mL, 7.59 mmol) in 25 mL of 
CH3CN. This procedure afforded 487 mg (67%) of the title compound as a yellow oil. 1H 
NMR (500 MHz, CDCl3) δ 7.34–7.25 (m, 5 H), 6.80–6.78 (m, 2 H), 6.69–6.66 (m, 2 H), 
4.59 (s, 2 H), 4.04 (s, 2 H), 3.74 (s, 3 H), 3.72 (s, 3 H); 13C NMR (176 MHz, CDCl3) δ 
171.4, 152.2, 143.1, 138.7, 128.6, 127.1, 127.0, 114.8, 114.4, 56.2, 55.7, 52.8, 51.9; IR 
(film) 1741 cm–1. MS (ESI+) 286.1439 (286.1438 calcd for C17H19NO3, M + H+). 
 
 
Methyl 2-{benzyl[4-(trifluoromethyl)phenyl]amino}acetate (3-25). General procedure 
3 was used for the alkylation of N-benzyl-4-(trifluoromethyl)aniline (130 mg, 0.517 
mmol) with bromoacetic acid (0.1 mL, 1.03 mmol) and iPr2NEt (0.27 mL, 1.55 mmol) in 5 
mL of CH3CN. This procedure afforded 37 mg (22%) of the title compound as a yellow 
oil. 1H NMR (400 MHz, CDCl3) δ 7.43 (d, J = 8.6 Hz, 2 H), 7.34 (t, J = 7.1 Hz, 2 H), 
7.29–7.24 (m, 3 H), 6.69 (d, J = 8.6 Hz, 2 H), 4.69 (s, 2 H), 4.14 (s, 2 H), 3.76 (s, 3 H); 
13C NMR (126 MHz, CDCl3) δ 170.8, 150.8, 137.2, 128.9, 127.4, 126.64, 126.61, 
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126.59, 126.55, 111.7, 55.6, 52.2, 52,1; IR (film) 1746 cm–1. MS (ESI+) 324.1204 
(324.1206 calcd for C16H15F3NO2, M + H+). 
 
 
Methyl 2-[(4-bromobenzyl)(phenyl)amino]acetate (3-27). General procedure 3 was 
used for the alkylation of N-(4-bromobenzyl)aniline (459 mg, 1.75 mmol) with 
bromoacetic acid (0.50 mL, 5.25 mmol) and iPr2NEt (0.91 mL, 5.25 mmol) in 18 mL of 
CH3CN. This procedure afforded 368 mg (63%) of the title compound as a yellow solid 
(m.p. 97–100 ºC). 1H NMR (500 MHz, CDCl3) δ 7.46–7.43 (m, 2 H), 7.22–7.17 (m, 4 H), 
6.80 (t, J = 7.3 Hz, 1 H), 6.65 (d, J = 8.1 Hz, 2 H), 4.59 (s, 2 H), 4.08 (s, 2 H), 3.74 (s, 3 
H); 13C NMR (126 MHz, CDCl3) δ 171.5, 148.2, 137.5, 131.8, 129.3, 128.5, 120.8, 
118.0, 112.6, 55.3, 52.4, 52.0; IR (film) 1746 cm–1. MS (ESI+) 334.0437 (334.0437 
calcd for C16H16BrNO2, M + H+). 
 
 
Methyl 2-[(2-bromobenzyl)(phenyl)amino]acetate (3-29). General procedure 3 was 
used for the alkylation of N-(2-bromobenzyl)aniline (700 mg, 2.67 mmol) with 
bromoacetic acid (0.76 mL, 8.01 mmol) and iPr2NEt (1.40 mL, 8.01 mmol) in 27 mL of 
CH3CN. This procedure afforded 256 mg (40%) of the title compound as a pale yellow 
oil. 1H NMR (500 MHz, CDCl3) δ 7.59–7.58 (m, 1 H), 7.29–7.18 (m, 4 H), 7.15–7.12 (m, 
1 H), 6.77 (t, J = 7.4 Hz, 1 H), 6.59 (d, J = 8.1 Hz, 2 H), 4.65 (s, 2 H), 4.14 (s, 2 H), 3.78 
(s, 3 H); 13C NMR (126 MHz, CDCl3) δ 171.5, 147.9, 136.8, 132.9, 129.3, 128.6, 128.1, 
127.6, 122.7, 117.8, 112.3, 56.7, 52.8, 52.1; IR (film) 1748 cm–1. MS (ESI+) 334.0435 
(334.0437 calcd for C16H16BrNO2, M + H+). 
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Methyl 2-[(furan-2-ylmethyl)(phenyl)amino]acetate (3-31). General procedure 3 was 
used for the alkylation of N-(furan-2-ylmethyl)aniline (455 mg, 2.63 mmol) with 
bromoacetic acid (0.37 mL, 3.94 mmol) and iPr2NEt (1.37 mL, 7.88 mmol) in 26 mL of 
CH3CN. This procedure afforded 534 mg (83%) of the title compound as a pale yellow 
oil. 1H NMR (700 MHz, CDCl3) δ 7.37 (s, 1 H), 7.22 (t, J = 7.9 Hz, 2 H), 6.79–6.76 (m, 3 
H), 6.31 (d, J = 3.0 Hz, 1 H), 6.24 (d, J = 3.0 Hz, 1 H), 4.55 (d, 2 H), 4.07 (s, 2 H), 3.73 
(s, 3 H); 13C NMR (176 MHz, CDCl3) δ 171.6, 151.8, 148.1, 142.2, 129.2, 118.0, 112.9, 
110.3, 107.8, 52.0, 51.8, 48.5; IR (film) 1735 cm–1. MS (ESI+) 246.1129 (246.1125 
calcd for C14H15NO3, M + H+). 
 
 
Methyl N-phenyl-N-(thiophen-2-ylmethyl)glycinate (3-33). General procedure 3 was 
used for the alkylation of N-(thiophene-2-ylmethyl)aniline (155.5 mg, 0.821 mmol) with 
bromoacetic acid (0.12 mL, 1.23 mmol) and iPr2NEt (0.43 mL, 2.46 mmol) in 8.2 mL of 
CH3CN. This procedure afforded 160.6 mg (75%) of the title compound as a colorless 
oil.1H NMR (500 MHz, CDCl3) δ 7.28–7.19 (m, 3 H), 7.00–6.93 (m, 2 H), 6.83–6.73 (m, 
3 H), 4.78 (s, 2 H), 4.09 (s, 2 H), 3.74 (s, 3 H); 13C NMR (126 MHz, CDCl3) δ 171.5, 
148.1, 142.0, 129.3, 126.9, 125.2, 124.7, 118.2, 113.1, 52.0, 51.6, 50.9; IR (film) 1740, 
1504 cm–1. MS (ESI+) 262.0893 (262.0896 calcd for C14H15NO2S, M + H+). 
 
 
Methyl N-phenyl-N-((1-tosyl-1H-pyrrol-2-yl)methyl)glycinate (3-35). General 
procedure 3 was used for the alkylation of N-(thiophene-2-ylmethyl)aniline (150 mg, 046 
mmol) with bromoacetic acid (0.07 mL, 0.69 mmol) and iPr2NEt (0.24 mL, 1.38 mmol) in 
4.6 mL of CH3CN. This procedure afforded 119.2 mg (65%) of the title compound as a 
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pale yellow oil. 1H NMR (500 MHz, CDCl3) δ 7.66 (d, J = 8.2 Hz, 2 H), 7.38 (dd, J = 3.3, 
1.8 Hz, 1 H), 7.29 (d, J = 8.1 Hz, 2 H), 7.13–7.05 (m, 2 H), 6.72 (t, J = 7.1 Hz, 1 H), 6.37 
(d, J = 8.1 Hz, 2 H), 6.21 (t, J = 3.3 Hz, 1 H), 6.14–6.09 (m, 1 H), 4.67 (s, 2 H), 3.81 (s, 
2 H), 3.71 (s, 3 H), 2.44 (s, 3 H); 13C NMR (126 MHz, CDCl3) δ 171.4, 147.6, 145.0, 
136.1, 130.8, 130.0, 129.1, 126.9, 123.4, 117.9, 114.2, 112.5, 111.5, 52.0, 51.6, 49.1, 
21.6; IR (film) 1749, 1505, 1365 cm–1. MS (ESI+) 421.1197 (421.1192 calcd for 
C21H22N2O4S, M + Na+). 
 
 
2-[Phenyl(1-phenylethyl)amino]acetic acid. A flame dried flask was cooled under a 
stream of nitrogen and charged with N-phenylglycine (200 mg, 1.32 mmol) and THF 
(2.7 mL), and the resulting solution was cooled to -78 ºC. To this solution was added n-
BuLi (1.16 mL, 2.5 M soln in hexanes). After stirring 15 min, 1-(bromoethyl)benzene (0.2 
mL, 1.46 mmol) was added dropwise, and the mixture was allowed to warm to rt over 2 
h. The reaction was then quenched with saturated sodium bicarbonate solution, and the 
resulting mixture was transferred to a separatory funnel. The layers were separated and 
the aqueous layer washed was twice with ethyl acetate. The aqueous layer was then 
acidified with H2SO4 and then extracted three times with diethyl ether. The combined 
ether layers were dried over anhydrous sodium sulfate and concentrated in vacuo. The 
crude product was purified by flash chromatography on silica gel to afford 167 mg (49%) 
of the title compound as a white solid, mp 108–114 ºC. 1H NMR (700 MHz, CDCl3) δ 
10.68 (s, br, 1 H), 7.37–7.30 (m, 4 H), 7.25–7.22 (m, 3 H), 6.79 (t, J = 7.3 Hz, 1 H), 6.75 
(d, J = 8.3 Hz, 2 H), 5.18 (q, J = 6.9 Hz, 1 H), 3.95 (s, 2 H), 1.62 (d, J = 6.9 Hz, 3 H); 13C 
NMR (176 MHz, CDCl3) δ 176.9, 148.1, 141.9, 129.4, 128.7, 127.3, 127.0, 118.6, 113.9, 
57.0, 48.5, 17.9; IR (film) 1720 cm–1. MS (ESI-) 254.1187 (254.1187 calcd for 
C16H17NO2, M - H+). 
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Methyl 2-[phenyl(1-phenylethyl)amino]acetate (3-37). A flame dried flask was cooled 
under a stream of nitrogen and charged with methanol (16 µL, 0.407 mmol) and 
dichloromethane (2.0 mL, 0.2 M), and the resulting solution was cooled to 0 ºC. DMAP 
(25 mg, 0.204 mmol), EDC (78 mg, 0.407 mmol), and 2-(phenyl(1-
phenylethyl)amino)acetic acid (104 mg, 0.407 mmol) were added, and the mixture was 
allowed to warm to rt overnight. The dichloromethane was removed in vacuo, and the 
resulting crude oil was diluted with water and ethyl acetate. The mixture was transferred 
to a separatory funnel, the layers were separated, and the organic layer was dried over 
anhydrous sodium sulfate and concentrated in vacuo. The crude product was purified 
by flash chromatography on silica gel to afford 84 mg (76%) of the title compound as a 
colorless oil. 1H NMR (700 MHz, CDCl3) δ 7.35–7.28 (m, 4 H), 7.27–7.17 (m, 3 H), 
6.77–6.68 (m, 3 H), 5.17 (q, J = 7.0 Hz, 1 H), 3.95 (s, 2 H), 3.69 (s, 3 H), 1.60 (d, J = 7.0 
Hz, 3 H); 13C NMR (176 MHz, CDCl3) δ 172.2, 148.5, 142.4, 129.3, 128.6, 127.1, 127.0, 
117.7, 113.2, 56.5, 52.0, 48.5, 18.1; IR (film) 1750, 1597 cm–1. MS (ESI+) 270.1496 
(270.1496 calcd for C17H19NO2, M + H+). 
 
 
Methyl 2-[phenyl(1-phenylethyl)amino]acetate (3-39): A flame-dried flask was cooled 
under a stream of nitrogen and then charged with iPr2NH (0.11 mL, 0.76 mmol) in THF 
(0.5 mL). The reaction mixture was cooled to –78 ºC then a 1.6 M solution of n-BuLi in 
hexanes (0.4 mL, 0.65 mmol) was added and the resulting solution was stirred for 5 
min. To this solution was added compound 3-19 (150 mg, 0.59 mmol) in THF (0.5 mL). 
After stirring for 15 min, iodomethane (0.44 mL, 0.71 mmol) was added and the 
resulting solution was stirred for 15 min at -78 ºC and then 1 h at 0 ºC. The mixture was 
warmed to rt, diluted with NH4Cl and EtOAc, and transferred to a separatory funnel. The 
layers were separated, and the organic layers were washed with brine, dried over 
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sodium sulfate, filtered, and concentrated in vacuo. The crude product was purified by 
flash chromatography on silica gel to afford 78 mg (49%) of the title compound as a 
colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.31 (d, J = 4.4 Hz, 4 H), 7.23–7.19 (m, 1 H), 
7.19–7.15 (m, 2 H), 6.74 (t, J = 7.4 Hz, 1 H), 6.70 (d, J = 8.1 Hz, 2 H), 4.70–7.53 (m, 3 
H), 3.70 (s, 3 H), 1.50 (d, J = 7.4, 3 H); 13C NMR (126 MHz, CDCl3) δ 174.3, 148.9, 
140.1, 129.1, 128.5, 126.6, 126.3, 117.9, 113.7, 56.7, 52.1, 52.0, 16.2; IR (film) 1733 
cm–1. MS (ESI+) 270.1491 (270.1489 calcd for C17H19NO2, M + H+). 
 
Synthesis of N-Arylphenylalanine Methyl Esters via Aza-[1,2]-Wittig 
Rearrangement 
 
General Procedure 4: A flame-dried Schlenk tube was evacuated and backfilled with 
nitrogen three times then charged with a 1 M solution of dibutylboron triflate in 
dichloromethane (3.2 equiv). The solution was cooled to 0 ºC and iPr2NEt (4.0 equiv) 
was added dropwise. A 1 M solution of the ester substrate (1.0 equiv) in methylene 
chloride was then added, and the resulting solution was warmed to 40 ºC. After stirring 
for 1–7 h the starting material had been completely consumed and the mixture was 
cooled to 0 ºC, opened to air, and quenched by the addition of pH 7 buffer solution (ca. 
3 mL/mmol substrate), methanol (ca. 6–8 mL/mmol substrate), and 30% aqueous H2O2 
(ca. 1 mL/mmol substrate). This mixture was warmed to rt and stirred for 1 h. The 
solution was then cooled to 0 ºC and Na2S2O3 (ca. 7 mL/mmol substrate) was added. 
This solution was allowed to stir for 1 min before it was diluted with water and extracted 
twice with Et2O. The combined organic layers were dried over anhydrous sodium 
sulfate, filtered, and concentrated in vacuo. The crude product was purified by flash 
chromatography on silica gel using 5–10% diethyl ether in hexanes as the eluent. 
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Methyl 3-phenyl-2-(phenylamino)propanoate (3-20): General procedure 4 was used 
for the rearrangement of 3-19 (51 g, 0.2 mmol) with dibutylboron triflate (0.64 mL, 0.64 
mmol) and iPr2NEt (0.14 mL, 0.8 mmol) in 0.2 mL of dichloromethane. This procedure 
afforded 33 mg (65%) of the title compound as a colorless oil with spectroscopic 
properties identical to those previously reported.41 1H NMR (700 MHz, CDCl3) δ 7.30–
7.28 (m, 2 H), 7.25–7.23 (m, 1 H), 7.18–7.16 (m, 4 H), 6.74 (t, J = 7.3 Hz, 1 H), 6.60 (d, 
J = Hz, 2 H), 4.37 (t, J = 6.3 Hz, 1 H), 4.16 (s, br, 1 H), 3.67 (s, 3 H), 3.16 (dd, J = 13.7, 
6.0 Hz, 1 H), 3.10 (dd, J = 13.6, 6.5 Hz, 1 H); 13C NMR (176 MHz, CDCl3) δ 173.6, 
146.3, 136.3, 129.4, 129.2, 128.5, 127.0, 118.4, 113.6, 57.7, 52.0, 38.6. 
 
 
Methyl 2-[(4-bromophenyl)amino]-3-phenylpropanoate (3-22): General procedure 4 
was used for the rearrangement of 3-21 (67 mg, 0.2 mmol) with dibutylboron triflate 
(0.64 mL, 0.64 mmol) and iPr2NEt (0.14 mL, 0.8 mmol) in 0.2 mL of dichloromethane. 
This procedure afforded 39 mg (59%) of the title compound as an orange oil. 1H NMR 
(500 MHz, CDCl3) δ 7.30–7.23 (m, 5 H), 7.13 (d, J = 6.9 Hz, 2 H), 6.47–6.44 (m, 2 H), 
4.31 (t, J = 6.3 Hz, 1 H), 4.16 (s, br, 1 H), 3.67 (s, 3 H), 3.14 (dd, J = 6.1, 13.7 Hz, 1 H), 
3.08 (dd, J = 6.3, 13.7 Hz, 1 H); 13C NMR (126 MHz, CDCl3) δ 173.2, 145.4, 136.0, 
132.1, 129.2, 128.6, 127.1, 115.1, 110.1, 57.6, 52.1, 38.5; IR (film) 3395,1736 cm–1. MS 
(ESI+) 334.0432 (334.0437 calcd for C16H16BrNO2, M + H+). 
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Methyl 2-[(4-methoxyphenyl)amino]-3-phenylpropanoate (3-24): General procedure 
4 was used for the rearrangement of 3-23 (50 mg, 0.18 mmol) with dibutylboron triflate 
(0.56 mL, 0.56 mmol) and iPr2NEt (0.12 mL, 0.7 mmol) in 0.18 mL of dichloromethane. 
This procedure afforded 35 mg (70%) of the title compound as an orange oil. 1H NMR 
(500 MHz, CDCl3) δ 7.31–7.23 (m, 3 H), 7.17 (d, J = 7.1 Hz, 2 H), 6.77–6.74 (m, 2 H), 
6.59–6.56 (m, 2 H), 4.27 (t, J = 6.4 Hz, 1 H), 3.88 (s, br, 1 H), 3.73 (s, 3 H), 3.64 (s, 3 
H), 3.15–3.06 (m, 2 H); 13C NMR (125 MHz, CDCl3) δ 173.9, 152.9, 140.4, 136.5, 129.2, 
128.5, 126.9, 115.3, 114.9, 59.0, 55.7, 52.0, 38.9; IR (film) 3337,1684 cm–1. MS (ESI+) 
286.1438 (286.1438 calcd for C17H19NO2, M + H+). 
 
 
Methyl 3-phenyl-2-{[4-(trifluoromethyl)phenyl]amino}propanoate (3-26): General 
procedure 4 was used for the rearrangement of 3-25 (97 mg, 0.3 mmol) with 
dibutylboron triflate (0.96 mL, 0.96 mmol) and iPr2NEt (0.21 mL, 1.2 mmol) in 0.3 mL of 
dichloromethane. This procedure afforded 23 mg (24%) of the title compound as a 
yellow oil.1H NMR (700 MHz, CDCl3) δ 7.39 (d, J = 8.4 Hz, 2 H), 7.32–7.22 (m, 3 H), 
7.15–7.11 (m, 2 H), 6.59 (d, J = 8.4 Hz, 2 H), 4.48 (d, J = 8.4 Hz, 1 H), 4.42–4.39 (m, 1 
H), 3.70 (s, 3 H), 3.18 (dd, J = 13.7, 5.9 Hz, 1 H), 3.11 (dd, J = 13.8, 6.2 Hz, 1 H); 13C 
NMR (176 MHz, CDCl3) δ 172.7, 148.8, 135.8, 129.2, 128.6, 127.2, 126.74, 126.71, 
112.6, 57.0, 52.3, 38.3, 29.7; IR (film) 3390, 1739 cm–1. MS (ESI+) 324.1206 (324.1206 
calcd for C17H16F3NO2, M + H+). 
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Methyl 3-(4-bromophenyl)-2-(phenylamino)propanoate (3-28): General procedure 4 
was used for the rearrangement of 3-27 (75 mg, 0.22 mmol) with dibutylboron triflate 
(0.72 mL, 0.72 mmol) and iPr2NEt (0.16 mL, 0.88 mmol) in 0.25 mL of dichloromethane. 
This procedure afforded 53 mg (70%) of the title compound as a yellow oil. 1H NMR 
(700 MHz, CDCl3) δ 7.40 (d, J = 8.2 Hz, 2 H), 7.17 (t, J = 5.5 Hz, 2 H), 7.02 (d, J = 7.8 
Hz, 2 H), 6.75 (td, J = 1.1, 7.4 Hz, 1 H), 6.60 (d, J = 8.5 Hz, 2 H), 4.37–4.34 (m, 1 H), 
4.14 (d, J = 8.3 Hz, 1 H), 3.67 (s, 3 H), 3.11 (dd, J = 6.0, 13.7 Hz, 1 H), 3.04 (dd, J = 
6.2, 13.8 Hz, 1 H); 13C NMR (176 MHz, CDCl3) δ 173.2, 146.0, 135.3, 131.6, 131.0, 
129.4, 121.0, 118.6, 113.5, 57.4, 52.2, 37.9; IR (film) 3405, 1738 cm–1. MS (ESI+) 
334.0440 (334.0437 calcd for C16H16BrNO2, M + H+). 
 
 
 
 
Methyl 3-(2-bromophenyl)-2-(phenylamino)propanoate (3-30): General procedure 4 
was used for the rearrangement of compound 3-29 (67 mg, 0.2 mmol) with dibutylboron 
triflate (0.64 mL, 0.64 mmol) and iPr2NEt (0.14 mL, 0.8 mmol) in 0.2 mL of 
dichloromethane. This procedure afforded 31 mg (47%) of the title compound as a white 
solid (m.p. 100–102 ºC). 1H NMR (500 MHz, CDCl3) δ 7.55 (d, J = 8.0 Hz, 1 H), 7.22–
7.20 (m, 2 H), 7.13 (t, J = 7.6 Hz, 2 H), 7.11–7.08 (m, 1 H), 6.72 (t, J = 7.3 Hz, 1 H), 
6.60 (d, J = 7.8 Hz, 2 H), 4.45 (t, J = 6.6 Hz, 1 H), 4.23 (s, br, 1 H), 3.63 (s, 3 H), 3.28 
(dd, J = 7.5, 13.6 Hz, 1 H), 3.21 (dd, J = 7.8, 13.8 Hz, 1 H); 13C NMR (176 MHz, CDCl3) 
δ 173.7, 146.4, 136.3, 133.0, 131.4, 129.3, 128.7, 127.5, 124.8, 118.5, 113.6, 56.7, 
MeO
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Br
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52.1, 39.4; IR (film) 3385,1736 cm–1. MS (ESI+) 334.0438 (334.0437 calcd for 
C16H16BrNO2, M + H+). 
 
 
Methyl 3-(furan-2-yl)-2-(phenylamino)propanoate (3-32): General procedure 4 was 
used for the rearrangement of compound 3-31 (49 mg, 0.2 mmol) with dibutylboron 
triflate (0.64 mL, 0.64 mmol) and iPr2NEt (0.14 mL, 0.8 mmol) in 0.2 mL of 
dichloromethane. This procedure afforded 36 mg (73%) of the title compound as a pale 
yellow solid (m.p. 66–68 ºC). 1H NMR (400 MHz, CDCl3) δ 7.33 (d, J = 1.6 Hz, 1 H), 
7.17 (t, J = 8.0 Hz, 2 H), 6.74 (t, J = 7.3 Hz, 1 H), 6.60 (d, J = 6.9 Hz, 2 H), 6.28 (dd, J = 
3.2, 1.9 Hz, 1 H), 6.10 (d, J = 3.2 Hz, 1 H), 4.38 (dt, J = 8.2, 5.9 Hz, 1 H), 4.24 (d, J = 
8.4 Hz, 1 H), 3.70 (s, 3 H), 3.17 (d, J = 6.0 Hz, 2 H); 13C NMR (176 MHz, CDCl3) δ 
173.3, 150.6, 146.3, 142.1, 129.3, 118.5, 113.6, 110.4, 107.8, 55.9, 52.2, 31.4; IR (film) 
3393, 1737 cm–1. MS (ESI+) 246.1134 (246.1125 calcd for C14H15NO3, M + H+). 
 
 
Methyl 2-(phenylamino)-3-(thiophen-2-yl)propanoate (3-34): General procedure 4 
was used for the rearrangement of compound 3-33 (52.3 mg, 0.2 mmol) with 
dibutylboron triflate (0.64 mL, 0.64 mmol) and iPr2NEt (0.14 mL, 0.8 mmol) in 0.2 mL of 
dichloromethane. This procedure afforded 36.8 mg (70%) of the title compound as a 
pale yellow oil. 1H NMR (500 MHz, CDCl3) δ 7.23–7.13 (m, 3 H), 6.94 (dd, J = 5.2, 3.4 
Hz, 1 H), 6.84 (d, J = 3.4 Hz, 1 H), 6.67 (t, J = 7.3 Hz, 1 H), 6.43 (d, J = 7.5 Hz, 2 H), 
4.41–4.37 (m, 1 H), 4.29 (d, J = 8.8 Hz, 1 H), 3.73 (s, 3 H), 3.40 (dd, J = 14.6, 5.3 Hz, 1 
H) , 3.33 (dd, J = 14.8, 6.7 Hz, 1 H); 13C NMR (126 MHz, CDCl3) δ 173.0, 146.1, 137.9, 
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129.4, 126.9, 126.6, 124.8, 118.6, 113.7, 57.5, 52.3, 32.7; IR (film) 3370,1732 cm–1. MS 
(ESI+) 262.0899 (262.0896 calcd for C14H15NO2S, M + H+). 
 
 
Methyl 2-(phenylamino)-3-(1-tosyl-1H-pyrrol-2-yl)propanoate (3-36): General 
procedure 4 was used for the rearrangement of compound 3-35 (64.9 mg, 0.163 mmol) 
with dibutylboron triflate (0.52 mL, 0.521 mmol) and iPr2NEt (0.11 mL, 0.652 mmol) in 
0.15 mL of dichloromethane. This procedure afforded 36.3 mg (59%) of the title 
compound as a pale yellow oil. 1H NMR (700 MHz, CDCl3) δ 7.63 (d, J = 8.4 Hz, 2 H), 
7.29 (dd, J = 3.4, 1.7 Hz, 1 H), 7.25 (d, J = 8.2 Hz, 2 H), 7.20–7.11 (m, 2 H), 6.72 (t, J = 
7.3 Hz, 1 H), 6.56 (d, J = 7.9 Hz, 2 H), 6.19 (t, J = 3.3 Hz, 1 H), 6.09 (dd, J = 3.4, 1.7 Hz, 
1 H), 4.36 (q, J = 7.0 Hz, 1 H), 4.20 (s, br, 1 H), 3.63 (s, 3 H), 3.22 (dd, J = 15.1, 7.4Hz, 
1 H), 3.17 (dd, J = 15.2, 6.6 Hz, 1 H), 2.38 (s, 3 H); 13C NMR (176 MHz, CDCl3) δ 173.8, 
146.4, 145.1, 136.2, 130.1, 129.9, 129.3, 126.6, 123.4, 118.4, 115.0, 113.5, 111.8, 56.8, 
52.1, 31.0, 21.6; IR (film) 3370,1736, 1601, 1362 cm–1. MS (ESI+) 399.1379 (399.1373 
calcd for C21H22N2O4S, M + H+). 
 
 
Methyl 3-phenyl-2-(phenylamino)butanoate (3-38): General procedure 4 was used 
for the rearrangement of 3-37 (48.4 mg, 0.18 mmol) with dibutylboron triflate (0.58 mL, 
0.58 mmol) and iPr2NEt (0.13 mL, 0.72 mmol) in 0.2 mL of dichloromethane. This 
procedure afforded 32 mg (66%) of the title compound as a white solid (m.p. 55–57 ºC). 
The diastereoselectivity of the transformation could not be determined through 1H NMR 
analysis of the crude reaction mixture prior to purification due to signal overlap with 
boron-containing byproducts; the isolated product was obtained with 1.6:1 dr following 
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purification. Data are for the mixture. 1H NMR (500 MHz, CDCl3) δ 7.37–7.20 (m, 5 H), 
7.12 (t, J = 7.6 Hz, 2 H), 6.73–6.69 (m, 1 H), 6.58–6.54 (m, 2 H), 4.22–4.17 (m, 1.4 H), 
3.90 (d, J = 8.7 Hz, 0.6 H), 3.68 (s, 1.8 H), 3.49 (s, 1.2 H), 3.32–3.29 (m, 0.6 H), 3.22–
3.20 (m, 0.4 H), 1.46 (d, J = 7.2 Hz, 1.2 H), 1.40 (d, J = 7.1 Hz, 1.8 H); 13C NMR (176 
MHz, CDCl3) δ 173.9, 147.1, 142.0, 129.3, 128.6, 127.8, 127.2, 118.5, 113.8, 63.1, 
52.0, 43.0, 18.4; IR (film) 3387, 1734 cm–1. MS (ESI+) 270.1480 (270.1489 calcd for 
C17H19NO2, M + H+). 
 
Synthesis and Characterization of N-Allyl-N-Aryl Glycine Methyl Esters 
 
 
 
General Procedure 5: A flame-dried flask was cooled under a stream of nitrogen and 
then charged with a solution of aniline (1.0 equiv), aldehyde (1.0 equiv), triethylamine 
(1.4 equiv) and methanol (0.5 M). This mixture was allowed to stir at rt until complete as 
judged by TLC. When complete, the solution was cooled to 0 ºC and NaBH4 (1.0 equiv) 
was added slowly. The solution was allowed to warm to rt and stirred until complete as 
judged by TLC. When complete, the reaction mixture was diluted with water and 
extracted twice with hexanes. The combined organic layers were washed with brine, 
dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. The crude 
product was purified by flash chromatography on silica gel using 5-20% ethyl acetate in 
hexanes as the eluent. 
General Procedure 6: A flame-dried flask was cooled under a stream of nitrogen and 
then charged with a solution of aryl amine (1.0 equiv), methyl bromoacetate (2.0-3.0 
equiv), and Hunig’s base (3.0 equiv) in acetonitrile (0.1 M). The mixture was stirred at 
reflux for 24 h. After cooling to rt, the solution was concentrated in vacuo, then 
partitioned between saturated NaHCO3 and CH2Cl2. The organic layer was dried over 
anhydrous sodium sulfate, filtered, and concentrated in vacuo. The crude product was 
purified by flash chromatography on silica gel using 3-10% ethyl acetate in hexanes as 
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the eluent. 
 
 
N-Crotylaniline. General prodedure 5 was used for the condensation of crotonaldehyde 
(0.41 mL, 5.0 mmol) with aniline (0.46 mg, 5.0 mmol) and NEt3 (0.7 mL, 5.0 mmol) in 10 
mL of methanol. The subsequent reduction was carried out with NaBH4 (265 mg, 7.0 
mmol). This procedure afforded 406 mg (55%) of 4-methylpent-2-yn-1-ol as a colorless 
oil with spectroscopic properties identical to those previously reported.42 1H NMR (500 
MHz, CDCl3) δ 7.15–7.19 (m, 2 H), 6.68–6.71 (m, 1 H), 6.60–6.63 (m, 2 H), 5.68–5.74 
(m, 1 H), 5.57–5.62 (m, 1 H), 3.68–3.69 (m, 3 H), 1.70 (dd, J = 1.5, 6.4 Hz, 3 H). 
 
 
N-Cinnamylaniline. General prodedure 5 was used for the condensation of 
cinnamaldehyde (1 g, 14.7 mmol) with aniline (620 mg, 20.6 mmol) and NEt3 (11.0 mL, 
17.6 mmol) in 18 mL of methanol. The subsequent reduction was carried out with LiAlH4 
(1.47 mL, 5 mmol). This procedure afforded 1.2 g (55%) of 4-methylpent-2-yn-1-ol as a 
pale yellow oil with spectroscopic properties identical to those previously reported.43 1H 
NMR (500 MHz, CDCl3) δ 7.38–7.29 (m, 4 H), 7.24–7.17 (m, 3 H), 6.74–6.61 (m, 4 H), 
6.37–6.30 (m, 1 H), 3.94 (d, J = 5.6 Hz, 2 H), 3.84 (s, br, 1 H).  
 
 
N-(2-Mthylallyl)aniline. A flame dried flask was cooled under a stream of nitrogen and 
charged with a solution of 3-chloro-2-methylpropene (0.69 mL, 7 mmol) in acetonitrile 
(28 mL, 0.25 M). To this solution was added aniline (1.28 mL, 14 mmol) and NEt3 (1.95 
mL, 14 mmol). This solution was heated to reflux overnight. The solvent was removed in 
vacuo and the crude product was purified by flash column chromatography on silica gel. 
This procedure afforded 394 mg (38%) of the title compound as a colorless oil with 
spectroscopic properties identical to those previously reported.44 1H NMR (400 MHz, 
CDCl3) δ 7.13–7.18 (m, 2 H), 6.68 (td, J = 1.0, 7.4, 1 H), 6.59 (dd, J = 1.0, 8.5, 2 H), 
H
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4.96 (s, 1 H), 4.87 (s, 1 H), 3.67 (s, 2 H), 1.78 (s, 3 H). 
 
 
N-(3-Methylbut-2-en-1-yl)aniline. General prodedure 5 was used for the condensation 
of 3-methyl-2-butenal (0.48 mL, 5 mmol) with aniline (0.46 mL, 5 mmol) and NEt3 (0.7 
mL, 5 mmol) in 10 mL of methanol. The subsequent reduction was carried out with 
NaBH4 (265 mg, 7 mmol). This procedure afforded 655.7 mg (81%) of the title 
compound as a yellow oil with spectroscopic properties identical to those previously 
reported.45 1H NMR (400 MHz, Chloroform-d) δ 7.23–7.13 (m, 2 H), 6.71 (t, J = 7.3 Hz, 
1 H), 6.66–6.58 (m, 2 H), 5.34 (t, J = 6.7 Hz, 1 H), 3.69 (d, J = 6.7 Hz, 2 H), 3.57 (s, br, 
1 H), 1.74 (d, J = 14.7 Hz, 6 H). 
 
 
(E)-4-Methoxy-N-(oct-2-en-1-yl)aniline. General prodedure 5 was used for the 
condensation of 2-octenal (0.75 mL, 5 mmol) with anisidine (616 mg, 5 mmol) and NEt3 
(0.7 mL, 5 mmol) in 10 mL of methanol. The subsequent reduction was carried out with 
NaBH4 (265 mg, 7 mmol). This procedure afforded 711 mg (61%) of the title compound 
as a pale yellow oil. 1H NMR (500 MHz, CDCl3) δ 6.79 (d, J = 8.8 Hz, 2 H), 6.60 (d, J = 
8.9 Hz, 2 H), 5.72–5.66 (m, 1 H), 5.62–5.51 (m, 1 H), 3.75 (s, 3 H), 3.65 (d, J = 6.1 Hz, 
2 H), 3.42 (s, br, 1 H), 2.02 (q, J = 7.4 Hz, 2 H), 1.44–1.21 (m, 6 H), 0.89 (t, J = 7.1 Hz, 
3 H); 13C NMR (126 MHz, CDCl3) δ 152.1, 142.5, 133.4, 127.0, 114.8, 114.3, 55.8, 47.1, 
32.3, 31.4, 28.9, 22.5, 14.0; IR (film) 3394, 1511, 1233 cm–1. MS (ESI+) 234.1850 
(234.1852 calcd for C15H23NO, M + H+). 
 
 
(E)-4-Chloro-N-(pent-2-en-1-yl)aniline. General prodedure 5 was used for the 
condensation of 2-pentenal (0.49 mL, 5 mmol) with 4-chloroaniline (638 mg, 5 mmol) 
and NEt3 (0.7 mL, 5 mmol) in 10 mL of methanol. The subsequent reduction was carried 
out with NaBH4 (265 mg, 7 mmol). This procedure afforded 504.7 mg (52%) of the title 
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compound as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.09 (d, J = 8.0 Hz, 2 H), 
6.51 (d, J = 8.2 Hz, 2 H), 5.76–5.69 (m, 1 H), 5.58–5.45 (m, 1 H), 3.72–3.61 (m, 3 H), 
2.08–2.01 (m, 2 H), 0.98 (td, J = 7.5, 1.0 Hz, 3 H); 13C NMR (126 MHz, CDCl3) δ 146.8, 
135.2, 129.0, 125.3, 121.8, 114.0, 46.1, 25.3, 13.5; IR (film) 3415, 1600 cm–1. MS 
(ESI+) 196.0885 (196.0888 calcd for C11H14ClN, M + H+). 
 
 
N-(Cyclohex-1-en-1-ylmethyl)aniline. General prodedure 5 was used for the 
condensation of 1-cyclohexene-1-carboxaldehyde (0.52 mL, 4.54 mmol) with aniline 
(0.42 mL, 4.54 mmol) and NEt3 (0.63 mL, 4.54 mmol) in 9 mL of methanol. The 
subsequent reduction was carried out with NaBH4 (240 mg, 6.36 mmol). This procedure 
afforded 682 mg (80%) of the title compound as a colorless oil with spectroscopic 
properties identical to those previously reported.46 1H NMR (400 MHz, CDCl3) δ 7.15 
(dd, J = 8.6, 7.2 Hz, 2 H), 6.67 (t, J = 7.3 Hz, 1 H), 6.67–6.56 (m, 2 H), 5.66 (s, 1 H), 
3.74 (s, 1 H), 3.59 (s, 2 H), 2.06–1.95 (m, 5 H), 1.69–1.51 (m, 3 H). 
 
 
Methyl-2-(allyl(phenyl)amino)acetate (3-40).  General prodedure 6 was used for the 
alkylation of N-allylaniline (418 mg, 3.14 mmol) with methylbromoacetate (0.60 mL, 6.28 
mmol) and iPr2NEt (1.64 mL, 9.42 mmol) in 31 mL of CH3CN. This procedure afforded 
546 mg (85%) of the title compound as a colorless oil with spectroscopic properties 
identical to those previously reported.40 1H NMR (700 MHz, CDCl3) δ 7.21 (td, J = 1.8, 
7.3 Hz, 2 H), 6.75 (t, J = 7.3 Hz, 1 H), 6.66 (d, J = 8.1 Hz, 2 H), 5.86–5.92 (m, 1 H), 
5.18–5.25 (m, 2 H), 4.04 (s, 2 H), 4.03 (d, J = 4.9 Hz, 2 H), 3.74 (s, 3 H); 13C NMR (176 
MHz, CDCl3) δ 171.8, 148.1, 133.7, 129.2, 117.5, 116.6, 112.4, 54.2, 52.0, 51.9. 
 
 
N
H
Ph
MeO
O
N
MeO
O
N
	   80	  
Methyl-2-(allyl(phenyl)amino)acetate (3-43).  General prodedure 6 was used for the 
alkylation of N-crotylaniline (353 mg, 2.40 mmol) with methylbromoacetate (0.34 mL, 3.6 
mmol) and iPr2NEt (1.25 mL, 7.2 mmol) in 24 mL of CH3CN. This procedure afforded 
389 mg (74%) of the title compound as a colorless oil. 1H NMR (700 MHz, CDCl3) δ 7.21 
(t, J = 7.3 Hz, 2 H), 6.73 (t, J = 7.2 Hz, 1 H), 6.70 (t, J = 8.0 Hz, 2 H), 5.68–5.60 (m, 1 
H), 5.54–5.50 (m, 1 H), 4.01 (s, 2 H), 3.94 (d, J = 5.6 Hz, 2 H), 3.72 (s, 3 H), 1.70 (d, J = 
6.3 Hz, 3 H); 13C NMR (176 MHz, CDCl3) δ 171.9, 148.3, 129.2, 128.1, 126.4, 117.3, 
112.5, 53.3, 52.0, 51.6, 17.7; IR (film) 1746 cm–1. MS (ESI+) 220.1332 (220.1332 calcd 
for C13H17NO2, M + H+). 
 
 
Methyl-2-(cinnamyl(phenyl)amino)acetate (3-45).  General prodedure 6 was used for 
the alkylation of N-cinnamylaniline (168 mg, 0.805 mmol) with methylbromoacetate 
(0.11 mL, 1.2 mmol) and iPr2NEt (0.42 mL, 2.4 mmol) in 8 mL of CH3CN. This 
procedure afforded 148 mg (65%) of the title compound as a pale yellow solid, m.p. 46–
49 ºC. 1H NMR (500 MHz, CDCl3) δ 7.35–7.37 (m, 2 H), 7.25–7.32 (m, 2 H), 7.21–7.25 
(m, 3 H), 6.77 (t, J = 7.3 Hz, 1 H), 6.72 (dd, J = 1.0, 9.0 Hz, 2 H), 6.56 (d, J = 15.9 Hz, 1 
H), 6.28 (dt, J = 5.3, 15.8 Hz, 1 H), 4.19 (dd, J = 1.4, 5.3, 2 H), 4.09 (s, 2 H), 3.74 (s, 3 
H); 13C NMR (176 MHz, CDCl3) δ 171.8, 148.3, 136.7, 131.6, 129.3, 128.6, 127.5, 
126.4, 125.5, 117.6, 112.5, 53.8, 52.0, 51.9; IR (film) 1747 cm–1. MS (ESI+) 282.1492 
(282.1489 calcd for C19H19NO2, M + Na+). 
 
 
Methyl-2-((3-methylbut-2-en-1-yl)(phenyl)amino)acetate (3-47). General prodedure 6 
was used for the alkylation of N-(3-methylbut-2-en-1-yl)aniline (666 mg, 4.13 mmol) with 
methylbromoacetate (0.59 mL, 6.19 mmol) and iPr2NEt (2.16 mL, 12.38 mmol) in 41 mL 
of CH3CN. This procedure afforded 869 mg (90%) of the title compound as a colorless 
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oil. 1H NMR (400 MHz, CDCl3) δ 7.24–7.15 (m, 2 H), 6.76–6.62 (m, 3 H), 5.31–5.20 (m, 
1 H), 4.03–3.93 (m, 4 H), 3.71 (s, 3 H), 1.71 (d, J = 14.5 Hz, 6 H); 13C NMR (176 MHz, 
CDCl3) δ 172.0, 148.5, 135.6, 129.2, 120.9, 117.3, 112.6, 51.9, 51.7, 49.1, 25.8, 17.9; 
IR (film) 1745, 1598 cm–1. MS (ESI+) 234.1484 (234.1489 calcd for C14H19NO2, M + H+). 
 
 
Methyl-2-((2-methylallyl)(phenyl)amino)acetate (3-49).  General prodedure 6 was 
used for the alkylation of N-(2-methylallyl)aniline (394 mg, 2.67 mmol) with 
methylbromoacetate (0.38 mL, 4.05 mmol) and iPr2NEt (1.40 mL, 8.1 mmol) in 27 mL of 
CH3CN. This procedure afforded 436.7 mg (75%) of 4-methylpent-2-yn-1-ol as a 
colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.19 (t, J = 7.4 Hz, 2 H), 6.71 (t, J = 7.3 Hz, 1 
H), 6.61 (d, J = 8.3 Hz, 2 H), 4.86 (s, 2 H), 4.02 (s, 2 H), 3.88 (s, 2 H), 3.72 (s, 3 H), 1.73 
(s, 3 H); 13C NMR (176 MHz, CDCl3) δ 171.8, 148.5, 140.9, 129.1, 117.3, 112.2, 111.1, 
57.7, 51.91, 51.89, 19.9; IR (film) 1746 cm–1. MS (ESI+) 220.1331 (220.1332 calcd for 
C13H17NO2, M + H+). 
 
 
(E)-Methyl 2-((4-methoxyphenyl)(oct-2-en-1-yl)amino)acetate (3-51). General 
prodedure 6 was used for the alkylation of (E)-4-methoxy-N-(oct-2-en-1-yl)aniline (710 
mg, 3.04 mmol) with methylbromoacetate (0.43 mL, 4.56 mmol) and iPr2NEt (1.59 mL, 
9.12 mmol) in 30 mL of CH3CN. This procedure afforded 554 mg (89%) of the title 
compound as a yellow oil. 1H NMR (400 MHz, CDCl3) δ 6.79 (d, J = 9.2 Hz, 2 H), 6.65 
(d, J = 9.0 Hz, 2 H), 5.70–5.55 (m, 1 H), 5.52–5.39 (m, 1 H), 3.95 (s, 2 H), 3.87 (d, J = 
5.9 Hz, 2 H), 3.72 (s, 3 H), 3.69 (s, 3 H), 2.06–1.96 (m, 2 H), 1.40–1.16 (m, 6 H), 0.86 
(t, J = 6.9 Hz, 3 H); 13C NMR (126 MHz, CDCl3) δ 172.1, 152.1, 143.2, 133.9, 125.5, 
114.7, 114.6, 55.7, 54.0, 52.2, 51.8, 32.2, 31.3, 28.9, 22.5, 14.0; IR (film) 1745, 1512 
cm–1. MS (ESI+) 306.2069 (306.2064 calcd for C18H27NO3, M + H+). 
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(E)-Methyl 2-((4-chlorophenyl)(pent-2-en-1-yl)amino)acetate (3-53). General 
prodedure 6 was used for the alkylation of (E)-4-chloro-N-(pent-2-en-1-yl)aniline (505 
mg, 2.58 mmol) with methylbromoacetate (0.37 mL, 3.87 mmol) and iPr2NEt (1.35 mL, 
7.74 mmol) in 26 mL of CH3CN. This procedure afforded 479 mg (69%) of the title 
compound as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.17–7.08 (m, 2 H), 6.61–
6.50 (m, 2 H), 5.65 (dt, J = 15.5, 6.3 Hz, 1 H), 5.49–5.37 (m, 1 H), 3.98 (s, 2 H), 3.90 (d, 
J = 5.7 Hz, 2 H), 3.71 (s, 3 H), 2.09–2.02 (m, 2 H), 0.96 (t, J = 7.4 Hz, 3 H); 13C NMR 
(176 MHz, CDCl3) δ 171.5, 147.0, 135.4, 128.9, 123.7, 122.1, 113.6, 53.5, 52.0, 51.7, 
25.2, 13.5; IR (film) 1745, 1598, 1498 cm–1. MS (ESI+) 268.1099 (268.1099 calcd for 
C14H18ClNO2, M + H+). 
 
 
Methyl 2-[(cyclohex-1-en-1-ylmethyl)(phenyl)amino]acetate (3-55). General 
prodedure 6 was used for the alkylation of N-(cyclohex-1-en-1-ylmethyl)aniline (0.5 mg, 
2.67 mmol) with methylbromoacetate (0.38 mL, 4.01 mmol) and iPr2NEt (1.40 mL, 8.01 
mmol) in 27 mL of CH3CN. This procedure afforded 554 mg (78%) of the title compound 
as a colorless oil. 1H NMR (700 MHz, CDCl3) δ 7.19 (t, J = 8.1 Hz, 2 H), 6.71 (t, J = 7.3 
Hz, 1 H), 6.64 (d, J = 8.1 Hz, 2 H), 5.57 (s, 1 H), 4.00 (s, 2 H), 3.84 (s, 2 H), 3.72 (s, 3 
H), 2.00 (s, 2 H), 1.91 (s, 2 H), 1.65–1.62 (m, 2 H), 1.62–1.53 (m, 2 H); 13C NMR (176 
MHz, CDCl3) δ 171.9, 148.8, 133.3, 129.1, 122.9, 117.1, 112.3, 57.6, 51.9, 51.5, 26.3, 
25.0, 22.6, 22.5; IR (film) 1748 cm–1. MS (ESI+) 260.1653 (260.1645 calcd for 
C16H21NO2, M + H+). 
 
Synthesis of Allylglycine Derivatives via Aza-[2,3]-Wittig Rearrangement 
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General Procedure 7: A flame-dried flask was evacuated and backfilled with nitrogen 
three times then charged with a 1 M solution of dibutylboron triflate in methylene 
chloride (1.5 equiv). The solution was diluted to ca. 0.5 M with methylene chloride then 
cooled to 0 ºC before Hunig’s base (1.7 equiv) was added dropwise. A 1 M solution of 
the ester substrate (1.0 equiv) in methylene chloride was then added, and the resulting 
solution was warmed to 35 ºC. After stirring for 2–4 h, the mixture was cooled to 0 ºC, 
opened to air, and quenched by the addition of pH 7 buffer solution (ca. 3 mL/mmol 
substrate), methanol (ca. 6-8 mL/mmol substrate), and 30% aqueous H2O2 (ca. 1 
mL/mmol substrate). This mixture was warmed to rt and stirred for 1 h. The solution was 
then cooled to 0 ºC and Na2S2O3 (ca. 7 mL/mmol substrate) was added. This solution 
was allowed to stir for 1 min before it was diluted with water and extracted twice with 
Et2O. The combined organic layers were dried over anhydrous sodium sulfate, filtered, 
and concentrated in vacuo. The crude product was purified by flash chromatography on 
silica gel using 5–10% diethyl ether in hexanes as the eluent. 
 
 
Methyl-2-(phenylamino)pent-4-enoate (3-41). General prodedure 7 was used for the 
reaction of 3-40 (41.1 mg, 0.2 mmol) with dibutylboron triflate (0.3 mL, 0.3 mmol) and 
iPr2NEt (0.06 mL, 0.34 mmol) in 0.7 mL of dichloromethane. This procedure afforded 
28.8 mg (70%) of the title compound as a pale yellow oil. 1H NMR (700 MHz, CDCl3) δ 
7.19–7.14 (m, 2 H), 6.74 (t, J = 7.4 Hz, 1 H), 6.63–6.59 (m, 2 H), 5.81–5.75 (m, 1 H), 
5.19–5.13 (m, 2 H), 4.15 (s, 1 H), 3.72 (s, 3 H), 2.64–2.53 (m, 2 H).; 13C NMR (176 
MHz, CDCl3) δ 173.9, 146.5, 132.7, 129.3, 119.0, 118.4, 113.4, 56.0, 52.1, 37.0; IR 
(film) 3400, 1737, 1603 cm–1. MS (ESI+) 206.1171 (206.1176 calcd for C12H15NO2, M + 
H+). 
1) Bu2BOTf (1.5 eq), 
iPr2NEt, CH2Cl2, 35 ºC
2) H2O2, pH 7 buffer
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(2S*,3R*)-Methyl-3-methyl-2-(phenylamino)pent-4-enoate (3-44). General prodedure 
7 was used for the reaction of 3-43 (43.9 mg, 0.2 mmol) with dibutylboron triflate (0.3 
mL, 0.3 mmol) and iPr2NEt (0.06 mL, 0.34 mmol) in 0.7 mL of dichloromethane. This 
procedure afforded 25.7 mg (59%) of the title compound as a colorless oil. The 
diastereoselectivity of the transformation could not be determined through 1H NMR 
analysis of the crude reaction mixture prior to purification due to signal overlap with 
boron-containing byproducts; the isolated product was obtained with 7:1 dr following 
purification. 1H NMR (700 MHz, CDCl3) δ 7.19–7.14 (m, 2 H), 6.76–6.71 (m, 1 H), 6.64–
6.58 (m, 2 H), 5.79–5.73 (m, 1 H), 5.19–5.08 (m, 2 H), 4.15 (d, J = 9.6 Hz, 1 H), 4.01 
(dd, J = 9.4, 5.8 Hz, 1 H), 3.69 (s, 3 H), 2.67–2.64 (m, 1 H), 1.16 (d, J = 7.0 Hz, 3 H); 
13C NMR (176 MHz, CDCl3) δ 173.4, 146.9, 139.1, 129.3, 118.4, 116.5, 113.6, 61.1, 
51.8, 41.4, 16.5; IR (film) 3396, 1735, 1602 cm–1. MS (ESI+) 220.1335 (220.1332 calcd 
for C13H17NO3, M + H+). 
 
 
(2S*,3S*)-Methyl-3-phenyl-2-(phenylamino)pent-4-enoate (3-45). General prodedure 
7 was used for the reaction of 3-45 (56.3 mg, 0.2 mmol) with dibutylboron triflate (0.3 
mL, 0.3 mmol) and iPr2NEt (0.06 mL, 0.34 mmol) in 0.7 mL of dichloromethane. This 
procedure afforded 41.1 mg (73%) of a 4:1 mixture of 15c and a product resulting from 
the aza-[1,2]-Wittig rearrangement. Small amounts of each compound were isolated for 
characterization. The title compound was isolated as a yellow solid, mp 71–74 ºC. The 
diastereoselectivity of the transformation could not be determined through 1H NMR 
analysis of the crude reaction mixture prior to purification due to signal overlap with 
boron-containing byproducts; the isolated product was obtained with >20:1 dr following 
purification. 1H NMR (500 MHz, CDCl3) δ 7.34–7.30 (m, 2 H), 7.32–7.19 (m, 3 H), 7.21–
7.10 (m, 2 H), 6.73 (t, J = 7.3 Hz, 1 H), 6.60 (d, J = 7.8 Hz, 2 H), 6.19–6.11 (m, 1 H), 
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5.26–5.16 (m, 2 H), 4.38 (t, J = 7.6 Hz, 1 H), 3.99 (d, J = 8.1 Hz, 1 H), 3.79 (t, J = 8.1 
Hz, 1 H), 3.65 (s, 3 H); 13C NMR (126 MHz, CDCl3) δ 173.2, 146.6, 139.2, 136.8, 129.2, 
128.8, 127.9, 127.3, 118.6, 117.7, 113.7, 61.3, 53.2,, 51.8; IR (film) 3384, 1737, 1601 
cm–1. MS (ESI+) 282.1491 (282.1489 calcd for C18H19NO2, M + H+). 
 
 
Side Product Methyl (E)-5-phenyl-2-(phenylamino)pent-4-enoate 1H NMR (400 
MHz, CDCl3) δ 7.36–7.13 (m, 7 H), 6.78–6.74 (m, 1 H), 6.64 (d, J = 8.0 Hz, 2 H), 6.51 
(d, J = 15.7 Hz, 1 H), 6.17–6.14 (m, 1 H), 4.26–4.24 (m, 2 H), 3.74 (s, 3 H), 2.81–2.71 
(m, 2 H). 
 
 
Methyl-3,3-dimethyl-2-(phenylamino)pent-4-enoate (3-48). General prodedure 7 was 
used for the reaction of 3-47 (46.7 mg, 0.2 mmol) with dibutylboron triflate (0.3 mL, 0.3 
mmol) and iPr2NEt (0.06 mL, 0.34 mmol) in 0.7 mL of dichloromethane. This procedure 
afforded 35.1 mg (75%) of a 2:1 mixture of 15d and a product resulting from the aza-
[1,2]-Wittig rearrangement. Small amounts of each compound were isolated for 
characterization. The title compound was isolated as a white solid, mp 45–47 ºC. 
Title Compound X: 1H NMR (400 MHz, CDCl3) δ 7.14 (dd, J = 8.5, 7.2 Hz, 2 H), 6.71 (t, 
J = 7.3 Hz, 1 H), 6.64–6.56 (m, 2 H), 5.97–5.90 (m, 1 H), 5.20–5.06 (m, 2 H), 4.09 (d, J 
= 9.9 Hz, 1 H), 3.84 (d, J = 9.8 Hz, 1 H), 3.66 (s, 3 H), 1.16 (d, J = 13.7 Hz, 6 H); 13C 
NMR (176 MHz, CDCl3) δ 173.4, 147.2, 143.2, 129.3, 118.3, 114.2, 113.6, 64.6, 51.6, 
40.2, 24.9, 23.7; IR (film) 3384, 1736, 1603 cm–1. MS (ESI+) 234.1488 (234.1489 calcd 
for C14H19NO2, M + H+). 
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Side Product Methyl-5-methyl-2-(phenylamino)hex-4-enoate. 1H NMR (400 MHz, 
CDCl3) δ 7.20–7.11 (m, 2 H), 6.71 (t, J = 7.3 Hz, 1 H), 6.59 (d, J = 8.0 Hz, 2 H), 5.11 (t, 
J = 7.5 Hz, 1 H), 4.08 (t, J = 6.1 Hz, 1 H), 3.70 (s, 3 H), 2.61–2.44 (m, 2 H), 1.71 (s, 3 
H), 1.60 (s, 3 H); 13C NMR (176 MHz, CDCl3) δ 174.2, 146.7, 136.0, 129.3, 118.2, 
118.1, 113.4, 56.5, 52.1, 31.4, 25.9, 17.9; IR (film) 3369, 1738, 1604 cm–1. MS (ESI+) 
234.1486 (234.1489 calcd for C14H19NO2, M + H+). 
 
 
Methyl-4-methyl-2-(phenylamino)pent-4-enoate (3-50). General prodedure 7 was 
used for the reaction of 3-49 (43.9 mg, 0.2 mmol) with dibutylboron triflate (0.3 mL, 0.3 
mmol) and iPr2NEt (0.06 mL, 0.34 mmol) in 0.7 mL of dichloromethane. This procedure 
afforded 24 mg (55%) of the title compound as a colorless oil. 1H NMR (700 MHz, 
CDCl3) δ 7.24–7.13 (m, 2 H), 6.74 (t, J = 7.3 Hz, 1 H), 6.64–6.58 (m, 2 H), 4.89 (s, 1 H), 
4.83 (s, 1 H), 4.17 (q, J = 6.7 Hz, 1 H), 4.06 (s, br, 1 H), 3.71 (s, 3 H), 2.58 (dd, J = 13.8, 
6.1 Hz, 1 H), 2.50 (dd, J = 13.8 , 8.2 Hz, 1 H), 1.76 (s, 3 H).; 13C NMR (176 MHz, 
CDCl3) δ 174.4, 146.6, 140.7, 129.3, 118.4, 114.5, 113.3, 55.0, 52.1, 41.2, 21.8; IR 
(film) 3318, 1738, 1603 cm–1. MS (ESI+) 220.1325 (220.1332 calcd for C13H17NO2, M + 
H+). 
 
 
(2S*,3R*)-Methyl-2-((4-methoxyphenyl)amino)-3-vinyloctanoate (3-52). General 
prodedure 7 was used for the reaction of 3-51 (61.6 mg, 0.2 mmol) with dibutylboron 
triflate (0.3 mL, 0.3 mmol) and iPr2NEt (0.06 mL, 0.34 mmol) in 0.7 mL of 
dichloromethane. This procedure afforded 35.5 mg (58%) of the title compound as a 
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colorless oil. The diastereoselectivity of the transformation could not be determined 
through 1H NMR analysis of the crude reaction mixture prior to purification due to signal 
overlap with boron-containing byproducts; the isolated product was obtained with 5:1 dr 
following purification. 1H NMR (400 MHz, CDCl3) δ 6.79–6.70 (m, 2 H), 6.63–6.52 (m, 2 
H), 5.66–5.57 (m, 1 H), 5.21–5.05 (m, 2 H), 3.97–3.91 (m, 2 H), 3.73 (s, 3 H), 3.66 (s, 3 
H), 2.42–2.38 (m, 1 H), 1.64–1.59 (m, 1 H), 1.43–1.26 (m, 7 H), 0.88 (t, J = 6.8 Hz, 3 H); 
13C NMR (176 MHz, CDCl3) δ 173.7, 152.8, 141.0, 137.8, 118.1, 115.3, 114.9, 61.4, 
55.7, 51.6, 47.7, 31.7, 30.9, 26.8, 22.5, 14.0; IR (film) 3394, 1735, 1512 cm–1. MS 
(ESI+) 306.2062 (306.2064 calcd for C18H27NO3, M + H+). 
 
 
(2S*,3R*)-Methyl-2-((4-chlorophenyl)amino)-3-ethylpent-4-enoate (3-54). General 
prodedure 7 was used for the reaction of 3-53 (56.3 mg, 0.2 mmol) with dibutylboron 
triflate (0.3 mL, 0.3 mmol) and iPr2NEt (0.06 mL, 0.34 mmol) in 0.7 mL of 
dichloromethane. This procedure afforded 34.7 mg (62%) of the title compound as a 
colorless oil.	   The diastereoselectivity of the transformation could not be determined 
through 1H NMR analysis of the crude reaction mixture prior to purification due to signal 
overlap with boron-containing byproducts; the isolated product was obtained with 8:1 dr 
following purification. 1H NMR (700 MHz, CDCl3) δ 7.12–7.07 (m, 2 H), 6.56–6.49 (m, 2 
H), 5.61–5.56 (m, 1 H), 5.20–5.12 (m, 2 H), 4.18 (d, J = 10.0 Hz, 1 H), 4.00 (dd, J = 
10.0, 5.9 Hz, 1 H), 3.67 (s, 3 H), 2.34–2.31 (m, 1 H), 1.69–1.62 (m, 1 H), 1.40–1.31 (m, 
1 H), 0.91 (t, J = 7.4 Hz, 3 H); 13C NMR (176 MHz, CDCl3) δ 173.1, 145.4, 137.1, 129.2, 
123.0, 118.8, 114.7, 59.9, 51.8, 49.4, 24.0, 11.8; IR (film) 3394, 1734, 1600 cm–1. MS 
(ESI+) 268.1094 (268.1099 calcd for C14H18ClNO2, M + H+). 
 
 
(2S*,1’S*)-Methyl-2-(2’-methylenecyclohexyl)-2-(phenylamino)acetate (3-56). 
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General prodedure 7 was used for the reaction of 3-55 (69.5 mg, 0.27 mmol) with 
dibutylboron triflate (0.4 mL, 0.4 mmol) and iPr2NEt (0.08 mL, 0.46 mmol) in 1.0 mL of 
dichloromethane. This procedure afforded 39.0 mg (56%) of the title compound as a 
white solid, mp 65–71 ºC. The diastereoselectivity of the transformation could not be 
determined through 1H NMR analysis of the crude reaction mixture prior to purification 
due to signal overlap with boron-containing byproducts; the isolated product was 
obtained with 2:1 dr following purification. Data are for the mixture. 1H NMR (400 MHz, 
CDCl3) δ 7.20–1.14 (m, 2 H), 6.76–6.71 (m, 1 H), 6.66 (d, J = 8.0 Hz, 1.25 H), 6.60 (d, J 
= 8.0 Hz, 0.75 H), 4.86 (s, 0.38 H), 4.82 (s, 0.38 H), 4.73 (s, 0.62 H), 4.66 (s, 0.62 H), 
4.32 (d, J = 9.4 Hz, 0.62 H), 4.12 (d, J = 9.9 Hz, 0.38 H), 3.74 (s, 1.14 H), 3.62 (s, 1.86 
H), 2.59–2.52 (m, 1 H), 2.35–2.27 (m, 0.75 H), 2.21–2.07 (m, 2.25 H), 1.75–1.43 (m, 5 
H); 13C NMR (176 MHz, CDCl3) δ 174.4, 148.2, 147.1, 129.4, 129.3, 118.5, 118.2, 
113.5, 113.0, 110.3, 109.7, 76.2, 57.7, 57.3, 52.1, 51.6, 47.2, 46.3, 33.0, 29.9, 28.5, 
28.2, 28.0, 27.9, 22.6, 22.2 (two carbon signals missing due to incidental overlap); IR 
(film) 3385, 1737, 1603 cm–1. MS (ESI+) 260.1642 (260.1645 calcd for C16H21NO2, M + 
H+). 
 
Synthesis and Characterization of [2,3] Rearrangement/Hydroboration Products 
 
 
 
General Procedure 8: A flame-dried flask was evacuated and backfilled with nitrogen 
three times then charged with a 1 M solution of dibutylboron triflate in methylene 
chloride (1.5–2.0 equiv). The solution was cooled to 0 ºC and Hunig’s base (4.0 equiv) 
was added dropwise. A 1 M solution of the ester substrate (1.0 equiv) in methylene 
chloride was then added, and the resulting solution was warmed to 35–40 ºC. After 
stirring for 2 h, the mixture was cooled to 0 ºC, and additional Bu2BOTf (2.0 eq, 1 M 
solution in CH2Cl2) was added. The reaction was heated to 40 ºC and allowed to stir for 
4 hours. The flask was then cooled to 0 ºC, opened to air, and quenched by the addition 
1) Bu2BOTf (2.0+2.0 Eq), 
iPr2NEt, CH2Cl2, 40 ºC
2) H2O2, pH 7 buffer
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of pH 7 buffer solution (ca. 3 mL/mmol substrate), methanol (ca. 6-8 mL/mmol 
substrate), and 30% aqueous H2O2 (ca. 1 mL/mmol substrate). This mixture was 
warmed to rt and stirred for 1 h. The solution was then cooled to 0 ºC and Na2S2O3 (ca. 
7 mL/mmol substrate) was added. This solution was allowed to stir for 1 min before it 
was diluted with water and extracted twice with Et2O. The combined organic layers were 
dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. The crude 
product was purified by flash chromatography on silica gel using 30–40% ethyl acetate 
in hexanes as the eluent. 
 
 
Methyl-5-hydroxy-2-(phenylamino)pentanoate (3-42). General prodedure 8 was used 
for the reaction of 3-40 (41.1 mg, 0.2 mmol) with dibutylboron triflate (0.7 mL, 0.7 mmol) 
and iPr2NEt (0.14 mL, 0.8 mmol) in 0.7 mL of dichloromethane. This procedure afforded 
24.1 mg (54%) of the title compound as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 
7.17 (t, J = 7.4 Hz, 2 H), 6.75 (t, J = 7.2 Hz, 1 H), 6.62 (d, J = 7.7 Hz, 2 H), 4.11 (dd, J = 
5.4, 7.0 Hz, 1 H), 3.72 (s, 3 H), 3.67 (t, J = 6.0 Hz, 2 H), 2.01–1.80 (m, 2 H), 1.74–1.67 
(m, 2 H); 13C NMR (126 MHz, CDCl3) δ 174.6, 146.7, 129.4, 118.6, 113.6, 62.2, 56.6, 
52.2, 29.7, 28.8; IR (film) 3382, 1732 cm–1. MS (ESI+) 224.1288 (224.1281 calcd for 
C12H17NO3, M + H+). 
 
 
(2S*,3R*)-Methyl-5-hydroxy-3-methyl-2-(phenylamino)pentanoate (3-57). General 
prodedure 8 was used for the reaction of 3-43 (43.9 mg, 0.2 mmol) with dibutylboron 
triflate (0.7 mL, 0.7 mmol) and iPr2NEt (0.14 mL, 0.8 mmol) in 0.7 mL of 
dichloromethane. This procedure afforded 26.3 mg (55%) of the title compound as a 
colorless oil. The diastereoselectivity of the transformation could not be determined 
through 1H NMR analysis of the crude reaction mixture prior to purification due to signal 
overlap with boron-containing byproducts; the isolated product was obtained with 10:1 
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dr following purification. 1H NMR (400 MHz, CDCl3) δ 7.17 (t, J = 7.4 Hz, 2 H), 6.75 (t, J 
= 7.4 Hz, 1 H), 6.64 (d, J = 7.8 Hz, 2 H), 4.06 (d, J = 4.5 Hz, 1 H), 3.81–3.64 (m, 5 H), 
2.31–2.20 (m, 1 H), 1.83–1.74 (m, 1 H), 1.59–1.51 (m, 1 H), 1.03 (d, J = 7.0 Hz, 3 H); 
13C NMR (176 MHz, CDCl3) δ 174.1, 147.2, 129.4, 118.6, 113.9, 60.9, 60.4, 52.1, 36.2, 
33.0, 15.3; IR (film) 3388, 1731 cm–1. MS (ESI+) 238. 1445 (238.1438 calcd for 
C13H17NO3, M + H+). 
 
 
(2S*,3S*)-Methyl-5-hydroxy-3-phenyl-2-(phenylamino)pentanoate (3-58). General 
prodedure 8 was used for the reaction of 3-45 (56.3 mg, 0.2 mmol) with dibutylboron 
triflate (0.7 mL, 0.7 mmol) and iPr2NEt (0.14 mL, 0.8 mmol) in 0.7 mL of 
dichloromethane. This procedure afforded 34.3 mg (57%) of the title compound as a 
colorless oil. The diastereoselectivity of the transformation could not be determined 
through 1H NMR analysis of the crude reaction mixture prior to purification due to signal 
overlap with boron-containing byproducts; the isolated product was obtained with >20:1 
dr following purification. 1H NMR (500 MHz, CDCl3) δ 7.33–7.24 (m, 3 H), 7.19 (d, J = 
7.0 Hz, 2 H), 7.12 (t, J = 7.4 Hz, 2 H), 6.71 (t, J = 7.4 Hz, 1 H), 6.58 (d, J = 7.9 Hz, 2 H), 
4.32 (d, J = 6.0 Hz, 1 H), 3.90 (s, br, 1 H), 3.66 (s, 3 H), 3.63–3.57 (m, 1 H), 3.49–3.37 
(m, 2 H), 2.10–2.05 (m, 2 H); 13C NMR (126 MHz, CDCl3) δ 173.6, 147.1, 139.0, 129.3, 
128.7, 128.3, 127.5, 118.6, 113.8, 61.5, 60.5, 52.0, 45.1, 34.9; IR (film) 3388, 1731 cm–
1. MS (ESI+) 300.1600 (300.1594 calcd for C18H21NO3, M + H+). 
 
 
Methyl-5-hydroxy-3,3-dimethyl-2-(phenylamino)pentanoate (3-59). General 
prodedure 8 was used for the reaction of 3-47 (46.7 mg, 0.2 mmol) with dibutylboron 
triflate (0.7 mL, 0.7 mmol) and iPr2NEt (0.14 mL, 0.8 mmol) in 0.7 mL of 
dichloromethane. This procedure afforded 22.7 mg (45%) of the title compound as a 
yellow oil. 1H NMR (400 MHz, CDCl3) δ 7.22–7.10 (m, 2 H), 6.75 (t, J = 7.3 Hz, 1 H), 
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6.73–6.62 (m, 2 H), 3.96 (s, 1 H), 3.81–3.72 (m, 2 H), 3.66 (s, 3 H), 1.70 (t, J = 6.7 Hz, 2 
H), 1.06 (d, J = 5.9 Hz, 6 H). 13C NMR (176 MHz, CDCl3) δ 174.0, 147.1, 129.4, 119.0, 
114.3, 64.6, 59.1, 51.7, 42.6, 36.4, 25.4, 23.8; IR (film) 3388, 1730, 1602 cm–1. MS 
(ESI+) 252.1599 (252.1594 calcd for C13H19NO3, M + H+). 
 
 
Methyl-5-hydroxy-4-methyl-2-(phenylamino)pentanoate (3-60). General prodedure 8 
was used for the reaction of 3-49 (43.9 mg, 0.2 mmol) with dibutylboron triflate (0.7 mL, 
0.7 mmol) and iPr2NEt (0.14 mL, 0.8 mmol) in 0.7 mL of dichloromethane. This 
procedure afforded 24.4 mg (51%) of the title compound as a pale yellow oil. The 
diastereoselectivity of the transformation could not be determined through 1H NMR 
analysis of the crude reaction mixture prior to purification due to signal overlap with 
boron-containing byproducts; the isolated product was obtained with 1:1 dr following 
purification. Data are for the mixture. 1H NMR (500 MHz, CDCl3) δ 7.23–7.13 (m, 2 H), 
6.76 (td, J = 7.3, 3.7 Hz, 1 H), 6.65 (dd, J = 7.5, 3.3 Hz, 2 H), 4.20–4.17 (m, 1 H), 4.14–
4.11 (m, 1 H), 3.70 (d, J = 5.9 Hz, 3 H), 3.61–3.44 (m, 2 H), 1.99–1.79 (m, 2 H), 1.72–
1.67 (m, 1 H), 1.02 (d, J = 6.8 Hz, 2 H), 0.97 (d, J = 6.8 Hz, 2 H); 13C NMR (126 MHz, 
CDCl3) δ 175.1, 146.8, 129.4, 118.9, 118.8, 114.0, 113.8, 68.0, 67.5, 55.6, 55.0, 52.2, 
52.1, 37.6, 37.1, 33.3, 32.6, 17.0, 16.9 (three carbon signals are missing due to 
incidental equivalence); IR (film) 3372, 1733, 1601 cm–1. MS (ESI+) 238.1438 
(238.1438 calcd for C13H19NO3, M + H+). 
 
 
(2S*,3R*)-Methyl-3-(2-hydroxyethyl)-2-((4-methoxyphenyl)amino)octanoate (3-61). 
General prodedure 8 was used for the reaction of 3-51 (61.1 mg, 0.2 mmol) with 
dibutylboron triflate (0.7 mL, 0.7 mmol) and iPr2NEt (0.14 mL, 0.8 mmol) in 0.7 mL of 
dichloromethane. This procedure afforded 28.2 mg (44%) of the title compound as a 
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pale yellow oil. The diastereoselectivity of the transformation could not be determined 
through 1H NMR analysis of the crude reaction mixture prior to purification due to signal 
overlap with boron-containing byproducts; the isolated product was obtained with 9:1 dr 
following purification.  1H NMR (500 MHz, CDCl3) δ 6.78–6.75 (m, 2 H), 6.66–6.64 (m, 2 
H), 4.06 (d, J = 4.1 Hz, 1 H), 3.77–3.63 (m, 8 H), 2.08–2.03 (m, 1 H), 1.80–1.64 (m, 2 
H), 1.45–1.23 (m, 8 H), 0.90 (t, J = 6.8 Hz, 3 H); 13C NMR (176 MHz, CDCl3) δ 174.4, 
153.2, 140.9, 116.1, 114.8, 61.3, 60.3, 55.6, 52.0, 38.6, 33.8, 31.9, 29.6, 26.8, 22.5, 
14.0; IR (film) 3397, 1732, 1512 cm–1. MS (ESI+) 324.2172 (324.2169 calcd for 
C18H29NO4, M + H+). 
 
 
(2S*,3R*)-Methyl-2-((4-chlorophenyl)amino)-3-ethyl-5-hydroxypentanoate (3-62). 
General prodedure 8 was used for the reaction of 3-53 (56.3 mg, 0.2 mmol) with 
dibutylboron triflate (0.8 mL, 0.7 mmol) and iPr2NEt (0.14 mL, 0.8 mmol) in 0.7 mL of 
dichloromethane. This procedure afforded 27.3 mg (48%) of the title compound as a 
yellow oil. The diastereoselectivity of the transformation could not be determined 
through 1H NMR analysis of the crude reaction mixture prior to purification due to signal 
overlap with boron-containing byproducts; the isolated product was obtained with 13:1 
dr following purification.  1H NMR (700 MHz, CDCl3) δ 7.13–7.08 (m, 2 H), 6.57–6.52 
(m, 2 H), 4.31 (s, br, 1 H), 4.10 (d, J = 4.5 Hz, 1 H), 3.77–3.75 (m, 1 H), 3.70 (s, 3 H), 
3.68–3.65 (m, 1 H), 2.00–1.97 (m, 1 H), 1.75–1.66 (m, 1 H), 1.64–1.59 (m, 1 H), 1.54–
1.49 (m, 1 H), 1.47–1.38 (m, 1 H), 0.97 (t, J = 7.4 Hz, 3 H); 13C NMR (176 MHz, CDCl3) 
δ 173.9, 145.7, 129.2, 123.2, 114.8, 60.8, 59.2, 52.1, 40.0, 33.0, 23.1, 11.6; IR (film) 
3402, 3336, 1728, 1600 cm–1. MS (ESI+) 286.1203 (286.1204 calcd for C14H20ClNO3, M 
+ H+). 
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(2S*,1S,2S)-Methyl-2-(2-(hydroxymethyl)cyclohexyl)-2-(phenylamino)acetate (3-
63). General prodedure 8 was used for the reaction of 3-55 (71.5 mg, 0.28 mmol) with 
dibutylboron triflate (0.95 mL, 0.95 mmol) and iPr2NEt (0.19 mL, 1.1 mmol) in 1.0 mL of 
dichloromethane. This procedure afforded 29.4 mg (38%) of the title compound as a 
yellow solid, mp 90–93 ºC. 1H NMR (500 MHz, CDCl3) δ 7.22–7.14 (m, 2 H), 6.80 (t, J = 
7.3 Hz, 1 H), 6.74–6.64 (m, 2 H), 4.15 (d, J = 26.1 Hz, 1 H), 4.07–3.95 (m, 1 H), 3.68 (s, 
3 H), 3.60 (dd, J = 11.6, 5.6 Hz, 1 H), 2.12–1.98 (m, 2 H), 1.82 (s, 2 H), 1.78–1.71 (m, 1 
H), 1.53–1.25 (m, 5 H); 13C NMR (126 MHz, CDCl3) δ 174.5, 146.5, 129.4, 119.8, 114.9, 
61.6, 60.7, 52.1, 43.4, 40.6, 29.8, 26.4, 22.9, 21.3; IR (film) 3381, 1730, 1602 cm–1. MS 
(ESI+) 278.1752 (278.1751 calcd for C16H23NO3, M + H+). 
 
 
Methyl N-allyl-N-phenylalaninate (3-64): A flame-dried flask was cooled under a 
stream of nitrogen and then charged with iPr2NH (0.09 mL, 0.63 mmol) in THF (0.4 mL). 
After cooling to -78 ºC, a 2.5 M solution of n-BuLi in hexanes (0.21 mL, 0.54 mmol) was 
added and the resulting solution was stirred for 5 min. To this solution was added 3-40 
(100 mg, 0.49 mmol) in THF (0.4 mL). After stirring for 15 min, iodomethane (0.036 mL, 
0.58 mmol) was added and the resulting solution was stirred for 15 min at -78 ºC and 
then 1 h at 0 ºC. The mixture was warmed to rt and diluted with NH4Cl and EtOAc. The 
layers were separated, and the organic layers were washed with brine, dried over 
sodium sulfate, and concentrated in vacuo. The crude product was purified by flash 
chromatography on silica gel to afford 65 mg (61%) of the title compound as a colorless 
oil. 1H NMR (500 MHz, CDCl3) δ 7.27–7.17 (m, 2 H), 6.78–6.70 (m, 3 H), 5.96–5.89 (m, 
1 H), 5.28–5.23 (m, 1 H), 5.18–5.14 (m, 1 H), 4.48 (q, J = 7.2 Hz, 1 H), 4.07–4.02 (m, 1 
H), 3.96–3.90 (m, 1 H), 3.70 (d, J = 3.8 Hz, 3 H), 1.50 (d, J = 7.2 Hz, 3 H); 13C NMR 
(126 MHz, CDCl3) δ 174.3, 148.7, 136.1, 129.1, 117.6, 115.6, 113.5, 56.3, 52.0, 50.5, 
16.0; IR (film) 1734 cm–1. MS (ESI+) 220.1333 (220.1332 calcd for C13H17NO2, M + H+). 
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Methyl-3-phenyl-2-(phenylamino)pent-4-enoate (3-66). General prodedure 3 was 
used for the reaction of 3-64 (44.0 mg, 0.2 mmol) with dibutylboron triflate (0.3 mL, 0.3 
mmol) and iPr2NEt (0.06 mL, 0.34 mmol) in 0.7 mL of dichloromethane. This procedure 
afforded 8.5 mg (21%) of the title compound as a pale yellow oiil. 1H NMR (500 MHz, 
CDCl3) δ 7.29–7.16 (m, 2 H), 6.89–6.76 (m, 2 H), 5.99–5.92 (m, 1 H), 5.27–5.00 (m, 2 
H), 4.45 (q, J = 7.2 Hz, 1 H), 4.06–3.96 (m, 2 H), 1.52 (d, J = 7.2 Hz, 3 H); 13C NMR 
(126 MHz, CDCl3) δ 178.1, 148.3, 135.7, 129.3, 129.1, 118.7, 116.3, 114.6, 57.2, 51.0, 
15.3; IR (film) 1711, 1599 cm–1. MS (ESI+) 206.1176 (206.1176 calcd for C12H15NO2, M 
+ H+). 
. 
 
 
(1S,2R)-2-phenylcyclohexyl 2-[benzyl(phenyl)amino]acetate (3-68). A flame dried 
flask was cooled under a stream of nitrogen and charged with trans-2-
phenylcyclohexanol (140 mg, 0.792 mmol) and dichloromethane (4 mL, 0.2 M), and the 
resulting solution was cooled to 0 ºC. DMAP (48 mg, 0.396 mmol), EDC (151 mg, 0.792 
mmol), and 2-(benzyl(phenyl)amino)acetic acid (191 mg, 0.792 mmol), which was 
prepared according to published procedure,47 were added, and the mixture was allowed 
to warm to rt overnight. The dichloromethane was removed in vacuo, and the crude oil 
was diluted with water and ethyl acetate. The mixture was transferred to a separatory 
funnel, the layers were separated, and the organic layer was dried over anhydrous 
sodium sulfate and concentrated in vacuo. The crude product was purified by flash 
chromatography on silica gel to afford 214 mg (68%) of the title compound as a white 
solid (mp 110–112 ºC). 1H NMR (700 MHz, CDCl3) δ 7.31–7.16 (m, 8 H), 7.12 (d, J = 
7.4 Hz, 2 H), 7.09–7.04 (m, 2 H), 6.68 (t, J = 7.3 Hz, 1 H), 6.33 (d, J = 7.8 Hz, 2 H), 5.07 
(td, J = 10.8, 4.4 Hz, 1 H), 4.38 (d, J = 17.1 Hz, 1 H), 4.28 (d, J = 17.1 Hz, 1 H), 3.74 (d, 
J = 4.3 Hz, 2 H), 2.68–2.61 (m, 1 H), 2.12–2.07 (m, 1 H), 1.93 (d, J = 13.4 Hz, 1 H), 
1.86–1.84 (m, 1 H), 1.79–1.74 (m, 1 H), 1.59–1.31 (m, 4 H); 13C NMR (176 MHz, CDCl3) 
δ 170.3, 148.6, 142.9, 138.5, 129.0, 128.5, 128.4, 127.6, 126.9, 126.7, 126.5, 117.3, 
112.3, 76.6, 55.3, 52.0, 50.0, 33.8, 32.2, 25.7, 24.7; IR (film) 1744 cm–1. MS (ESI+) 
O
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400.2269 (400.2271 calcd for C27H29NO2, M + H+). 
 
 
2-(allyl(phenyl)amino)acetic acid A flame dried flask was cooled under a stream of 
nitrogen and charged with N-phenylglycine (302 mg, 2 mmol) and THF (4.0 mL, 0.5 M), 
and the resulting solution was cooled to -78 ºC. To this solution was added n-BuLi (1.76 
mL, 2.5 M soln in hexanes). After stirring 15 min, allylbromide (0.26 mL, 2.2 mmol) was 
added dropwise, and the mixture was allowed to warm to rt over 2 h. The reaction was 
then quenched with 1 M HCl, and the resulting mixture was extracted three times with 
ethyl acetate. The combined ether layers were dried over anhydrous sodium sulfate and 
concentrated in vacuo. The crude product was purified by flash chromatography on 
silica gel to afford 349 mg (91%) of the title compound as a brown oil. 1H NMR (700 
MHz, CDCl3) δ 7.26–7.19 (m, 2 H), 6.78 (t, J = 7.3 Hz, 1 H), 6.69 (d, J = 7.9 Hz, 2 H), 
5.91–5.88 (m, 1 H), 5.26–5.21 (m, 2 H), 4.05 (s, 2 H), 4.00 (d, J = 5.3 Hz, 2 H); 13C 
NMR (176 MHz, CDCl3) δ 177.4, 148.0, 133.5, 129.3, 117.9, 117.0, 112.6, 54.2, 51.8; IR 
(film) 2920, 1722 cm–1. MS (ESI+) 192. 1017 (192.1019 calcd for C11H13NO2, M + H+). 
 
 
(1’S,2’R)-1-(Allyl(phenyl)amino)-3-(2’-phenylcyclohexyl)propan-2-one (3-70). A 
flame dried flask was cooled under a stream of nitrogen and charged with trans-2-
phenylcyclohexanol (322 mg, 1.83 mmol) and dichloromethane (9.1 mL, 0.2 M), and the 
resulting solution was cooled to 0 ºC. DMAP (112 mg, 0.92 mmol), EDC (349 mg, 1.83 
mmol), and 2-(allyl(phenyl)amino)acetic acid (349 mg, 1.83 mmol) were added, and the 
mixture was allowed to warm to rt overnight. The dichloromethane was removed in 
vacuo, and the crude oil was diluted with water and ethyl acetate. The mixture was 
transferred to a separatory funnel, the layers were separated, and the organic layer was 
dried over anhydrous sodium sulfate and concentrated in vacuo. The crude product was 
purified by flash chromatography on silica gel to afford 309.7 mg (49%) of the title 
compound as a white solid (mp 101–104 ºC). 1H NMR (500 MHz, CDCl3) δ 7.33–7.16 
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(m, 5 H), 7.12–7.05 (m, 2 H), 6.72 (t, J = 7.1 Hz, 1 H), 6.36 (d, J = 8.0 Hz, 2 H), 5.81–
5.76 (m, 1 H), 5.14–5.09 (m, 3 H), 3.82–3.68 (m, 4 H), 2.72–2.68 (m, 1 H), 2.17–2.15 
(m, 1 H), 1.99–1.96 (m, 1 H), 1.91–1.88 (m, 1 H), 1.82–1.80 (m, 1 H), 1.63–1.37 (m, 4 
H); 13C NMR (126 MHz, CDCl3) δ 170.4, 148.3, 143.0, 133.9, 129.1, 128.4, 127.7, 
126.6, 117.1, 116.2, 112.3, 76.6, 54.0, 51.7, 50.0, 33.9, 32.4, 25.8, 24.8; IR (film) 1745, 
1600 cm–1. MS (ESI+) 350.2125 (350.2115 calcd for C23H27NO2, M + H+). 
 
(1S,2R)-2-phenylcyclohexyl 3-phenyl-2-(phenylamino)propanoate (3-69). General 
procedure 8 was used for the rearrangement of 3-68 (79.9 mg, 0.2 mmol) with 
dibutylboron triflate (0.64 mL, 0.64 mmol) and iPr2NEt (0.14 mL, 0.8 mmol) in 0.2 mL of 
dichloromethane. This procedure afforded 68.1 mg (85%) of the title compound as a 
colorless oil. The diastereoselectivity of the transformation could not be determined 
through 1H NMR analysis of the crude reaction mixture prior to purification due to signal 
overlap with boron-containing byproducts; the isolated product was obtained with 1.6:1 
dr following purification. Data are for the mixture. 1H NMR (700 MHz, CDCl3) δ 7.35–
7.09 (m, 8 H), 7.08 (t, J = 7.9 Hz, 1.2 H), 7.04 (d, J = 7.2 Hz, 0.8 H), 7.00 (t, J = 7.7 Hz, 
0.8 H), 6.79–6.63 (m, 2.2 H), 6.42 (d, J = 8.0 Hz, 1.2 H), 6.23 (d, J = 8.0 Hz, 0.8 H), 
5.00–4.92 (m, 1 H), 4.11–4.09 (m, 0.6 H), 3.96–3.94 (m, 0.4 H), 3.88 (d, J = 7.5 Hz, 1 
H), 2.88 (dd, J = 12.4, 6.1 Hz, 0.4 H), 2.81 (dd, J = 13.9, 7.1 Hz, 0.4 H), 2.74 (td, J = 
12.6, 3.7 Hz, 0.6 H), 2.68–2.60 (m, 1 H), 2.45 (dd, J = 14.0, 6.9 Hz, 0.6 H), 2.15–2.13 
(m, 0.6 H), 1.97–1.91 (m, 1 H), 1.85–1.83 (m, 0.4 H), 1.80–1.74 (m, 1 H), 1.87–1.63 (m, 
5 H); 13C NMR (176 MHz, CDCl3) δ 172.4, 146.5, 146.3, 143.1, 136.4, 129.3, 129.2, 
128.5, 128.4, 127.7, 126.9, 118.1, 113.5, 77.6, 57.5, 49.8, 38.5, 33.9, 32.4, 25.8, 24.7; 
IR (film) 3396, 1731 cm–1. MS (ESI+) 400.2284 (400.2271 calcd for C27H29NO2, M + H+). 
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(1S,2R)-2-Phenylcyclohexyl 2’-(phenylamino)pent-4-enoate (3-71). General 
prodedure 8 was used for the reaction of 3-70 (49.0 mg, 0.14 mmol) with dibutylboron 
triflate (0.21 mL, 0.21 mmol) and iPr2NEt (0.04 mL, 0.24 mmol) in 0.5 mL of 
dichloromethane. This procedure afforded 31.4 mg (64%) of the title compound as a 
colorless oil. The diastereoselectivity of the transformation could not be determined 
through 1H NMR analysis of the crude reaction mixture prior to purification due to signal 
overlap with boron-containing byproducts; the isolated product was obtained with 1.3:1 
dr following purification. Data are for the mixture. 1H NMR (500 MHz, CDCl3) δ 7.33–
7.16 (m, 5 H), 7.12–7.08 (m, 1.12 H), 7.04–7.01 (m, 0.87 H), 6.69 (dt, J = 12.5, 7.3 Hz, 
1 H), 6.49 (d, J = 8.0 Hz, 1.12 H), 6.27 (d, J = 8.0 Hz, 0.87 H), 5.48–5.42 (m, 0.44 H), 
5.15–4.97 (m, 2.43 H), 4.89–4.78 (m, 1.12 H), 3.95 (s, br, 1 H), 3.88 (t, J = 5.7 Hz, 0.56 
H), 3.78 (t, J = 6.1 Hz, 0.44 H), 2.73–2.66 (m, 1H), 2.36–2.31 (m, 1 H), 2.16–1.77 (m, 5 
H), 1.59–1.28 (m, 4 H); 13C NMR (126 MHz, CDCl3) δ 172.5, 172.4, 146.5, 146.4, 143.0, 
132.7, 132.6, 129.2, 129.1, 128.5, 128.4, 127.5, 127.4, 126.6, 126.5, 118.8, 118.5, 
118.2, 118.0, 113.4, 113.2, 77.1, 76.9, 55.6, 55.5, 49.9, 49.7, 36.8, 36.3, 34.1, 34.0, 
32.4, 32.1, 25.8, 25.7, 24.7, 24.6 (one carbon signal missing due to incidental overlap); 
IR (film) 3416, 1734, 1603 cm–1. MS (ESI+) 350.2113 (350.2115 calcd for C23H27NO2, M 
+ H+). 
 
Determination of stereochemistry 
The relative stereochemistry of compounds 3-44 and 3-56 were assigned via 1D and 2D 
NOESY experiments of the following lactones generated by acid catalyzed cyclization of 
3-44 and 3-56. Significant nOe relationships are shown below. The stereochemistry of 
3-45, 3-52, and 3-54 were assigned based on analogy to 3-44. 
 
 
 
General Procedure 9: A flame-dried flask was evacuated and backfilled with nitrogen 
three times then charged with a 1 M solution of the [2,3] rearrangement product in 
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methylene chloride. To this solution was added p-toluenesulfonic acid (1 equiv). The 
solution was heated to 40 ºC  until the cyclization was complete as judged by TLC. 
When the reaction was complete, the mixture was cooled to rt, before it was quenched 
with saturated sodium bicarbonate solution and extracted twice with DCM. The 
combined organic layers were dried over anhydrous sodium sulfate, filtered, and 
concentrated in vacuo. The crude product was purified by flash chromatography on 
silica gel using 5-20% ethyl acetate in hexanes as the eluent. 
 
 
(3S*,4R*)-4-Methyl-3-(phenylamino)tetrahydro-2H-pyran-2-one. General prodedure 
9 was used for the reaction of 3-57 (26.3 mg, 0.11 mmol) with p-toluenesulfonic acid 
(21.1 mg, 0.11 mmol) in 1.1 mL of dichloromethane. This procedure afforded 10.2 mg 
(45%) of the title compound as a pale yellow oil. 1H NMR (400 MHz, CDCl3) δ 7.22–7.11 
(m, 2 H), 6.75 (t, J = 7.3 Hz, 1 H), 6.67 (d, J = 7.9 Hz, 2 H), 4.45–4.27 (m, 2 H), 4.10 (s, 
br, 1 H), 3.75 (d, J = 10.9 Hz, 1 H), 2.26–2.17 (m, 1 H), 2.05–1.98 (m, 1 H), 1.76–1.69 
(m, 1 H), 1.25 (d, J = 6.7 Hz, 3 H); 13C NMR (126 MHz, CDCl3) δ 173.4, 147.8, 129.3, 
118.8, 113.9, 66.1, 59.5, 33.8, 30.1, 20.3; IR (film) 1746 cm–1. MS (ESI+) 206.1171 
(206.1176 calcd for C12H15NO2, M + H+). 
 
 
 
(4S*,4aR*,8aR*)-4-(Phenylamino)hexahydro-1H-isochromen-3(4H)-one. General 
prodedure 8 was used for the reaction of 3-63 (29.4 mg, 0.11 mmol) with p-
toluenesulfonic acid (20.2 mg, 0.11 mmol) in 1.1 mL of dichloromethane. This procedure 
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afforded 10.2 mg (39%) of the title compound as a white solid, mp 110–112 ºC. 1H NMR 
(400 MHz, CDCl3) δ 7.15 (dd, J = 8.6, 7.3 Hz, 2 H), 6.67 (t, J = 7.3 Hz, 1 H), 6.65 (d, J = 
8.0 Hz, 2 H), 4.32 (dd, J = 11.5, 3.2 Hz, 1 H), 4.25 (dd, J = 11.2, 5.4 Hz, 1 H), 4.02 (d, J 
= 8.9 Hz, 1 H), 3.84 (s, br, 1 H), 3.59 (s, 2 H), 2.06–1.95 (m, 2 H), 1.79–1.39 (m, 8 H); 
13C NMR (176 MHz, CDCl3) δ 1728, 147.4, 129.3, 118.6, 113.8, 72.1, 55.3, 38.5, 34.3, 
26.6, 25.0, 23.4, 21.4; IR (film) 3384, 1730, 1602 cm–1. MS (ESI+) 246.1489 (246.1489 
calcd for C15H19NO2, M + H+). 
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Chapter 4
Generation of Vicinal Stereocenters via Asymmetric Tandem Wittig 
Rearrangement/Aldol Reactions  	  
4.1 Introduction 
 The aldol reaction is an extremely valuable method of carbon-carbon bond 
formation, and it has been utilized extensively in organic synthesis, with particular focus 
on diastereo- and enantioselective methods.1-4 While ketone-aldehyde aldol reactions 
are ubiquitous, ketone-ketone reactions remain a significant challenge. Compared to 
aldehydes, ketones are less electrophilic and the intrinsic retro-aldol reaction is rapid. 
Furthermore, the lack of steric and electronic disparity between the two ketone 
substituents leads to low stereo-differentiation.5 Current methods typically involve the 
use of a pre-formed enol ether paired with a Lewis acid or Lewis base in order to create 
favorable conditions and to prevent ketone self-coupling.6 Despite the inherent 
challenges, aldol reactions using ketone coupling partners are capable of generating 
tertiary alcohols containing up to two new stereocenters. Recent studies have focused 
on catalytic, enantioselective methods.7-9 
Our group has recently developed asymmetric tandem Wittig/aldol10 and 
Wittig/Mannich11 reactions for the synthesis of α,β-dihydroxy esters and α-hydroxy-β-
amino esters, respectively. We envisioned using this tandem reaction sequence for the 
asymmetric synthesis of vicinal quaternary stereocenters, which is still a difficult 
problem in organic synthesis.12,13 Though aldol reactions to ketones remain challenging, 
we hypothesized that the doubly-boronated enolate 4-3, which is generated in situ in 
these reactions, may be reactive enough to undergo the desired coupling reaction 
(Scheme 4.1). 
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Scheme 4.1 Tandem Wittig Rearrangement/Aldol Reaction 
 
 
4.2 Preliminary Results 
By employing ketone coupling partners in these reactions, we hoped to generate 
α,β-dihydroxy ester derivatives, however, preliminary results14 indicated an unexpected 
transformation. When compound 4-6 was subjected to the previously employed 
rearrangement conditions followed by ketone addition, boronate ester 4-7 was 
generated in good yield and diastereoselectivity. The boron was not cleaved by the 
typical oxidative workup, however resubjecting the purified boronate ester to the 
peroxide conditions did successfully free the desired diol 4-8 (Scheme 4.2). 
 
Scheme 4.2 Preliminary Tandem Wittig/Aldol Results 
 
 
4.3 Synthesis of Boronate Esters 
A number of methyl ketones were examined in this transformation (Table 4.1). 
Expectedly, conversion of starting material to product was low, due to the attenuated 
reactivity of ketones relative to aldehydes. Aryl methyl ketones afforded the boronate 
esters in moderate yield, though excellent diastereoselectivity. For example, the 
reaction of 4-9 and p-bromoacetophenone generated boronate ester 4-12 in 56% yield 
and >20:1 dr. While di-aliphatic ketones produced boronate esters in similar yield, the 
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diastereoselectivity of these reactions was modest, due to the steric similarity between 
the two ketone substituents. Reactions with branched aliphatic methyl ketones were 
unsuccessful. When substrate 4-9 was subjected to rearrangement conditions followed 
by the addition of 3-methyl-2-butanone, no ketone was incorporated into the product; 
rather, only the rearranged starting material was observed (Table 4.1, entry 9). 
 
Table 4.1 Formation of Boronate Estera 
	  	  
Entry R R1 Product Yieldb dr 
1 Bn (4-9) Ph 4-10 73% >20:1 
2 Bn p-OMe-Ph 4-11 50% >20:1 
3 Bn p-Br-Ph 4-12 56% >20:1 
4 Bn  4-13 50% >20:1 
5 Bn (CH2)2Ph 4-14 45% 4:1 
6 Bn C3H7 4-15 42% 3:1 
7 Bn CH3 4-16 54% - 
8 Bn –C4H8– 4-17 46% - 
9 Bn iPr - NR - 
aConditions: (i) 1.0 equiv of 4.9, 3.2 equiv of Bu2BOTf, 4.0 equiv of NEt3 or iPr2NEt, 
CH2Cl2, 0.25 M, 15 min, 0º C to rt. (ii) 1.0–1.5 equiv. of ketone, 0 ºC to rt, 16 hr (iii) 
Rochelle salt, 0º C to rt. bIsolated yield, average of two or more experiments. 
 
Resubjection of the purified boronate esters to the peroxide workup conditions 
freed the α,β-dihydroxy ester products (Table 4.2), though we sought to find a more 
direct path to the desired diol. By using a large excess of peroxide in the initial workup 
step, the boronate ester could be cleaved completely, allowing the desired diol to be 
accessed directly from the substrate 4-9. Under these conditions, the α,β-dihydroxy 
ester could be generated in a single step, though conversion remained low. 
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Table 4.2 Boron Cleavagea 
 
Entry R R1 Product Yieldb 
1 Bn p-OMe-Ph (4-11) 4-19 34% 
2 Bn p-Br-Ph (4-12) 4-20 25% 
3 Bn (4-13) 4-21 68% 
4 Bn (CH2)2Ph (4-14) 4-22 59% 
5 Bn C3H7 (4-15) 4-23 59% 
6 Bn CH3 (4-16) 4-24 75% 
7 Bn –C4H8– (4-18) 4-25 53% 
aConditions: (i) 1.0 equiv of boronate ester, H2O2 (1 mL/mmol substrate), MeOH, 0.1 M, 
0º C to rt. bIsolated yield, average of two or more experiments. 
 
4.4 Synthesis of α,β-Dihydroxy Esters 
With optimized workup conditions in hand, the tandem reaction was examined 
again. A number of methyl ketones successfully underwent the Wittig/aldol sequence to 
generate the α,β-dihydroxy esters in a single step (Table 4.3). As before, aryl and 
alkenyl methyl ketones formed the diol in moderate yield and excellent 
diastereoselectivity. Additionally, the [2,3] Wittig rearrangement/aldol reaction was 
explored when O-allyl substrate 4-26 was subjected to the optimized reaction 
conditions. Diol products were generated in modest yield with both p-bromo-
acetophenone as well as cyclohexanone, though a large quantity of starting material 
was recovered, indicating potential water contamination. 
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Table 4.3 Asymmetric Wittig Rearrangement/Aldol Reactiona 
 
Entry R R1 Product Yieldb dr 
1 Bn (4-9) Ph 4-27 45% >20:1 
2 Bn p-Me-Ph 4-28 43% 17:1 
3 Bn p-Br-Ph 4-20 42% >20:1 
4 Bn  4-21 58% >20:1 
5 Bn (CH2)2Ph 4-22 43% 8:1 
 Bn C3H7 4-23 52% 4:1 
6 Bn Me 4-24 57% - 
7 Bn –C5H10– 4-25 24% - 
8 Bn iPr - NR - 
9 Bn m-F-Ph 4-29 20% 15:1 
10 Allyl (4-26) p-Br-Ph 4-30 15% 10:1 
11 Allyl –C5H10– 4-31 16% - 
aConditions: (i) 1.0 equiv of 4-9 or 4-26, 3.2 equiv of Bu2BOTf, 4.0 equiv of NEt3 or 
iPr2NEt, CH2Cl2, 0.25 M, 15 min, 0º C to rt. (ii) 1.0–1.5 equiv. of ketone, 0 ºC to rt, 16 hr 
(iii) pH 7 buffer, H2O2, 1 hr, 0º C to rt. bIsolated yield, average of two or more 
experiments. 
 
4.5 Chiral Auxiliary Removal 
In order to assess optical purity of the products, and in order for this tandem 
reaction to be utilized in practical applications, a method must be developed for the 
removal of the chiral auxiliary. Previously, our group has employed two alternate 
methods of chiral auxiliary removal: a two-step process consisting of acetonide 
formation followed by ester hydrolysis (Scheme 4.3a) or ester reduction using LiAlH4 
(Scheme 4.3b). 
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Scheme 4.3 Previous Method of Chiral Auxiliary Removal  
 
 
Acetonide formation proved unsuccessful for these diol products, as only 
unreacted starting material was recovered from these reactions, presumably due to the 
additional steric hindrance around the adjacent quaternary centers. As depicted in Table 
4.4, LiAlH4 reduction showed moderate success, though this method appears to be 
limited to diols resulting from di-aliphatic ketones. LiAlH4 reduction of diols generated 
from aryl ketones resulted in removal of the chiral auxiliary as well as complete retro-
aldol reaction.  
 
Table 4.4 Chiral Auxiliary Cleavagea 
 
Entry R Product Yieldb 
1 Me (4-24) 4-35 66% 
2 (4-21) 4-36 28% 
3 Ph (4-27) - decomposition 
aConditions: (i) 1.0 equiv of diol, 3.0 equiv of LiAlH4, THF, 0.1 M, 16 hr, 0º C to rt. 
bIsolated yield, average of two or more experiments. 
 
 A number of alternate chiral auxiliary removal methods were explored, though 
none were successful, and retro-aldol reaction remains a significant issue. Methanolysis 
under both acidic and basic conditions were unsuccessful; the former resulted in 
unreacted starting material and the latter resulted in retro-aldol reaction (Scheme 4.4).  
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Scheme 4.4 Methanolysis Resulting in Retro-Aldol Reaction 
 
 
The diol ester products were unreactive towards DIBAlH as well as Lewis acid-
catalyzed Weinreb amide conditions (AlMe3 and N,O-dimethylhydroxylamine). 
Furthermore, subjection to LiBH4 resulted in the retro-aldol reaction.  
 
Scheme 4.5 Silyl Protection 
 
 
Though acetonide formation was unsuccessful, a protecting group appeared to 
be necessary in order to prevent the undesirable retro-aldol reaction. Thus, silyl 
protecting groups were briefly explored. A mono-protected diol 4-41 was subjected to 
LiAlH4 or NaOMe, however, each reaction resulted in the removal of the protecting 
group followed by the retro-aldol reaction (Scheme 4.5). 
 
4.6 Conclusions and Future Directions 
 Though removal of the chiral auxiliary remains a significant obstacle, we have 
developed a tandem Wittig/aldol sequence that constructs two contiguous stereocenters 
in a single reaction with excellent selectivity. The asymmetric generation of vicinal 
quaternary stereocenters is still a challenging problem in organic synthesis, and our 
tandem sequence affords highly substituted enantioenriched diols from simple starting 
materials. Efforts are currently underway to find a suitable method for chiral auxiliary 
removal that will not result in a retro-aldol reaction. 
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General Considerations: All reactions were carried out under a nitrogen atmosphere in 
flame-dried glassware. All reagents were obtained from commercial sources and were 
used as obtained unless otherwise noted. Dichloromethane was purified using a 
GlassContour solvent purification system. Hunig’s base was distilled from CaH2. Yields 
refer to isolated yields of compounds estimated to be ≥95% pure as determined by 1H 
NMR analysis unless otherwise noted. The yields reported in the supporting information 
describe the result of a single experiment, whereas yields reported in Tables 4.1–4.4 
and are average yields of two or more experiments. Thus, the yields reported in the 
supporting information may differ from those shown in Tables 4.1–4.4.  
Handling of Dialkylboron reagents: Dibutylboron triflate (1.0 M solution in methylene 
chloride) was obtained from Aldrich Chemical Co. and used as obtained. Due to the air 
and moisture sensitivity of this reagent, it must be stored and transferred under a 
rigorously maintained nitrogen atmosphere. 
 
Synthesis and Characterization of Diol Products 
 
 
General Procedure 1: An oven-dried flask was evacuated and backfilled with nitrogen 
three times then charged with a 1 M solution of dibutylboron triflate in methylene 
chloride (3.2 equiv). The solution was cooled to 0 ºC and triethylamine (4.0 equiv) was 
added dropwise. A 1 M solution of the ester substrate (1.5 equiv) in methylene chloride 
was then added, and the resulting solution was warmed to rt over 15–20 min, at which 
point the solution was again cooled to 0 ºC and a 1 M solution of the appropriate ketone 
was added. The reaction was allowed to stir 14–24 hours at room temperature. When 
the reaction was complete, the flask was opened to air and quenched by the addition of 
Rochelle Salt (ca. 6–8 mL/mmol substrate) and diluted with Et2O. The resulting solution 
was stirred at rt for 10 min before extracting three times with Et2O. The combined 
organic layers were dried over anhydrous sodium sulfate, filtered, and concentrated in 
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vacuo. The crude product was purified by flash chromatography on silica gel using 5% 
diethyl ether in hexanes as the eluent. 
General Procedure 2: The purified boron chelate was dissolved in methanol (0.1 M) 
and cooled to 0 °C before 30% aqueous H2O2 (ca. 1 mL/mmol substrate) was added 
slowly. The mixture was allowed to stir at rt until the reaction was judged complete by 
TLC. The solution was then cooled to 0 ºC and Na2S2O3 (ca. 6–8 mL/mmol substrate) 
was added. The mixture was stirred at rt for 10 min before extracting three times with 
Et2O. The combined organic layers were dried over anhydrous sodium sulfate, filtered, 
and concentrated in vacuo. The crude product was purified by flash chromatography on 
silica gel using 3–10% ethyl acetate in hexanes as the eluent.  
 
 
 
General Procedure 3: A flame-dried flask was evacuated and backfilled with nitrogen 
three times then charged with a 1 M solution of dibutylboron triflate in methylene 
chloride (3.2 equiv). The solution was cooled to 0 ºC and triethylamine (4.0 equiv) was 
added dropwise. A 1 M solution of the ester substrate (1.0 equiv) in methylene chloride 
was then added, and the resulting solution was warmed to rt over 15 min, at which point 
the solution was again cooled to 0 ºC and a 1 M solution of the appropriate ketone was 
added. The reaction was allowed to stir 14–24 hours at room temperature. When the 
reaction was complete, the flask was opened to air and quenched by the addition of 
methanol (ca. 19 mL/mmol substrate). The resulting solution was transferred to a larger 
flask and cooled to 0 °C before 30% aqueous H2O2 (ca. 26 mL/mmol substrate) was 
added slowly. This mixture was warmed to rt and stirred for 1 h. The solution was then 
diluted with water and extracted twice with Et2O. The combined organic layers were 
washed with water, saturated Na2S2O3, and brine then dried over anhydrous sodium 
sulfate, filtered, and concentrated in vacuo. The crude product was purified by flash 
chromatography on silica gel using 5–20% ethyl acetate in hexanes as the eluent. 
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(1R,2S,2’R,3’S)-2-phenylcyclohexyl-2’-benzyl-5’-butyl-3’-phenyl-3’-methyl-4’,6’-
dioxa-5’-borolane-4’-carboxylate (4-10). General procedure 1 was employed to 
transform (–)-(1R,2S)-2-phenylcyclohexyl-2’-(benzyloxy)acetate (100 mg, 0.308 mmol) 
to form boronate ester 4-10 using dibutylboron triflate solution (1.0 mL) and 
acetophenone (54 µL, 0.462 mmol). This procedure afforded 115.0 mg (73%) of the title 
compound as a pale yellow oil. The diastereoselectivity of the transformation could not 
be determined through 1H NMR analysis of the crude reaction mixture prior to 
purification due to signal overlap with boron-containing byproducts; the isolated product 
was obtained with 20:1 dr following purification. 1H NMR (400 MHz, CDCl3) δ 7.32–7.31 
(m, 4 H), 7.28–7.26 (m, 4 H), 7.21–7.18 (m, 1 H), 7.13–7.12 (m, 3 H), 7.07–7.05 (m, 3 
H), 5.11–5.06 (m, 1 H), 2.83–2.78 (m, 1 H), 2.41 (d, J = 14.7 Hz, 1 H), 2.22 (d, J = 14.7 
Hz, 1 H), 1.97–1.94 (m, 1 H), 1.87–1.82 (m, 1 H), 1.74–1.71 (m, 2 H), 1.53–1.33 (m, 9 
H), 1.03–0.99 (m, 3 H), 0.94–0.91 (m, 4 H); 13C NMR (125 MHz, CDCl3) δ 170.2, 143.6, 
141.5, 135.8, 130.2, 128.8, 127.8, 127.7, 127.5, 127.4, 127.3, 127.0, 126.5, 125.9, 90.6, 
87.2, 78.4, 49.6, 42.9, 35.5, 31.6, 26.1, 25.9, 25.7, 25.4, 24.6, 13.9; IR (film) 1739 cm–1. 
MS (ESI+) 528.3284 (528.3280 calcd for C33H39BO4, M + NH4+). 
 
 
(1R,2S,2’R,3’S)-2-phenylcyclohexyl-2’-benzyl-5’-butyl-3’-(4-methoxyphenyl)-3’-
methyl-4’,6’-dioxa-5’-borolane-4’-carboxylate (4-11). General procedure 1 was 
employed to transform (–)-(1R,2S)-2-phenylcyclohexyl-2’-(benzyloxy)acetate  (50 mg, 
0.154 mmol) to form boronate ester 4-11 using dibutylboron triflate solution (0.49 mL) 
and p-methoxyacetophenone (23.2 mg, 0.231 mmol). This procedure afforded 41.5 mg 
(50%) of the title compound as a colorless oil. The diastereoselectivity of the 
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transformation could not be determined through 1H NMR analysis of the crude reaction 
mixture prior to purification due to signal overlap with boron-containing byproducts; the 
isolated product was obtained with >20:1 dr following purification. 1H NMR (400 MHz, 
CDCl3) δ 7.36–7.24 (m, 4 H), 7.26–7.08 (m, 6 H), 6.93 (s, 2 H), 6.82–6.75 (m, 2 H), 5.06 
(td, J = 10.9, 4.2 Hz, 1 H), 3.81 (s, 3H), 2.82–2.75 (m, 1 H), 2.37 (d, J = 14.7 Hz, 1 H), 
2.31–2.17 (m, 1 H), 1.99–1.89 (m, 1 H), 1.87–1.76 (m, 1 H), 1.76–1.66 (m, 2 H), 1.56–
1.20 (m, 7 H), 0.95 (t, J = 7.5 Hz, 3 H), 0.93–0.87 (s, 6 H); 13C NMR (176 MHz, CDCl3) δ 
170.3, 158.8, 143.6, 136.0, 133.7, 130.2, 128.8, 127.7, 127.5, 127.1, 127.0, 126.5, 
113.1, 90.7, 87.0, 78.3, 55.2, 49.6, 42.9, 35.5, 31.6, 31.5, 26.1, 25.9, 25.8, 25.7, 25.5, 
25.4, 24.6, 14.0, 13.9; IR (film) 1742 cm–1. MS (ESI) 558.3391 (558.3385 calcd for 
C34H41BO5, M + NH4+). 
 
 
(1R,2S,2’R,3’S)-2-phenylcyclohexyl-2’-benzyl-5’-butyl-3’-(4-bromophenyl)-3’-
methyl-4’,6’-dioxa-5’-borolane-4’-carboxylate (4-12). General procedure 1 was 
employed to transform (–)-(1R,2S)-2-phenylcyclohexyl-2’-(benzyloxy)acetate (50 mg, 
0.154 mmol) to form boronate ester 4-12 using dibutylboron triflate solution (0.49 mL) 
and p-bromoacetophenone (46.1 mg, 0.231 mmol). This procedure afforded 54.6 mg 
(60%) of the title compound as a pale yellow oil. The diastereoselectivity of the 
transformation could not be determined through 1H NMR analysis of the crude reaction 
mixture prior to purification due to signal overlap with boron-containing byproducts; the 
isolated product was obtained with >20:1 dr following purification. 1H NMR (700 MHz, 
CDCl3) δ 7.38 (d, J = 7.5 Hz, 2 H), 7.29–7.33 (m, 4 H), 7.20 (t, J = 7.0 Hz, 1 H), 7.12–
7.15 (m, 3 H), 7.06 (dd, J = 2.7, 7.7 Hz, 2 H), 6.91 (s, br., 2 H), 5.11 (dt, J = 4.2, 10.9 
Hz, 1 H), 2.79 (dt, J = 3.9, 11.2 Hz, 1 H), 2.37 (d, J = 14.4 Hz, 1 H), 2.23 (d, J = 15.6 Hz, 
1 H), 1.96 (d, J = 13.6 Hz, 1 H), 1.81–1.84 (m, 1 H), 1.71–1.74 (m, 2 H), 1.29–1.53 (m, 9 
H), 1.02–1.08 (m, 1 H), 0.99 (t, J = 9.0 Hz, 2 H), 0.85 (t, J = 7.3 Hz, 3 H); 13C NMR (176 
MHz, CDCl3) δ 169.8, 143.5, 140.6, 135.4, 131.0, 130.9, 130.2, 128.9, 127.8, 127.4, 
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127.1, 126.6, 121.5, 90.3, 86.9, 78.4, 49.6, 43.1, 35.7, 31.7, 26.0, 25.9, 25.7, 25.4, 24.6, 
14.0, 13.9; IR (film) 1742 cm–1. MS (ESI+) 606.2395 (606.2385 calcd for C33H38BBrO4, 
M + NH4+). 
 
 
(1R,2S,2’R,3’S)-2-phenylcyclohexyl-2’-benzyl-5’-butyl-3’-styryl-3’-methyl-4’,6’-
dioxa-5’-borolane-4’-carboxylate (4-13). General procedure 1 was employed to 
transform (–)-(1R,2S)-2-phenylcyclohexyl-2’- (benzyloxy)acetate (50 mg, 0.154 mmol) 
to form boronate ester 4-13 using dibutylboron triflate solution (0.49 mL) and 
benzylideneacetone (33.8 mg, 0.231 mmol). This procedure afforded 45.7 mg (55%) of 
the title compound as a yellow oil. The diastereoselectivity of the transformation could 
not be determined through 1H NMR analysis of the crude reaction mixture prior to 
purification due to signal overlap with boron-containing byproducts; the isolated product 
was obtained with >20:1 dr following purification.1H NMR (700 MHz, CDCl3) δ 7.45–7.33 
(m, 4 H), 7.34–7.25 (m, 4 H), 7.28–7.14 (m, 7 H), 6.58 (d, J = 15.9 Hz, 1 H), 5.85 (d, J = 
15.9 Hz, 1 H), 4.92 (td, J = 10.9, 4.3 Hz, 1 H), 2.91 (d, J = 14.4 Hz, 1 H), 2.79–2.75 (m, 
2 H), 1.96–1.92 (m, 2 H), 1.76 (d, J = 12.3 Hz, 2 H), 1.62–1.26 (m, 6 H), 1.00–0.94 (m, 1 
H), 0.96–0.85 (m, 6 H), 0.51 (s, 3 H); 13C NMR (126 MHz, CDCl3) δ 169.5, 143.5, 136.6, 
135.8, 130.2, 129.0, 128.9, 128.8, 128.6, 127.9, 127.8, 127.6, 127.1, 126.7, 126.6, 89.6, 
85.4, 78.9, 49.8, 42.1, 34.6, 31.8, 29.7, 26.0, 25.7, 25.4, 24.6, 23.7, 13.9; IR (film) 1750 
cm–1. MS (ESI) 554.3443 (554.3436 calcd for C35H41BO4, M + H+). 
 
 
(1R,2S,2’R,3’S)-2-phenylcyclohexyl-2’-benzyl-5’-butyl-3’-phenethyl-3’-methyl-4’,6’-
dioxa-5’-borolane-4’-carboxylate (4-14). General procedure 1 was employed to 
transform (–)-(1R,2S)-2-phenylcyclohexyl-2’-(benzyloxy)acetate (50 mg, 0.154 mmol) to 
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form boronate ester 4-14 using dibutylboron triflate solution (0.49 mL) and 
benzylacetone (35 µL, 0.231 mmol). This procedure afforded 43.9 mg (53%) of the title 
compound as a colorless oil. The diastereoselectivity of the transformation could not be 
determined through 1H NMR analysis of the crude reaction mixture prior to purification 
due to signal overlap with boron-containing byproducts; the isolated product was 
obtained with 4:1 dr following purification. 1H NMR (700 MHz, CDCl3) δ 7.34–7.13 (m, 
14 H), 7.14 – 6.95 (m, 1 H), 4.87 (td, J = 10.9, 4.3 Hz, 1 H), 2.98 (d, J = 14.0 Hz, 1 H), 
2.93–2.86 (m, 1 H), 2.70–2.59 (m, 2 H), 2.41 (td, J = 13.0, 5.4 Hz, 1 H), 1.93–1.79 (m, 4 
H), 1.79 (dt, J = 12.3, 3.8 Hz, 1 H), 1.63–1.38 (m, 10 H), 1.06–0.97 (m, 1 H), 0.97–0.81 
(m, 3 H), 0.36 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ 169.5, 143.6, 142.3, 135.8, 130.3, 
128.7, 128.5, 128.4, 128.0, 127.6, 126.8, 126.7, 126.0, 89.9, 84.7, 78.6, 49.7, 39.7, 
37.4, 34.7, 31.8, 30.0, 29.7, 26.0, 25.7, 25.4, 24.6, 20.9, 13.9; IR (film) 1751 cm–1. MS 
(ESI) 556.3604 (556.3593 calcd for C35H43BO4, M + NH4+). 
 
 
(1R,2S,2’R,3’S)-2-phenylcyclohexyl-2’-benzyl-5’-butyl-3’-propyl-3’-methyl-4’,6’-
dioxa-5’-borolane-4’-carboxylate (4-15). General procedure 1 was employed to 
transform (–)-(1R,2S)-2-phenylcyclohexyl-2’-(benzyloxy)acetate (50 mg, 0.154 mmol) to 
form boronate ester 4-15 using dibutylboron triflate solution (0.49 mL) and 2-pentanone 
(25 µL, 0.231 mmol). This procedure afforded 35 mg (48%) of the title compound as a 
white solid m.p. 54–60 ºC. The diastereoselectivity of the transformation could not be 
determined through 1H NMR analysis of the crude reaction mixture prior to purification 
due to signal overlap with boron-containing byproducts; the isolated product was 
obtained with 3:1 dr following purification. 1H NMR (700 MHz, CDCl3) δ 7.30–7.11 (m, 
10 H), 4.78 (dt, J = 30.0, 10.8 Hz, 1 H), 3.00 (d, J = 20.6 Hz, 1 H), 2.86 (d, J = 14.0 Hz, 
1 H), 2.73–2.64 (m, 1 H), 1.99–1.83 (m, 2 H), 1.76–1.69 (m, 2 H), 1.57–1.17 (m, 13 H), 
1.40–1.07 (m, 1 H), 0.98–0.80 (m, 6 H), 0.27 (s, 3 H); 13C NMR (175 MHz, CDCl3) δ 
169.5, 143.5, 135.9, 130.3, 128.6, 128.0, 127.5, 126.8, 126.7, 89.8, 85.0, 78.7, 49.7, 
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39.7, 37.4, 34.5, 31.8, 26.0, 25.7, 25.7, 25.4, 24.6, 21.1, 16.9, 14.5, 13.9; IR (film) 1752 
cm–1. MS (ESI+) 494.3447 (494.3436 calcd for C30H41BO4, M + NH4+). 
 
 
(1R,2S,2’R)-2-phenylcyclohexyl-2’-benzyl-5’-butyl-3’,3’-dimethyl-4’,6’-dioxa-5’-
borolane-4’-carboxylate (4-16). General procedure 1 was employed to transform (–)-
(1R,2S)-2-phenylcyclohexyl-2’-(benzyloxy)acetate (50 mg, 0.154 mmol) to form 
boronate ester 4-16 using dibutylboron triflate solution (0.49 mL) and acetone (17 µL, 
0.231 mmol). This procedure afforded 33.8 mg (49%) of the title compound as a white 
solid, mp 90–93 °C. 1H NMR (500 MHz, CDCl3) δ 7.30–7.17 (m, 10 H), 4.80 (td, J = 
10.8, 4.2 Hz, 1 H), 2.97 (d, J = 14.2 Hz, 1 H), 2.90 (d, J = 14.2 Hz, 1 H), 2.67 (dd, J = 
12.4, 10.9 Hz, 1 H), 1.95–1.82 (m, 2 H), 1.73 (d, J = 13.4 Hz, 2 H), 1.58–1.44 (m, 1 H), 
1.44–1.24 (m, 6 H), 1.11 (s, 3 H), 1.15–0.99 (m, 1 H), 1.01–0.74 (m, 5 H), 0.35 (s, 3 H); 
13C NMR (125 MHz, CDCl3) δ 169.7, 143.4, 136.0, 130.2, 128.6, 128.0, 127.6, 126.8, 
126.7, 89.1, 83.2, 78.9, 49.7, 40.1, 34.3, 31.7, 26.0, 25.7, 25.4, 24.7, 24.5, 23.4, 13.9; 
IR (film) 1738 cm–1. MS (ESI) 466.3132 (466.3123 calcd for C28H37BO4, M + NH4+). 
 
 
(1R,2S,2’R)-2-phenylcyclohexyl-4’-benzyl-5’-butyl-4’,6’-dioxa-5’-
boraspiro[4.4]nonane-4’-carboxylate (4-17). General procedure 1 was employed to 
transform (–)-(1R,2S)-2-phenylcyclohexyl-2’-(benzyloxy)acetate (50 mg, 0.154 mmol) to 
form boronate ester 4-17 using dibutylboron triflate solution (0.49 mL) and 
cyclopentanone (20.5 µL, 0.231 mmol). This procedure afforded 34 mg (46%) of the title 
compound as a white solid, mp 84–85 °C. 1H NMR (500 MHz, CDCl3) δ 7.32–7.18 (m, 
10 H), 4.81 (td, J = 10.8, 4.2 Hz, 1 H), 3.01 (d, J = 14.3 Hz, 1 H), 2.94 (d, J = 14.3 Hz, 1 
H), 2.66 (dd, J = 12.3, 10.8 Hz, 1 H), 1.94–1.83 (m, 2 H), 1.72 (d, J = 13.4 Hz, 2 H), 
1.69–1.61 (m, 2 H), 1.63–1.43 (m, 1 H), 1.54–1.28 (m, 8 H), 1.16–1.00 (m, 4 H), 1.02–
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0.80 (m, 6 H), 0.30 (dt, J = 13.0, 9.9 Hz, 1 H); 13C NMR (125 MHz, CDCl3) δ 169.8, 
143.3, 136.2, 130.2, 128.4, 128.0, 127.5, 126.7, 126.7, 126.6, 94.3, 87.2, 78.7, 49.7, 
40.7, 35.2, 34.4, 33.2, 31.6, 29.7, 26.0, 25.7, 25.3, 24.5, 21.9, 21.5, 13.9. MS (ESI+) 
492.3282 (492.3280 calcd for C30H39BO4, M + NH4+). 
 
 
(1R,2S,2’R,3’S)-2-Phenylcyclohexyl-2’-benzyl-3’-phenyl-2’,3’-dihydroxybutanoate 
(4-27). General procedure 3 was employed to transform (–)-(1R,2S)-2-
phenylcyclohexyl-2’-(benzyloxy)acetate (100 mg, 0.308 mmol) to form diol 4-27 using 
dibutylboron triflate solution (1.0 mL) and acetophenone (54 µL, 0.462 mmol). This 
procedure afforded 75 mg (48%) of the title compound as a white foam, mp 48–50 °C. 
The diastereoselectivity of the transformation could not be determined through 1H NMR 
analysis of the crude reaction mixture prior to purification due to signal overlap with 
boron-containing byproducts; the isolated product was obtained with >20:1 dr following 
purification. 1H NMR (700 MHz, CDCl3) δ 7.47 (t, J = 7.7 Hz, 2 H), 7.34 (t, J = 7.3 Hz, 1 
H), 7.32–7.23 (m, 4 H), 7.20–7.15 (m, 4 H), 7.13–7.11 (m, 2 H), 6.70–6.66 (m, 2 H), 
4.53 (td, J = 10.7, 4.0 Hz, 1 H), 3.34–3.27 (m, 2 H), 3.14 (d, J = 14.1 Hz, 1 H), 2.84 (s, 
br, 1 H), 2.71 (dd, J = 12.3, 10.7 Hz, 1 H), 1.91 (d, J = 13.8 Hz, 1 H), 1.73–1.67 (m, 1 
H), 1.61–1.50 (m, 6 H), 1.32–1.17 (m, 2 H), 0.80–0.71 (m, 1 H); 13C NMR (126 MHz, 
CDCl3) δ 173.4, 143.4, 143.1, 136.4, 130.5, 129.2, 127.9, 127.6, 127.5, 127.4, 126.9, 
126.6, 125.7, 82.3, 81.3, 77.4, 49.4, 38.4, 34.0, 30.8, 25.6, 24.4, 23.1; IR (film) 3560, 
3506, 1726 cm–1. MS (ESI) 467.2188 (467.2193 calcd for C29H32O4, M + Na+). 
 
 
(1R,2S,2’R,3’S)-2-Phenylcyclohexyl-2’-benzyl-3’-(p-methylphenyl)-2’,3’-
dihydroxybutanoate (4-27). General procedure 3 was employed to transform (–)-
(1R,2S)-2-phenylcyclohexyl-2’-(benzyloxy)acetate (75 mg, 0.231 mmol) to form diol 4-
Ph
O
O
HO
OH
Ph
Ph
O
O
HO
OH
Ph
	   117	  
27 using dibutylboron triflate solution (0.74 mL) and p-methylacetophenone (31 µL, 
0.231 mmol). This procedure afforded 43.7 mg (41%) of the title compound as a white 
foam, mp 52–56 °C. The diastereoselectivity of the transformation could not be 
determined through 1H NMR analysis of the crude reaction mixture prior to purification 
due to signal overlap with boron-containing byproducts; the isolated product was 
obtained with 17:1 dr following purification. 1H NMR (700 MHz, CDCl3) δ 7.49–7.46 (m, 
2 H), 7.37–7.26 (m, 5 H), 7.23–7.12 (m, 3 H), 6.91 (d, J = 7.9 Hz, 2 H), 6.50 (d, J = 7.9 
Hz, 2 H), 4.52 (td, J = 10.7, 3.9 Hz, 1 H), 3.34–3.26 (m, 2 H), 3.12 (d, J = 14.1 Hz, 1 H), 
2.75–2.66 (m, 2 H), 2.27 (s, 3 H), 1.91 (d, J = 13.8 Hz, 1 H), 1.71 (d, J = 12.6 Hz, 1 H), 
1.61–1.53 (m, 3 H), 1.47 (s, 3 H), 1.31–1.17 (m, 3 H), 0.75–0.72 (m, 1 H); 13C NMR 
(176 MHz, CDCl3) δ 173.5, 143.1, 140.4, 136.5, 136.4, 130.5, 129.2, 128.2, 127.9, 
127.6, 127.5, 126.6, 125.5, 82.4, 81.3, 77.3, 49.4, 38.3, 33.9, 30.8, 25.6, 24.4, 23.1, 
21.0; IR (film) 3561, 3506, 1725 cm–1. MS (ESI) 476.2794 (476.2795 calcd for C30H34O4, 
M + NH4+). 
 
 
(1R,2S,2’R,3’S)-2-Phenylcyclohexyl-2’-benzyl-3’-(p-bromophenyl)-2’,3’-
dihydroxybutanoate (4-20). General procedure 2 was employed to convert boronate 
ester 4-12 (41.5 mg, 0.077 mmol) to the title compound. This procedure afforded 12.4 
mg (34%) of the title compound  
General procedure 3 was employed to transform (–)-(1R,2S)-2-phenylcyclohexyl-2’-
(benzyloxy)acetate (50 mg, 0.154 mmol) to form diol 4-20 using dibutylboron triflate 
solution (0.49 mL) and p-bromoacetophenone (30.7 mg, 0.154 mmol). This procedure 
afforded 34.3 mg (42%) of the title compound as a white solid, mp 119–124 °C. The 
diastereoselectivity of the transformation could not be determined through 1H NMR 
analysis of the crude reaction mixture prior to purification due to signal overlap with 
boron-containing byproducts; the isolated product was obtained with >20:1 dr following 
purification. 1H NMR (700 MHz, CDCl3) δ 7.49–7.42 (m, 2 H), 7.38–7.22 (m, 1 H), 7.23–
7.14 (m, 4 H), 7.20–7.17 (m, 5 H), 6.50 (d, J = 8.2 Hz, 2 H), 4.54 (td, J = 10.7, 3.9 Hz, 1 
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H), 3.33 (s, br, 1 H), 3.26 (d, J = 14.1 Hz, 1 H), 3.12 (d, J = 14.1 Hz, 1 H), 2.81 (s, br, 1 
H), 2.71 (dd, J = 12.3, 10.7 Hz, 1 H), 1.91 (d, J = 13.8 Hz, 1 H), 1.65–1.58 (m, 1 H), 
1.58–1.48 (m, 3 H), 1.44 (s, 3 H), 1.27–1.24 (m, 2 H), 0.91–0.77 (m, 1 H); 13C NMR 
(175 MHz, CDCl3) δ 173.3, 143.1, 142.6, 136.1, 130.5, 130,4 129.3, 127.9, 127.7, 
127.6, 126.8, 121.2, 82.0, 81.6, 76.8, 49.4, 38.4, 34.0, 31.0, 25.5, 24.4, 23.2; IR (film) 
3555, 3501, 1726 cm–1. MS (ESI) 540.1742 (540.1744 calcd for C29H31BrO4, M + NH4+). 
 
 
 
(1R,2S,2’R,3’S)-2-Phenylcyclohexyl-2’-benzyl-3’-methyl-5’-phenyl-2’,3’-
dihydroxypent-4’-enoate (4-21). General procedure 2 was employed to convert 
boronate ester 4-13 (41.2 mg, 0.077 mmol) to the title compound. This procedure 
afforded 25.4 mg (70%) of the title compound  
General procedure 3 was employed to transform (–)-(1R,2S)-2-phenylcyclohexyl-2’-
(benzyloxy)acetate (75 mg, 0.231 mmol) to form diol 4-21 using dibutylboron triflate 
solution (0.75 mL) and benzylideneacetone (50.8 mg, 0.347 mmol). This procedure 
afforded 62.9 mg (58%) of the title compound as a white foam, mp 46–50 °C. The 
diastereoselectivity of the transformation could not be determined through 1H NMR 
analysis of the crude reaction mixture prior to purification due to signal overlap with 
boron-containing byproducts; the isolated product was obtained with >20:1 dr following 
purification. 1H NMR (700 MHz, CDCl3) δ 7.35 (t, J = 7.6 Hz, 2 H), 7.34–7.15 (m, 13 H), 
6.28 (d, J = 16.0 Hz, 1 H), 5.96 (d, J= 16.0 Hz, 1 H), 4.97 (td, J = 10.8, 4.2 Hz, 1 H), 
3.54 (s, br, 1 H), 3.10 (d, J = 14.1 Hz, 1 H), 3.05 (d, J = 14.1 Hz, 1 H), 2.80 (dd, J = 
12.3, 10.9 Hz, 1 H), 2.34 (s, br, 1H), 1.94 (d, J = 14.0 Hz, 1 H), 1.90–1.85 (m, 1 H), 
1.81–1.71 (m, 2 H), 1.52–1.36 (m, 4H), 0.88–0.80 (m, 3 H); 13C NMR (176 MHz, CDCl3) 
δ 171.1, 142.9, 137.3, 136.2, 131.8, 130.5, 129.2, 128.5, 128.4, 127.8, 127.3, 127.3, 
127.2, 126.7, 126.6, 81.5, 80.1, 75.8, 49.8, 38.3, 35.1, 31.9, 31.8, 29.7, 25.6, 24.6, 22.8, 
14.1; IR (film) 3549, 1715 cm–1. MS (ESI+) 488.2791 (488.2795 calcd for C31H34O4, M + 
NH4+). 
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(1R,2S,2’R,3’S)-2-Phenylcyclohexyl-2’-benzyl-3’-methyl-5’-phenyl-2’,3’-
dihydroxypentanoate (4-22). General procedure 2 was employed to convert boronate 
ester 4-14 (36.9 mg, 0.069 mmol) to the title compound. This procedure afforded 23.4 
mg (72%) of the title compound  
General procedure 3 was employed to transform (–)-(1R,2S)-2-phenylcyclohexyl-2’-
(benzyloxy)acetate (50 mg, 0.154 mmol) to form diol 4-22 using dibutylboron triflate 
solution (0.49 mL) and benzylacetone (35 µL, 0.231 mmol). This procedure afforded 
35.8 mg (43%) of the title compound as a white solid, mp 99–104 °C. The 
diastereoselectivity of the transformation could not be determined through 1H NMR 
analysis of the crude reaction mixture prior to purification due to signal overlap with 
boron-containing byproducts; the isolated product was obtained with >20:1 dr following 
purification. 1H NMR (700 MHz, CDCl3) δ 7.34–7.13 (m, 15 H), 4.99 (td, J = 10.8, 4.2 
Hz, 1 H), 3.45 (s, br, 1 H), 3.16 (d, J = 13.7 Hz, 1 H), 3.05 (d, J = 13.7 Hz, 1 H), 2.39 
(dd, J = 9.7, 7.6 Hz, 2 H), 1.93–1.87 (m, 2 H), 1.81–1.74 (m, 3 H), 1.71–1.66 (m, 1 H), 
1.46–1.27 (m, 5 H), 1.18–1.09 (m, 1 H), 0.83 (s, 3 H); 13C NMR (176 MHz, CDCl3) δ 
174.4, 142.9, 142.6, 136.3, 130.6, 129.2, 128.3, 128.2, 127.8, 127.2, 127.1, 126.6, 
125.6, 82.3, 80.0, 75.3, 49.8, 37.9, 37.6, 35.0, 32.0, 29.4, 25.6, 24.6, 19.4; IR (film) 
3561, 3502, 1715 cm–1. MS (ESI) 495.2904 (495.2506 calcd for C31H36O4, M + Na+). 
 
 
(1R,2S,2’R,3’S)-2-Phenylcyclohexyl-2’-benzyl-3’-methyl-2’,3’-dihydroxyhexanoate 
(4-23). General procedure 2 was employed to convert 4-15 (31.0 mg, 0.065 mmol) to 
the title compound. This procedure afforded 16.8 mg (63%) of the title compound. 
General procedure 3 was employed to transform (–)-(1R,2S)-2-phenylcyclohexyl-2’-
(benzyloxy)acetate (64.8 mg, 0.2 mmol) to form diol 4-22 using dibutylboron triflate 
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solution (0.64 mL) and 2-pentanone (21 µL, 0.2 mmol). This procedure afforded 43.0 
mg (52%) of the title compound as a white solid, mp 125–128 °C. The 
diastereoselectivity of the transformation could not be determined through 1H NMR 
analysis of the crude reaction mixture prior to purification due to signal overlap with 
boron-containing byproducts; the isolated product was obtained with 4:1 dr following 
purification. 1H NMR (400 MHz, CDCl3) δ 7.36–7.24 (m, 2 H), 7.28–7.12 (m, 8 H), 5.05–
4.87 (m, 1 H), 3.37 (s, br, 1 H), 3.16 (d, J = 13.8 Hz, 1 H), 3.11–2.95 (m, 1 H), 2.83–2.71 
(m, 1 H), 1.98–1.87 (m, 1 H), 1.89–1.70 (m, 3 H), 1.56 (d, J = 6.8 Hz, 1 H), 1.55–1.14 
(m, 5 H), 1.10–0.89 (m, 2 H), 0.79–0.64 (m, 6 H); 13C NMR (176 MHz, CDCl3) δ 174.7, 
143.0, 136.5, 130.6, 129.1, 127.8, 127.7, 127.2, 127.1, 126.6, 82.4, 80.2, 75.4, 49.8, 
38.7, 37.6, 34.9, 32.0, 25.6, 24.6, 19.2, 16.3, 14.5; IR (film) 3552, 1713, 1259 cm–1. MS 
(ESI+) 433.2347 (433.2349 calcd for C26H34O4, M + H+). 
 
 
(1R,2S,2’R)-2-Phenylcyclohexyl-2’-benzyl-3’-methyl-2’,3’-dihydroxybutanoate (4-
23). General procedure 2 was employed to convert 4-16 (28 mg, 0.062 mmol) to the title 
compound. This procedure afforded 19.6 mg (82%) of the title compound  
General procedure 3 was employed to transform (–)-(1R,2S)-2-phenylcyclohexyl-2’-
(benzyloxy)acetate (50 mg, 0.154 mmol) to form diol 4-24 using dibutylboron triflate 
solution (0.49 mL) and acetone (11 µL, 0.154 mmol). This procedure afforded 35.3 mg 
(60%) of the title compound as a white solid, mp 116–121 °C. 1H NMR (700 MHz, 
CDCl3) δ 7.32 (t, J = 7.6 Hz, 2 H), 7.19–7.26 (m, 8 H), 5.01 (dt, J = 4.2, 10.5 Hz, 1 H), 
3.36 (s, 1 H), 3.15 (d, J = 13.7 Hz, 1 H), 2.99 (d, J = 13.9 Hz, 1 H), 2.78 (dt, J = 3.6, 
11.3 Hz, 1 H), 1.95 (d, J = 13.7 Hz, 1 H), 1.75–1.88 (m, 4 H), 1.26–1.51 (m, 4 H), 0.83 
(s, 3 H), 0.60 (s, 3 H); 13C NMR (126 MHz, CDCl3) δ 174.6, 142.9, 136.4, 130.6, 129.2, 
127.8, 127.3, 126.6, 81.8, 79.9, 73.3, 49.9, 37.8, 34.9, 32.1, 25.6, 24.7, 24.2, 23.6; IR 
(film) 3549, 3406, 1724 cm–1. MS (ESI) 405.2030 (405.2036 calcd for C24H30O4, M + 
Na+). 
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(1R,2S,2’R)-2-Phenylcyclohexyl-2’-benzyl-3’-cyclohexyl-2’,3’-dihydroxypropanoate 
(4-25). General procedure 3 was employed to transform (–)-(1R,2S)-2-
phenylcyclohexyl-2’-(benzyloxy)acetate (75 mg, 0.231 mmol) to form diol 4-25 using 
dibutylboron triflate solution (0.74 mL) and cyclohexanone (24 µL, 0.231 mmol). This 
procedure afforded 23.7 mg (24%) of the title compound as a white solid, mp 159–160 
°C. 1H NMR (700 MHz, CDCl3) δ 7.33 (t, J = 7.6 Hz, 2 H), 7.29–7.15 (m, 8 H), 4.94 
(td, J = 10.9, 3.9 Hz, 1 H), 3.37 (s, br, 1 H), 3.17 (d, J = 13.9 Hz, 1 H), 2.96 (d, J = 13.8 
Hz, 1 H), 2.80–2.73 (m, 1 H), 1.93 (d, J = 14.2 Hz, 1 H), 1.81–1.71 (m, 3 H), 1.54 (d, J = 
9.9 Hz, 1 H), 1.50–1.41 (m, 2 H), 1.41–1.31 (m, 4 H), 1.32–1.22 (m, 3 H), 1.11 (d, J = 
13.2 Hz, 1 H), 0.96 (q, J = 13.3 Hz, 1 H), 0.86–0.82 (m, 1 H), 0.25–0.20 (m, 1 H); 13C 
NMR (126 MHz, CDCl3) δ 174.8, 142.9, 136.6, 130.6, 129.2, 127.8, 127.4, 127.1, 126.5, 
82.3, 80.0, 74.2, 49.8, 37.0, 35.0, 32.0, 31.5, 29.6, 25.6, 25.3, 24.6, 21.7, 21.3; IR (film) 
3546, 3376, 1726 cm–1. MS (ESI) 445.2348 (445.2349 calcd for C27H34O4, M + Na+). 
 
 
(1R,2S,2’R)-2-Phenylcyclohexyl-2’-benzyl-3’-cyclopentyl-2’,3’-
dihydroxypropanoate (4-25). General procedure 2 was employed to boronate ester 4-
18 (34.0 mg, 0.072 mmol) to the title compound. This procedure afforded 15.6 mg 
(53%) of the title compound as a white solid, mp X–X. 1H NMR (400 MHz, CDCl3) δ 7.33 
(t, J = 7.5 Hz, 2 H), 7.24–7.19 (m, 8 H), 4.97 (td, J = 10.6, 4.4 Hz, 1 H), 3.33–3.24 (m, 2 
H), 2.88 (d, J = 14.0 Hz, 1 H), 2.78 (td, J = 11.6, 3.8 Hz, 1 H), 2.04–1.26 (m, 12 H), 
0.91–0.79 (m, 4 H); 13C NMR (126 MHz, CDCl3) δ 174.8, 142.9, 136.4, 130.5, 129.3, 
127.8, 127.3, 127.2, 126.6, 84.6, 80.2, 79.9, 49.8, 39.1, 34.8, 33.5, 32.1, 25.6, 24.7, 
23.6, 23.5; IR (film) 3538, 1728, 1186 cm–1. MS (ESI+) 421.2193 (421.2193 calcd for 
C26H32O4, M + Na+). 
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(1R,2S,2’R,3’S)-2-Phenylcyclohexyl-2’-benzyl-3’-(m-fluorophenyl)-2’,3’-
dihydroxybutanoate (4-29). General procedure 3 was employed to transform (–)-
(1R,2S)-2-phenylcyclohexyl-2’-(benzyloxy)acetate (75 mg, 0.230 mmol) to form diol 4-
29 using dibutylboron triflate solution (0.74 mL) and m-fluoroacetophenone (28 µL, 
0.154 mmol). This procedure afforded 21.5 mg (20%) of the title compound as a white 
foam, mp 46–51 °C. The diastereoselectivity of the transformation could not be 
determined through 1H NMR analysis of the crude reaction mixture prior to purification 
due to signal overlap with boron-containing byproducts; the isolated product was 
obtained with 15:1 dr following purification. 1H NMR (700 MHz, CDCl3) 7.44 (t, J = 7.7 
Hz, 2 H), 7.36–7.28 (m, 1 H), 7.29–7.13 (m, 7 H), 7.14–7.01 (m, 1 H), 6.85 (t, J = 8.39 
Hz, 1 H), 6.66–6.58 (m, 1 H), 6.44 (d, J = 7.8 Hz, 1 H), 4.54 (td, J = 10.8, 4.0 Hz, 1 H), 
3.30 (s, br, 1 H), 3.25 (d, J = 14.1 Hz, 1 H), 3.11 (d, J = 14.1 Hz, 1 H), 2.79 (s, br, 1 H), 
2.69 (dd, J = 12.3, 10.7 Hz, 1 H), 1.90 (dt, J = 13.4, 3.0 Hz, 1 H), 1.72–1.54 (m, 3 H), 
1.57–1.48 (m, 1 H), 1.44 (d, J = 0.9 Hz, 3 H), 1.33–1.17 (m, 2 H), 0.83–0.72 (m, 1 H); 
13C NMR (125 MHz, CDCl3) δ 173.2, 162.1 (d, J = 244 Hz), 146.4 (d, J = 6.8 Hz), 142.8, 
136.1, 130.4, 129.4, 128.9, 128.8, 127.9, 127.5 (d, J = 6.8 Hz), 126.7, 121.3 (d, J = 2.7 
Hz), 113.8 (d, J = 21.1 Hz), 113.3 (d, J = 22.4 Hz), 82.1, 81.4, 49.5, 38.5, 34.0, 30.9, 
25.5, 24.4, 23.2 (one signal absent due to incidental equivalence); IR (film) 3555, 3454, 
1726 cm–1. MS (ESI) 480.2545 (480.2545 calcd for C29H31FO4, M + NH4+). 
 
 
(1R,2S,2’R,3’S)-2-Phenylcyclohexyl-2’-allyl-3’-(p-bromophenyl)-2’,3’-
dihydroxybutanoate (4-30). General procedure 3 was employed to transform (–)-
(1R,2S)-2-phenylcyclohexyl-2’-(allyloxy)acetate (75 mg, 0.231 mmol) to form diol 4-30 
using dibutylboron triflate solution (0.74 mL) and p-bromoacetophenone (54.4 mg, 0.231 
mmol). This procedure afforded 19.7 mg (15%) of the title compound as a white solid, 
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mp 129–134 °C. The diastereoselectivity of the transformation could not be determined 
through 1H NMR analysis of the crude reaction mixture prior to purification due to signal 
overlap with boron-containing byproducts; the isolated product was obtained with 10:1 
dr following purification. 1H NMR (700 MHz, CDCl3) δ 7.40 (t, J = 7.6 Hz, 2 H), 7.35–
7.29 (m, 1 H), 7.31–7.22 (m, 3 H), 7.21–7.14 (m, 1 H), 6.72 (d, J = 8.2 Hz, 2 H), 5.21–
5.16 (m, 1 H), 5.08–5.00 (m, 1 H), 4.93–4.88 (m, 1 H), 4.77 (td, J = 10.9, 4.3 Hz, 1 H), 
3.20 (s, br, 1 H), 3.09 (s, br, 1 H), 2.72–2.65 (m, 2 H), 2.46–2.39 (m, 1 H), 2.01–1.89 (m, 
1 H), 1.92–1.84 (m, 1 H), 1.82–1.71 (m, 2 H), 1.59–1.48 (m, 1 H), 1.37 (s, 3 H), 1.41–
1.23 (m, 2 H), 1.12–1.05 (m, 1 H); 13C NMR (175 MHz, CDCl3) δ 173.7, 142.9, 131.5, 
130.5, 129.1, 127.9, 127.5, 127.3, 121.1, 119.7, 80.9, 80.2, 76.7, 49.4, 38.0, 34.2, 31.7, 
25.5, 24.5, 23.1; IR (film) 3546, 3387, 1724 cm–1. MS (ESI) 495.1133 (495.1141 calcd 
for C25H29BrO4, M + Na+). 
 
 
(1R,2S,2’R)-2-Phenylcyclohexyl-2’-allyl-3’-cyclohexyl-2’,3’-dihydroxybutanoate (4-
31). General procedure 3 was employed to transform (–)-(1R,2S)-2-phenylcyclohexyl-2’-
(allyloxy)acetate (82 mg, 0.299 mmol) to form diol 4-31 using dibutylboron triflate 
solution (0.96 mL) and cyclohexanone (31 µL, 0.299 mmol). This procedure afforded 
17.7 mg (16%) of the title compound as a white solid, mp 128–130 °C. 1H NMR (500 
MHz, CDCl3) δ 7.32 (t, J = 7.6 Hz, 2 H), 7.30–7.13 (m, 3 H), 5.62–5.56 (m, 1 H), 5.15–
5.00 (m, 3 H), 3.32 (s, br, 1 H), 2.74 (dd, J = 12.3, 10.9 Hz, 1 H), 2.61 (dd, J = 13.9, 8.2 
Hz, 1 H), 2.39 (dd, J = 14.0, 6.1 Hz, 1 H), 2.18 (d, J = 12.4 Hz, 1 H), 2.00–1.90 (m, 1 H), 
1.87 (d, J = 11.8 Hz, 1 H), 1.83–1.74 (m, 1 H), 1.57–1.29 (m, 6 H), 1.30–0.97 (m, 3 H), 
0.92–0.72 (m, 2 H), 0.35 (d, J = 13.2 Hz, 1 H); 13C NMR (125 MHz, CDCl3) δ 175.0, 
142.9, 132.6, 129.1, 127.2, 127.1, 119.0, 81.5, 79.2, 73.9, 49.8, 36.2, 34.8, 32.2, 31.3, 
29.8, 25.6, 25.2, 24.6, 21.6, 21.2; IR (film) 3557, 3498, 1726 cm–1. MS (ESI) 395.2198 
(395.2193 calcd for C23H32O4, M + Na+). 
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